OBO_ID (LABEL):	UBERON_0002048 (lung)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1592148	7/2006	S62-PMC1592148	['acog, american college of obstetricians and gynecologists; aap, american academy of pediatrics; hp2010, healthy people 2010; fda, Food and Drug administration; epa, environmental protection agency; cdc, centers for disease control and prevention; iom, institute of medicine; nhlbi, national Heart, Lungs, and Blood institute; icsi, institute for clinical systems improvement; acs, american cancer society; ada, american diabetes association.']	N/A	N/A	[('CHEBI_33290', 'food', 130, 'Food'), ('CHEBI_23888', 'drug', 139, 'Drug'), ('UBERON_0000948', 'heart', 291, 'Heart'), ('UBERON_0002048', 'lung', 298, 'Lungs'), ('UBERON_0000178', 'blood', 309, 'Blood')]
PMC184457	8/2003	S48-PMC184457	['to promote fetal Lung maturity, betamethasone (12 mg × 2 doses) was administered via intramuscular injection.']	N/A	N/A	[('UBERON_0002048', 'lung', 17, 'lung')]
PMC1852384	1/2007	S52-PMC1852384	['complications were classified as systemic (prolonged intubation, deep Venous Thrombosis, Pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, Gi bleeding, Anastomotic stricture, and anastomotic ulcer).']	N/A	N/A	[('UBERON_0001638', 'vein', 70, 'venous'), ('GO_0007596', 'blood coagulation', 77, 'thrombosis'), ('UBERON_0002048', 'lung', 89, 'pulmonary'), ('UBERON_2001302', 'vagal ganglion 1', 240, 'GI'), ('UBERON_2000691', 'supraorbital bone', 253, 'anastomotic')]
PMC1852384	1/2007	S81-PMC1852384	['one patient, a 43-year-old woman with a bmi 59, died of a Pulmonary embolism (identified at autopsy) at home after 2\xa0weeks.']	N/A	N/A	[('UBERON_0002048', 'lung', 58, 'pulmonary')]
PMC2367680	5/2008	S124-PMC2367680	['the personal air sampling pump operated continuously at 4l/min to simulate normal Lung capacity.']	N/A	N/A	[('UBERON_0002048', 'lung', 82, 'lung')]
PMC2621211	12/2008	S5-PMC2621211	['results\nGenomic dna from whole Lung was isolated and subjected to msdk analysis using the methylation-sensitive enzyme not i as the mapping enzyme and nla iii as the fragmenting enzyme.']	N/A	N/A	[('SO_0001026', 'genome', 8, 'Genomic'), ('UBERON_0002048', 'lung', 31, 'lung')]
PMC2621211	12/2008	S38-PMC2621211	['for the generation of the Mouse msdk libraries we chose Lung Tissue from c57bl/6j Adult Mice that were Prenatally exposed to diets with increased (high methylation diet; hmd) or decreased (low methylation diet; lmd) methyl-donor content and challenged with Allergen in Adulthood [9].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 26, 'mouse'), ('UBERON_0002048', 'lung', 56, 'lung'), ('UBERON_0000479', 'tissue', 61, 'tissue'), ('UBERON_0007023', 'adult organism', 82, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'mice'), ('GO_0019230', 'proprioception', 103, 'prenatally'), ('CHEBI_50904', 'allergen', 257, 'allergen'), ('UBERON_0000113', 'post-juvenile adult stage', 269, 'adulthood')]
PMC2621211	12/2008	S39-PMC2621211	['the Mice Gestated on both diets developed features characteristic of an allergic phenotype including Airway hyper-reactivity, Lung lavage Eosinophilia, and increase Serum Ige concentrations [9].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'mice'), ('GO_0007565', 'female pregnancy', 9, 'gestated'), ('UBERON_0001005', 'respiratory airway', 101, 'airway'), ('UBERON_0002048', 'lung', 126, 'lung'), ('CL_0000771', 'eosinophil', 138, 'eosinophilia'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE')]
PMC2621211	12/2008	S40-PMC2621211	['Genomic dna was isolated from snap frozen Lung Tissue samples from two male Mice for each group using a dneasy kit (qiagen, valencia, ca) according to manufacturer instructions.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0002048', 'lung', 42, 'lung'), ('UBERON_0000479', 'tissue', 47, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 76, 'mice')]
PMC2621211	12/2008	S103-PMC2621211	['comparison between hmd/high responders (n = 6) and lmd/low responders (n = 6) in whole Lung Tissue obtained from challenged c57/bl6 Mice.']	N/A	N/A	[('UBERON_0002048', 'lung', 87, 'lung'), ('UBERON_0000479', 'tissue', 92, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'mice')]
PMC2621211	12/2008	S109-PMC2621211	['Genomic dna and rna for msdk and sage analysis was isolated from Lung Tissue from c57bl/6j Adult Mice that were Prenatally exposed to nutritional changes as described in [9].']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0002048', 'lung', 65, 'lung'), ('UBERON_0000479', 'tissue', 70, 'tissue'), ('UBERON_0007023', 'adult organism', 91, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'mice'), ('GO_0019230', 'proprioception', 112, 'prenatally')]
PMC2621211	12/2008	S123-PMC2621211	['the top canonical pathways that are significantly associated with the differentially Expressed Genes in the Lungs of hmd or lmd Animals are represented in figure3.']	N/A	N/A	[('GO_0010467', 'gene expression', 85, 'expressed'), ('SO_0000704', 'gene', 95, 'genes'), ('UBERON_0002048', 'lung', 108, 'lungs'), ('NCBITaxon_33208', 'Metazoa', 128, 'animals')]
PMC2621211	12/2008	S162-PMC2621211	['rna isolation and real-time pcr\ntotal rna was extracted from frozen Lung Tissue using the rnagents total rna isolation system (promega, madison, wi, usa).']	N/A	N/A	[('UBERON_0002048', 'lung', 68, 'lung'), ('UBERON_0000479', 'tissue', 73, 'tissue')]
PMC2621211	12/2008	S175-PMC2621211	["methylation specific pcr\nsodium Bisulfite modification of 500 ng Genomic Mouse Lung dna was performed using the ez Dna Methylation-gold kit (zymo research, orange, ca) according to manufacture's instructions."]	N/A	N/A	[('CHEBI_29874', 'bromine dioxide', 32, 'bisulfite'), ('SO_0001026', 'genome', 65, 'genomic'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'mouse'), ('UBERON_0002048', 'lung', 79, 'lung'), ('GO_0006306', 'DNA methylation', 115, 'DNA Methylation')]
PMC2776230	10/2009	S123-PMC2776230	['at any rate, neither the active group nor placebo had any improvement in Lung function.']	N/A	N/A	[('UBERON_0002048', 'lung', 73, 'lung')]
PMC2831604	1/2010	S54-PMC2831604	['in the subset of these who experienced progressive reductions in Lung growth compared to predicted measures, this was not prevented by inhaled Steroids.18\nobservational prospective data from martinez et al.']	N/A	N/A	[('UBERON_0002048', 'lung', 65, 'lung'), ('CHEBI_35341', 'steroid', 143, 'steroids')]
PMC2841444	2/2010	S607-PMC2841444	['application of continuous distending pressure to the Lung for Respiratory Distress syndrome (rds)\ncontinuous distending pressure (cdp) to the Lung includes applying positive pressure via the Nose or Trachea or negative pressure around the Chest, and is used to treat Respiratory distress syndrome (rds).']	N/A	N/A	[('UBERON_0002048', 'lung', 53, 'lung'), ('UBERON_0003495', 'respiratory system arteriole', 62, 'respiratory distress'), ('UBERON_0002048', 'lung', 142, 'lung'), ('UBERON_0000004', 'nose', 191, 'nose'), ('UBERON_0003126', 'trachea', 199, 'trachea'), ('UBERON_0001443', 'chest', 239, 'chest'), ('UBERON_0001004', 'respiratory system', 267, 'respiratory')]
PMC2841444	2/2010	S608-PMC2841444	['in the absence of Surfactant replacement therapy, cdp to the Lung reduces the need for intubation and mechanical ventilation (pooled rr 0.72; 95% ci 0.56-0.91) and decreases the composite outcome of death or Respiratory failure (pooled rr 0.65; 95% ci 0.52-0.81) [316].']	N/A	N/A	[('CHEBI_35195', 'surfactant', 18, 'surfactant'), ('UBERON_0002048', 'lung', 61, 'lung'), ('UBERON_0001004', 'respiratory system', 208, 'respiratory')]
PMC2841444	2/2010	S611-PMC2841444	['nasal cpap refers to the application of cdp to the Lungs via prongs placed in the Nose and is a valid alternative to routine intubation and mechanical ventilation in treating rds [318-324].']	N/A	N/A	[('UBERON_0002048', 'lung', 51, 'lungs'), ('UBERON_0000004', 'nose', 82, 'nose')]
PMC2872320	3/2010	S80-PMC2872320	['Minerogenic\nMinerogenic dust particles small enough to escape the filtering mechanisms of the Paranasal Sinuses enter the Lungs, eventually being deposited in the Pulmonary Alveoli.']	N/A	N/A	[('CHEBI_6954', 'Mitotane', 0, 'Minerogenic'), ('CHEBI_6954', 'Mitotane', 12, 'Minerogenic'), ('UBERON_0006683', 'posterior fontanelle', 94, 'paranasal sinuses'), ('UBERON_0002048', 'lung', 122, 'lungs'), ('UBERON_0002299', 'alveolus of lung', 163, 'pulmonary alveoli')]
PMC2872320	3/2010	S122-PMC2872320	['begin to multiply rapidly within the Lungs of infected Humans.']	N/A	N/A	[('UBERON_0002048', 'lung', 37, 'lungs'), ('NCBITaxon_9606', 'Homo sapiens', 55, 'humans')]
PMC2872320	3/2010	S132-PMC2872320	['the oldest form of airborne anthropogenic particulate materials is dark carbon from coal, wood and/or Dung fires.']	N/A	N/A	[('UBERON_0002048', 'lung', 102, 'dung')]
PMC2872320	3/2010	S214-PMC2872320	['the surfaces of the healthy Human body, both external (skin) and internal (Sinuses and Lungs, the Alimentary Canal), are populated with a plethora of species of microorganisms.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 28, 'human'), ('UBERON_0000093', 'sulcus', 75, 'sinuses'), ('UBERON_0002048', 'lung', 87, 'lungs'), ('UBERON_0006672', 'incisive canal', 98, 'alimentary canal')]
PMC3095978	4/2011	S26-PMC3095978	['the national Cholesterol education programme (ncep) expert panel on detection, evaluation, and treatment of high Blood Cholesterol in Adults (Adult treatment panel, or atp, iii) [3], the national Heart, Lung and Blood institute, and the american Heart association [4] have released a report on the criteria for diagnosing and managing ms.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 13, 'Cholesterol'), ('UBERON_0000178', 'blood', 113, 'blood'), ('CHEBI_16113', 'cholesterol', 119, 'cholesterol'), ('UBERON_0007023', 'adult organism', 134, 'adults'), ('UBERON_0007023', 'adult organism', 142, 'adult'), ('UBERON_0000948', 'heart', 196, 'Heart'), ('UBERON_0002048', 'lung', 203, 'Lung'), ('UBERON_0000178', 'blood', 212, 'Blood'), ('UBERON_0000948', 'heart', 246, 'Heart')]
PMC3098253	5/2011	S41-PMC3098253	['subjects with a history of Cardiovascular, Pulmonary, Kidney, or malignant disease as well as those currently taking Medications were excluded from the study.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 27, 'cardiovascular'), ('UBERON_0002048', 'lung', 43, 'pulmonary'), ('UBERON_0002113', 'kidney', 54, 'kidney'), ('CHEBI_25441', 'mycothiols', 117, 'medications')]
PMC3104979	5/2011	S109-PMC3104979	['medical risk factors include acute or chronic Lung disease; anemia (hemoglobin <10 gm/dl or hematocrit <30%); Cardiac disease; diabetes; eclampsia; Genital herpes; hemoglobinopathy; hydramnios/oligohydramnios; chronic hypertension; Pregnancy-induced hypertension, incompetent Cervix; previous infant >4,000 g; previous preterm, sga, or low Birth weight Delivery; Renal disease; rh sensitization; rubella; syphilis; and Uterine bleeding.']	N/A	N/A	[('UBERON_0002048', 'lung', 46, 'lung'), ('UBERON_0000948', 'heart', 110, 'cardiac'), ('UBERON_3011048', 'genital system', 148, 'genital'), ('GO_0007565', 'female pregnancy', 232, 'pregnancy'), ('UBERON_0000029', 'lymph node', 276, 'cervix'), ('GO_0007567', 'parturition', 340, 'birth'), ('GO_0007567', 'parturition', 353, 'delivery'), ('UBERON_0002113', 'kidney', 363, 'renal'), ('UBERON_0000995', 'uterus', 419, 'uterine')]
PMC3127778	5/2011	S182-PMC3127778	['Inflammatory Cells in Airway, Lung, and Cardiac Tissues\nthe work of rambaud et al.']	N/A	N/A	[('CL_0000635', "Deiter's cell", 0, 'Inflammatory cells'), ('UBERON_0001005', 'respiratory airway', 22, 'airway'), ('UBERON_0002048', 'lung', 30, 'lung'), ('UBERON_0000948', 'heart', 40, 'cardiac'), ('UBERON_0000479', 'tissue', 48, 'tissues')]
PMC3156327	4/2011	S119-PMC3156327	['a high Folate diet in Pregnant Mice resulted in altered Gene methylation patterns and decreased transcriptional activity in the Lung Tissue of the progeny with increased Airways hyper reactivity, Airway Eosinophilia and Production Of Inflammatory Chemokines (hollingsworth et al.2008).']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 7, 'folate'), ('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 31, 'mice'), ('GO_0010258', 'NADH dehydrogenase complex (plastoquinone) assembly', 56, 'gene'), ('SO_0000704', 'gene', 56, 'gene'), ('UBERON_0002048', 'lung', 128, 'lung'), ('UBERON_0000479', 'tissue', 133, 'tissue'), ('UBERON_0001005', 'respiratory airway', 170, 'airways'), ('UBERON_0001005', 'respiratory airway', 196, 'airway'), ('CL_0000771', 'eosinophil', 203, 'eosinophilia'), ('GO_0009951', 'polarity specification of dorsal/ventral axis', 220, 'production of inflammatory chemokines')]
PMC3240629	12/2011	S52-PMC3240629	['Liver, Left and right Kidneys, Heart, Lungs and Brain were dissected, weighed, and snap frozen in liquid nitrogen prior to storage at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0003907', 'left atrioventricular canal', 7, 'left ... kidneys'), ('UBERON_0000948', 'heart', 31, 'heart'), ('UBERON_0002048', 'lung', 38, 'lungs'), ('UBERON_0000955', 'brain', 48, 'brain')]
PMC3240629	12/2011	S92-PMC3240629	['Organ allometry\negg-lpd males had a reduced Lung weight ratio (when expressed as percentage of body weight) compared to egg-npd males (p<0.001) and an increased Carcass weight (body weight minus combined weight of Organs and Fat Pads; p\u200a=\u200a0.04) (table s1a–d).']	N/A	N/A	[('UBERON_0000033', 'head', 0, 'Organ'), ('UBERON_0002048', 'lung', 44, 'lung'), ('UBERON_0008979', 'carcass', 161, 'carcass'), ('UBERON_0000062', 'organ', 214, 'organs'), ('UBERON_0003916', 'fat pad', 225, 'fat pads')]
PMC3241136	9/2010	S5-PMC3241136	['chemical etiology of cancer\nmany chemical Compounds are known to cause cancer in Humans, smoking and Lung cancer (e.g., loeb et al.,1984; iarc,1986), and aflatoxin and Liver cancer (e.g., wogan,1992; wild and montesano,2009) as prime examples.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 42, 'compounds'), ('NCBITaxon_9606', 'Homo sapiens', 81, 'humans'), ('UBERON_0002048', 'lung', 101, 'lung'), ('UBERON_0002107', 'liver', 168, 'liver')]
PMC3241136	9/2010	S46-PMC3241136	['in Lung cancer patients, aberrant methylation patterns can be detected in Serum dna at all stages of tumor development (e.g., esteller et al.,1999, reviewed by pfeifer and rauch,2009).']	N/A	N/A	[('UBERON_0002048', 'lung', 3, 'lung'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC3248362	11/2011	S37-PMC3248362	['adverse conditions were defined as convulsions (eclampsia), diastolic pressure > 110 mm hg, Platelet count < 100,000 × 109/l, oliguria, protein Excretion ≥ 3 g/day, Pulmonary edema, elevated Liver enzymes, severe nausea and vomiting, frontal headache, Visual disturbances, persistent Abdominal pain in right upper quadrant, Chest pain or shortness of Breath, suspected abruptio Placentae, hellp syndrome, Intrauterine growth restriction, oligohydramnios, or absent or reverse Umbilical Artery end diastolic flow, as detected by doppler velocitometry.']	N/A	N/A	[('CL_0000233', 'platelet', 92, 'platelet'), ('GO_0007588', 'excretion', 144, 'excretion'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002107', 'liver', 191, 'liver'), ('GO_0007601', 'visual perception', 252, 'visual'), ('UBERON_0000916', 'abdomen', 284, 'abdominal'), ('UBERON_0001443', 'chest', 324, 'chest'), ('UBERON_0000310', 'breast', 351, 'breath'), ('UBERON_0001987', 'placenta', 378, 'placentae'), ('UBERON_0022293', 'reproductive gland secretion', 405, 'intrauterine'), ('UBERON_0001310', 'umbilical artery', 476, 'umbilical artery')]
PMC3262346	12/2011	S22-PMC3262346	['as part of the workup during the previous illness a Chest x-ray was obtained (figure 1), which demonstrated a cystic appearance to much of the left Lung and elevation of the left hemidiaphragm.']	N/A	N/A	[('UBERON_0001443', 'chest', 52, 'chest'), ('UBERON_0002048', 'lung', 148, 'lung')]
PMC3262346	12/2011	S39-PMC3262346	['typically, congenital Diaphragmatic hernias are detected at or near the time of Delivery and most presentations involve Respiratory distress secondary to a hypoplastic Lung.']	N/A	N/A	[('UBERON_0001103', 'diaphragm', 22, 'diaphragmatic'), ('GO_0007567', 'parturition', 80, 'delivery'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory'), ('UBERON_0002048', 'lung', 168, 'lung')]
PMC3277098	12/2011	S62-PMC3277098	['Lung structure and function\nin Mice, zosky et al.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('NCBITaxon_10088', 'Mus <genus>', 31, 'mice')]
PMC3277098	12/2011	S92-PMC3277098	['in their review on the Vitamin D axis in Lung disease chisimba et al.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0002048', 'lung', 41, 'lung')]
PMC3278486	1/2012	S77-PMC3278486	["caption (table-wrap): table 2\n\ncharacteristics of included observational studiesstudyparticipants n: Folic Acid group (nfolic), controls (nctrl); countrypopulation characteristics; case/control; sex; age years; % smokersdaily Intake of Folic Acid supplement/controltime of treatmentoutcome a. characteristics of the included case–control study freudenheim (1996)32\nnfolic: 192, Nctrl: 313; usa\npremenopausal women ≥40\u2005years diagnosed with Breast cancer/frequency-matched on basis of age and county, randomly selected from motor vehicles records; % smokers: not reportedfolic Acid ≥0.4\u2005mg/no Folic Acid supplementin-person interviews about usual diet in the period 2\u2005years before the interviewbreast cancer incidencestudytotal number of Persons with cancer/total number in the cohort, Folic Acid group (≥0.4\u2005mg) (nfolic), controls (Nctrl), countrypopulation characteristics; sex; age years; % smokersdaily Intake of Folic Acid supplement/controltime of treatment/follow-up yearsoutcomes b. characteristics of the included cohort studies \u2003stolzenberg-solomon (2006)33(plco)\n691 women with Breast cancer/25\u2008400 women; nfolic: 67\u2008143 person-years, Nctrl: 46\u2008652 person-years; usa\nwomen from the Prostate, Lung, Colorectal, and Ovarian cancer screening trial cohort; mean age: 63 (55–74); % smokers: not reportedfolic Acid ≥0.4\u2005mg/no Folic Acidcurrent or 2\u2005years ago/median 4.9\u2005yearsbreast cancer incidence\u2003maruti (2009)34(vital)\n743 women with Breast cancer/35\u2008023 women; nfolic: not reported*, Nctrl: not reported*; usa\nPostmenopausal women from the vitamins and lifestyle study; mean age: 62 (50–76); % smokers: not reportedfolic Acid ≥0.4\u2005mg/no Folic Acidmean 10\u2005years/mean 5\u2005yearsbreast cancer incidence\u2003lashner (1997)35\nfour Persons with Colorectal cancer/97 Persons; nfolic: 39, Nctrl: 58; usa\nhigh-risk patients with ulcerative colitis; both sexes; age: ∼30; % smokers: ∼7%Folic Acid: 0.4\u2005mg from multivitamin or 1\u2005mg from sole supplement/no Folic Acidat least 6\u2005months/until detection of cancer or date of last surveillance Colonoscopycolorectal cancer incidence\u2003skinner (2004)36\n326 Persons with Pancreatic cancer/125\u2008480 persons; nfolic: 219\u2008771 person-years, Nctrl: 1\u2008287\u2008823 person-years; usa\nwomen from the nurse's health study, age: 51.7±7 and men from the health professionals follow-up study, age: 54.9±10;\n% smokers: women: 22%, men: 9%folsyre ≥0.4\u2005mg/<0.3\u2005mg Folic Acid for men <0.2\u2005mg for women0 to ≥10\u2005years/14\u2005yearspancreatic cancer incidence\u2003oaks (2010)37(plco)\n266 Persons with Pancreatic cancer/109\u2008175 Persons; nfolic: not reported†; Nctrl: not reported†; usa\nmen and women from the Prostate, Lung, Colorectal, and Ovarian cancer screening trial; age: 55–74; % smokers: not specified for the supplement groupfolic Acid ≥0.4\u2005mg daily/no Folic Acidcurrent or 2\u2005years ago/median 6.5\u2005yearspancreatic cancer incidence\u2003slatore (2008)38(vital)\n521 Persons with Lung cancer/77\u2008721; nfolic: 21\u2008619, Nctrl: 24\u2008394; usa\nmen and women from vitamins and lifestyle study; cases–controls‡; % females: 43/52; age: 67±7/62±7; % smokers: 30/8folic Acid ≥0.4\u2005mg daily/no Folic Acidmean 10\u2005years/mean: 4\u2005yearslung cancer incidence\na total of 32\u2008023 women in the cohort were distributed over four quartile with respect to Intake."]	N/A	N/A	[('CHEBI_30751', 'formic acid', 101, 'folic acid'), ('GO_0007631', 'feeding behavior', 226, 'intake'), ('CHEBI_30751', 'formic acid', 236, 'folic acid'), ('PR_000011509', 'nuclear pore complex protein Nup155', 378, 'Nctrl'), ('UBERON_0000310', 'breast', 439, 'breast'), ('CHEBI_37527', 'acid', 575, 'acid'), ('CHEBI_30751', 'formic acid', 591, 'folic acid'), ('NCBITaxon_10088', 'Mus <genus>', 736, 'persons'), ('CHEBI_30751', 'formic acid', 784, 'folic acid'), ('PR_000011509', 'nuclear pore complex protein Nup155', 831, 'Nctrl'), ('GO_0007631', 'feeding behavior', 905, 'intake'), ('CHEBI_30751', 'formic acid', 915, 'folic acid'), ('UBERON_0000310', 'breast', 1087, 'breast'), ('PR_000011509', 'nuclear pore complex protein Nup155', 1144, 'Nctrl'), ('UBERON_0002367', 'prostate gland', 1191, 'Prostate'), ('UBERON_0002048', 'lung', 1201, 'Lung'), ('UBERON_0012652', 'colorectum', 1207, 'Colorectal'), ('UBERON_0000992', 'ovary', 1223, 'Ovarian'), ('CHEBI_37527', 'acid', 1313, 'acid'), ('CHEBI_50317', 'iodonium', 1329, 'folic acidCurrent'), ('UBERON_0000310', 'breast', 1440, 'breast'), ('PR_000011509', 'nuclear pore complex protein Nup155', 1491, 'Nctrl'), ('GO_0007564', 'regulation of chitin-based cuticle tanning', 1517, 'Postmenopausal'), ('CHEBI_37527', 'acid', 1628, 'acid'), ('CHEBI_36644', 'glycooctaosylceramide', 1644, 'folic acidMean'), ('NCBITaxon_10088', 'Mus <genus>', 1726, 'persons'), ('UBERON_0012652', 'colorectum', 1739, 'colorectal'), ('NCBITaxon_10088', 'Mus <genus>', 1760, 'persons'), ('PR_000011509', 'nuclear pore complex protein Nup155', 1781, 'Nctrl'), ('CHEBI_30751', 'formic acid', 1876, 'Folic acid'), ('CHEBI_48409', 'eprosartan methanesulfonate', 1945, 'folic acidAt'), ('UBERON_0010168', 'collection of eyelashes', 2028, 'colonoscopyColorectal'), ('NCBITaxon_10088', 'Mus <genus>', 2088, 'persons'), ('UBERON_0001264', 'pancreas', 2101, 'pancreatic'), ('PR_000011509', 'nuclear pore complex protein Nup155', 2166, 'Nctrl'), ('CHEBI_30751', 'formic acid', 2373, 'folic acid'), ('NCBITaxon_10088', 'Mus <genus>', 2484, 'persons'), ('UBERON_0001264', 'pancreas', 2497, 'pancreatic'), ('NCBITaxon_10088', 'Mus <genus>', 2523, 'persons'), ('PR_000011509', 'nuclear pore complex protein Nup155', 2555, 'Nctrl'), ('UBERON_0002367', 'prostate gland', 2604, 'Prostate'), ('UBERON_0002048', 'lung', 2614, 'Lung'), ('UBERON_0012652', 'colorectum', 2620, 'Colorectal'), ('UBERON_0000992', 'ovary', 2636, 'Ovarian'), ('CHEBI_37527', 'acid', 2735, 'acid'), ('CHEBI_50317', 'iodonium', 2757, 'folic acidCurrent'), ('NCBITaxon_10088', 'Mus <genus>', 2862, 'persons'), ('UBERON_0002048', 'lung', 2875, 'lung'), ('PR_000011509', 'nuclear pore complex protein Nup155', 2911, 'Nctrl'), ('CHEBI_37527', 'acid', 3051, 'acid'), ('CHEBI_36644', 'glycooctaosylceramide', 3073, 'folic acidMean'), ('GO_0007631', 'feeding behavior', 3222, 'intake')]
PMC3278486	1/2012	S95-PMC3278486	['for cancer mortality, the quality ranged from very low (Breast), low (Colorectal and Prostate) to moderate (total and Lung cancer mortality).']	N/A	N/A	[('UBERON_0000310', 'breast', 56, 'breast'), ('UBERON_0012652', 'colorectum', 70, 'colorectal'), ('UBERON_0002367', 'prostate gland', 85, 'prostate'), ('UBERON_0002048', 'lung', 118, 'lung')]
PMC3354911	12/2011	S8-PMC3354911	['introduction\nNoncommunicable diseases (ncds) represent a cluster of major chronic diseases including Cardiovascular diseases (cvds), diabetes, stroke, cancers, and chronic obstructive Pulmonary disease (copd).']	N/A	N/A	[('GO_0051294', 'establishment of spindle orientation', 13, 'Noncommunicable'), ('UBERON_0004535', 'cardiovascular system', 101, 'cardiovascular'), ('UBERON_0002048', 'lung', 184, 'pulmonary')]
PMC3360698	5/2012	S20-PMC3360698	['male offspring developed Liver and Adrenal tumors and female offspring developed Ovarian and Lung tumors[6].']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0002369', 'adrenal gland', 35, 'adrenal'), ('UBERON_0000992', 'ovary', 81, 'ovarian'), ('UBERON_0002048', 'lung', 93, 'lung')]
PMC3360698	5/2012	S163-PMC3360698	["for example, inhabitants of chile's region ii who were Born just prior to or during an acute increase in Water as concentrations, resulting in early-Life and Prenatal exposure, had higher mortality rates from malignant and nonmalignant Lung disease and acute Myocardial infarction as young Adults compared to unexposed Individuals from a different region[9],[10],[11]."]	N/A	N/A	[('GO_0007567', 'parturition', 55, 'born'), ('CHEBI_15377', 'water', 105, 'water'), ('UBERON_0000104', 'life cycle', 149, 'life'), ('GO_0007565', 'female pregnancy', 158, 'prenatal'), ('UBERON_0002048', 'lung', 236, 'lung'), ('UBERON_0002349', 'myocardium', 259, 'myocardial'), ('UBERON_0007023', 'adult organism', 290, 'adults'), ('NCBITaxon_1', 'root', 319, 'individuals')]
PMC3404653	3/2012	S165-PMC3404653	['cell culture experiments in Human Lung, Kidney, and Keratinocytes show that as increases methylation within the Promoter regions of the tumor suppressor Gene P53 , the noncanonical wnt Signaling Pathway and the death-Associated Protein Kinase ( dapk ) Gene, but reduces global Dna Methylation (chen et al.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 28, 'human'), ('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0002113', 'kidney', 40, 'kidney'), ('CL_0000312', 'keratinocyte', 52, 'keratinocytes'), ('SO_0000167', 'promoter', 112, 'promoter'), ('SO_0000704', 'gene', 153, 'gene'), ('PR_000003035', 'cellular tumor antigen p53', 158, 'p53'), ('GO_0045500', 'sevenless signaling pathway', 185, 'signaling pathway'), ('PR_000004670', 'protein PTHB1', 216, '-associated protein kinase'), ('SO_0000704', 'gene', 252, 'gene'), ('GO_0006306', 'DNA methylation', 277, 'DNA methylation')]
PMC3426771	1/2012	S98-PMC3426771	['ang i is further cleaved by angiontensinogen converting enzyme (ace), found primarily in the Lung, leading to the formation of Angiotensin Ii (Ang Ii).']	N/A	N/A	[('UBERON_0002048', 'lung', 93, 'lung'), ('PR_000002200', 'cytoplasmic tyrosine-protein kinase BMX', 127, 'angiotensin II'), ('PR_000003539', 'ATP-binding cassette sub-family A member 12', 143, 'Ang II')]
PMC3465343	10/2012	S35-PMC3465343	['abnormalities at lower penetrance were noted in other Systems including the Genitourinary Tract, Kidney, Diaphrapm, Lung, Aortic Arch, and Heart.']	N/A	N/A	[('UBERON_0000467', 'anatomical system', 54, 'systems'), ('UBERON_0022262', 'auditory radiation', 76, 'genitourinary tract'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0001103', 'diaphragm', 105, 'diaphrapm'), ('UBERON_0002048', 'lung', 116, 'lung'), ('UBERON_0001508', 'arch of aorta', 122, 'aortic arch'), ('UBERON_0000948', 'heart', 139, 'heart')]
PMC3465343	10/2012	S122-PMC3465343	['Spinal Cord, Heart, Lung, Kidney, etc.)[3].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 0, 'spinal cord'), ('UBERON_0000948', 'heart', 13, 'heart'), ('UBERON_0002048', 'lung', 20, 'lung'), ('UBERON_0002113', 'kidney', 26, 'kidney')]
PMC3501517	11/2012	S5-PMC3501517	['at 1 day, 3 days and 10 days, Mice were anesthetized and Lung elastance measured.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 30, 'mice'), ('UBERON_0002048', 'lung', 57, 'lung')]
PMC3501517	11/2012	S6-PMC3501517	['Mice were euthanized and Bronchoalveolar Lavage Fluid, Lungs and Serum were collected.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('UBERON_0004212', 'glomerular capillary', 25, 'bronchoalveolar lavage fluid'), ('UBERON_0002048', 'lung', 55, 'lungs'), ('UBERON_0001977', 'blood serum', 65, 'serum')]
PMC3501517	11/2012	S11-PMC3501517	['Vitamin D deficiency modestly impairs Neutrophil Chemotaxis; however, it does not affect Lung injury or its resolution in an Lps model of acute Lung injury.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000775', 'neutrophil', 38, 'neutrophil'), ('GO_0007567', 'parturition', 38, 'neutrophil'), ('GO_0006935', 'chemotaxis', 49, 'chemotaxis'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_16412', 'lipopolysaccharide', 125, 'LPS'), ('UBERON_0002048', 'lung', 144, 'lung')]
PMC3501517	11/2012	S55-PMC3501517	['after a 5-min stabilization period, the Lungs were twice inflated to an end-Inspiratory pressure of 30 cmh2o.']	N/A	N/A	[('UBERON_0002048', 'lung', 40, 'lungs'), ('GO_0007631', 'feeding behavior', 76, 'inspiratory')]
PMC3501517	11/2012	S56-PMC3501517	['multi-frequency forced oscillation waveform maneuvers were repeated 12 times to determine Lung elastance (h), using the constant phase model as previously reported[36],[37].']	N/A	N/A	[('UBERON_0002048', 'lung', 90, 'lung')]
PMC3501517	11/2012	S66-PMC3501517	['after fixation, the Lungs were embedded in paraffin.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'lungs')]
PMC3501517	11/2012	S67-PMC3501517	['for each Tissue block, four 4-µm sections were prepared after cutting ∼100 µm into the Lung.']	N/A	N/A	[('UBERON_0000479', 'tissue', 9, 'tissue'), ('UBERON_0002048', 'lung', 87, 'lung')]
PMC3501517	11/2012	S88-PMC3501517	['Lung Elastance over time was compared between two groups by repeated measures anova.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('GO_0050956', 'electroception', 5, 'elastance')]
PMC3501517	11/2012	S106-PMC3501517	['Lung injury and inflammation were measured by a variety of parameters at days 1, 3, and 10 after instillation with either pbs or Lps.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 129, 'LPS')]
PMC3501517	11/2012	S108-PMC3501517	['Lung injury and inflammation 1 day after Lps\nLps treatment caused significant weight loss (p<0.001) in both vds and vdd groups as compared to pbs controls.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 41, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 45, 'LPS')]
PMC3501517	11/2012	S110-PMC3501517	['Lung elastance was overall significantly higher after Lps treatment as compared with pbs treatment.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 54, 'LPS')]
PMC3501517	11/2012	S113-PMC3501517	['Lps treatment resulted in greater normalized Lung weights overall (p<0.001), but no difference was found between vds and vdd Mice 1 day after Lps treatment (2.49±0.18 vs. 2.47±0.25 mg/g, respectively) (figure 2c).']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 0, 'LPS'), ('UBERON_0002048', 'lung', 45, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 125, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 142, 'LPS')]
PMC3501517	11/2012	S115-PMC3501517	['no significant differences were observed between vds and vdd Mice after Lps treatment groups in total protein concentration (207.8±89.3 vs. 164.2±41.9 µg/ml) or Igm concentration (108.2±79.2 vs. 82.1±43.6 ng/ml)(figure 2d, 2e).10.1371/journal.pone.0049076.g002\n\ncaption (fig): figure 2\nLung injury 1 day after Lps instillation.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 61, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 72, 'LPS'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 161, 'IgM'), ('UBERON_0002048', 'lung', 286, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 310, 'LPS')]
PMC3501517	11/2012	S118-PMC3501517	['( a ) percent body weight change; ( b ) Lung elastance (h) over time following Lung recruitment (mean ± sem); ( c ) left Lung Lobe weight (wt) normalized to day 0 body weight; ( d ) total protein concentration of Bronchoalveolar Lavage (Bal) fluid; ( e ) Igm concentration of Bal Fluid.']	N/A	N/A	[('UBERON_0002048', 'lung', 40, 'Lung'), ('UBERON_0002048', 'lung', 79, 'lung'), ('UBERON_0000101', 'lobe of lung', 121, 'lung lobe'), ('UBERON_0013561', 'Brodmann (1909) area 43', 213, 'bronchoalveolar lavage ...'), ('UBERON_0002436', 'primary visual cortex', 237, 'BAL ...'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 255, 'IgM'), ('UBERON_0006310', 'vitelline venous plexus', 276, 'BAL fluid')]
PMC3501517	11/2012	S120-PMC3501517	['in contrast to measurements of Lung mechanics and permeability, total Bal Fluid Leukocyte count was modestly higher after Lps treatment in vds versus vdd Mice (2.0±0.54×105vs.']	N/A	N/A	[('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0006310', 'vitelline venous plexus', 70, 'BAL fluid'), ('CL_0000738', 'leukocyte', 80, 'leukocyte'), ('CHEBI_16412', 'lipopolysaccharide', 122, 'LPS'), ('NCBITaxon_10088', 'Mus <genus>', 154, 'mice')]
PMC3501517	11/2012	S131-PMC3501517	['Lung histological sections demonstrate mildly increased cellularity in both vds and vdd Mice one day after Lps exposure as compared to pbs-exposed Animals (figure 4).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 107, 'LPS'), ('NCBITaxon_33208', 'Metazoa', 147, 'animals')]
PMC3501517	11/2012	S138-PMC3501517	['Lung Elastance was elevated after Lps treatment as compared with pbs treatment but there was no significant difference between the vds and vdd Mice (37.9±4.8 vs. 34.5±4.0 cmh2o/ml) (figure 5b).10.1371/journal.pone.0049076.g005\n\ncaption (fig): figure 5\nLung injury and inflammation 3 days after Lps instillation.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('GO_0050956', 'electroception', 5, 'elastance'), ('CHEBI_16412', 'lipopolysaccharide', 34, 'LPS'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'mice'), ('UBERON_0002048', 'lung', 252, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 294, 'LPS')]
PMC3501517	11/2012	S141-PMC3501517	['( a ) percent body weight change; ( b ) Lung elastance (h) over time following Lung recruitment (mean ± sem); ( c ) left Lung Lobe weight (wt) normalized to day 0 body weight; ( d ) total protein concentration of Bronchoalveolar Lavage (Bal) fluid; ( e ) Igm concentration of Bal Fluid; ( f ) Bal Fluid total cell count; ( g ) Bal Neutrophil count.']	N/A	N/A	[('UBERON_0002048', 'lung', 40, 'Lung'), ('UBERON_0002048', 'lung', 79, 'lung'), ('UBERON_0000101', 'lobe of lung', 121, 'lung lobe'), ('UBERON_0013561', 'Brodmann (1909) area 43', 213, 'bronchoalveolar lavage ...'), ('UBERON_0002436', 'primary visual cortex', 237, 'BAL ...'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 255, 'IgM'), ('UBERON_0006310', 'vitelline venous plexus', 276, 'BAL fluid'), ('UBERON_0006310', 'vitelline venous plexus', 293, 'BAL fluid'), ('UBERON_0006378', 'strand of vibrissa hair', 327, 'BAL'), ('CL_0000775', 'neutrophil', 331, 'neutrophil')]
PMC3501517	11/2012	S157-PMC3501517	['( a ) percent body weight change, p<0.05 comparing vds and vdd Mice after Lps; ( b ) Lung elastance (h) over time following Lung recruitment (mean ± sem); ( c ) Left Lung Lobe weight (wt) normalized to day 0 body weight; ( d ) total protein concentration of Bronchoalveolar Lavage (Bal) Fluid; ( e ) Igm concentration of Bal Fluid; ( f ) Bal Fluid total cell count; ( g ) bal Neutrophil count.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 63, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 74, 'LPS'), ('UBERON_0002048', 'lung', 85, 'Lung'), ('UBERON_0002048', 'lung', 124, 'lung'), ('UBERON_0008951', 'left lung lobe', 161, 'Left lung lobe'), ('UBERON_0013561', 'Brodmann (1909) area 43', 258, 'bronchoalveolar lavage ...'), ('UBERON_0002436', 'primary visual cortex', 282, 'BAL ...'), ('UBERON_0006314', 'bodily fluid', 287, 'fluid'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 300, 'IgM'), ('UBERON_0006310', 'vitelline venous plexus', 321, 'BAL fluid'), ('UBERON_0006310', 'vitelline venous plexus', 338, 'BAL fluid'), ('CL_0000775', 'neutrophil', 376, 'neutrophil')]
PMC3501517	11/2012	S158-PMC3501517	['Lung inflammation and injury had resolved to a similar degree in both vds and vdd Mice by day 10 following Lps instillation.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 107, 'LPS')]
PMC3501517	11/2012	S160-PMC3501517	['there was no difference in Lung permeability between vds and vdd Mice as determined by the normalized Lung weight (2.46±0.50 vs. 2.34±0.15 mg/g), Bal Fluid total protein concentration (198.0±143.9 vs. 119.0±40.9 µg/ml), and Bal Fluid Igm concentration (105.7±105.5 vs. 55.1±42.9 ng/ml) (figures 6c, 6d, 6e).']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mice'), ('UBERON_0002048', 'lung', 102, 'lung'), ('UBERON_0006310', 'vitelline venous plexus', 146, 'BAL fluid'), ('UBERON_0006310', 'vitelline venous plexus', 224, 'BAL fluid'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 234, 'IgM')]
PMC3501517	11/2012	S187-PMC3501517	['Lung injury as measured by wet Lung weight, elastance, and permeability was greatest three days following Lps exposure without any difference seen between vds and vdd Mice for any measured parameter, including Bal Fluid Leukocytes.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0002048', 'lung', 31, 'lung'), ('CHEBI_16412', 'lipopolysaccharide', 106, 'LPS'), ('NCBITaxon_10088', 'Mus <genus>', 167, 'mice'), ('UBERON_0006310', 'vitelline venous plexus', 210, 'BAL fluid'), ('CL_0000738', 'leukocyte', 220, 'leukocytes')]
PMC3501517	11/2012	S230-PMC3501517	['minor differences were noted in early Leukocyte recruitment to the Lung as well as weight recovery by day 10.']	N/A	N/A	[('CL_0000738', 'leukocyte', 38, 'leukocyte'), ('UBERON_0002048', 'lung', 67, 'lung')]
PMC3513828	11/2012	S78-PMC3513828	['at that point, she received betamethasone for fetal Lung Maturation.']	N/A	N/A	[('GO_0060424', 'lung field specification', 52, 'lung maturation'), ('UBERON_0002048', 'lung', 52, 'lung')]
PMC3534321	12/2012	S154-PMC3534321	['Drugs such as Tadalafil, Sildenafil, and vardenafil that are Inhibitors of phosphodiesterases enzyme are widely used to treat Male Sexual Impotence and Pulmonary hypertension [61].']	N/A	N/A	[('CHEBI_23888', 'drug', 0, 'Drugs'), ('CHEBI_71940', 'tadalafil', 14, 'tadalafil'), ('CHEBI_9143', 'silychristin', 25, 'sildenafil'), ('CHEBI_35222', 'inhibitor', 61, 'inhibitors'), ('GO_0098764', 'meiosis I cell cycle phase', 126, 'male sexual impotence'), ('UBERON_0002048', 'lung', 152, 'pulmonary')]
PMC3552819	12/2012	S117-PMC3552819	['caption (table-wrap): table 3\n\nindividual cases of elevated Serum calcium or clinical adverse events among Pregnant participants who received 70,000 iu Vitamin D3A\xa0 eventbiochemistrybactionoutcomeiddescriptiontime of onsettimingalbumin –adjusted Serum [Ca] (mmol/l)Urine Ca:Cr (mmol/ mmol)[25(Oh)D] (nmol/l) \xa0\xa01 neonatal : neonatal death, secondary to Respiratory failure, and Pulmonary hemorrhage.delivery at 36 weeks Gestation; day 42 of follow-up.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 60, 'serum'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('CHEBI_33237', 'vitamin D4', 152, 'vitamin D3a'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 152, 'vitamin D3a'), ('UBERON_0001977', 'blood serum', 246, 'serum'), ('CHEBI_32588', 'potassium chloride', 253, 'Ca'), ('UBERON_0001088', 'urine', 265, 'Urine'), ('CHEBI_32588', 'potassium chloride', 271, 'Ca'), ('CHEBI_37987', 'Cy3 dye', 274, 'Cr'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 352, 'respiratory'), ('UBERON_0002048', 'lung', 377, 'pulmonary'), ('GO_0007565', 'female pregnancy', 419, 'gestation')]
PMC3553086	1/2013	S59-PMC3553086	['none of the Cpg Sites analysed for the smaller selection of bamse samples (n\u200a=\u200a260) were differentially methylated between the groups but they showed overall similar degree of methylation as compared to the Adult bioair samples (table s1).10.1371/journal.pone.0053877.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the bioair study population (n\u200a=\u200a171).mild Adult asthmasevere Adult asthmacopdp-valuen566748age (years)41.6±13.250.3±13.263.8±8.5<0.05gender (% males)44.643.375<0.05bmi (kg/m2)25.2±3.8128.7±5.327.4±5.31<0.05current smokers (n\u200a=\u200a14)1211<0.05former smokers (n\u200a=\u200a67)121837fev1(%pred)87.3±18.371.4±21.450.0±16.1<0.05fvc (%pred)104.6±16.187.5±20.6177.2±16.5<0.05blood Eosinophils (109/l)0.31±0.2720.37±0.3530.23±0.293nsrs2168891 cc/ct/tt (%)83.9/14.3/1.883.6/16.4/091.7/8.3/0nsrs2168890 cc/ct/tt (%)69.1/30.9/0171.4/28.6/0473.3/26.7/05nsrs2530547 cc/ct/tt (%)29.1/54.5/16.4140.9/45.5/13.6140.4/48.9/.10.61nsrs887020 aa/ag/gg (%)28.6/53.6/17.917.9/52.2/29.920.8/58.3/20.8ns\ncopd - chronic obstructive Pulmonary disease, bmi – body mass index, fev1– forced expiratory volume in 1 second, fvc – forced vital capacity.']	N/A	N/A	[('SO_0000036', 'matrix_attachment_site', 12, 'CpG sites'), ('UBERON_0007023', 'adult organism', 207, 'adult'), ('UBERON_0007023', 'adult organism', 366, 'Adult'), ('UBERON_0007023', 'adult organism', 385, 'Adult'), ('CL_0000771', 'eosinophil', 686, 'eosinophils'), ('UBERON_0002048', 'lung', 1018, 'Pulmonary')]
PMC3553086	1/2013	S164-PMC3553086	['Adult patients with mild controlled asthma, severe uncontrolled asthma and chronic obstructive Pulmonary disease (copd) were followed for one year.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('UBERON_0002048', 'lung', 95, 'pulmonary')]
PMC3577465	2/2013	S4-PMC3577465	['Pulmonary Vascular Endothelial Cells (Pvec) were isolated from the Rat Lungs by magnetic-activated cell sorting (macs).']	N/A	N/A	[('CL_0002510', 'CD103-negative, langerin-positive lymph node dendritic cell', 0, 'Pulmonary vascular endothelial cells'), ('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('UBERON_0001986', 'endothelium', 19, 'endothelial'), ('CL_0002358', 'pyrenocyte', 38, 'PVEC'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rat'), ('UBERON_0002048', 'lung', 71, 'lungs')]
PMC3577465	2/2013	S49-PMC3577465	['hypoxic Pulmonary hypertension Rat model\nhypoxic Pulmonary hypertension model was established according to our previous experiments [30,31].']	N/A	N/A	[('UBERON_0002048', 'lung', 8, 'pulmonary'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 31, 'rat'), ('UBERON_0002048', 'lung', 49, 'pulmonary')]
PMC3577465	2/2013	S52-PMC3577465	['after a 2-week hypoxic intervention, Rat Pulmonary Arterial pressure was measured, followed by Lung Tissue immunohistochemistry and isolation of Pulmonary Vascular Endothelial Cells.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 37, 'rat'), ('UBERON_0002048', 'lung', 41, 'pulmonary'), ('UBERON_0001637', 'artery', 51, 'arterial'), ('UBERON_0002048', 'lung', 95, 'lung'), ('UBERON_0000479', 'tissue', 100, 'tissue'), ('CL_1001568', 'pulmonary artery endothelial cell', 145, 'pulmonary vascular endothelial cells'), ('UBERON_0002048', 'lung', 145, 'pulmonary'), ('UBERON_0000116', 'lung saccule', 155, 'vascular'), ('UBERON_0001986', 'endothelium', 164, 'endothelial')]
PMC3577465	2/2013	S58-PMC3577465	['normal saline was injected into the Right Ventricle through the needle at a pressure of 20 cmh2o at room temperature and the Lung was flushed.']	N/A	N/A	[('UBERON_0002080', 'heart right ventricle', 36, 'right ventricle'), ('UBERON_0002048', 'lung', 125, 'lung')]
PMC3577465	2/2013	S59-PMC3577465	['Lungs were dissected once the effluent from the Left Atrium incision was clear of Blood.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lungs'), ('UBERON_0002079', 'left cardiac atrium', 48, 'left atrium'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC3577465	2/2013	S60-PMC3577465	['immunohistochemistry and physical measurements\nright Lung Tissues of different ages were removed, frozen in liquid nitrogen and stored at −80°c for western blotting.']	N/A	N/A	[('UBERON_0002048', 'lung', 53, 'lung'), ('UBERON_0000479', 'tissue', 58, 'tissues')]
PMC3577465	2/2013	S62-PMC3577465	['the Lung Tissues were imbedded in paraffin, sectioned at 4–5 μm, and processed for light microscopic immunohistochemistry as the previously described [19,30].']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung'), ('UBERON_0000479', 'tissue', 9, 'tissues')]
PMC3577465	2/2013	S64-PMC3577465	['at least eight slides from each Lung were taken and then analyzed.']	N/A	N/A	[('UBERON_0002048', 'lung', 32, 'lung')]
PMC3577465	2/2013	S70-PMC3577465	['isolation of Pulmonary Vascular Endothelial Cells (Pvec)\nPulmonary Vascular Endothelial Cells (Pvec) were isolated by magnetic-activated cell sorting (macs) as described earlier [19].']	N/A	N/A	[('CL_1001568', 'pulmonary artery endothelial cell', 13, 'pulmonary vascular endothelial cells'), ('UBERON_0002048', 'lung', 13, 'pulmonary'), ('UBERON_0001986', 'endothelium', 32, 'endothelial'), ('CL_0002358', 'pyrenocyte', 51, 'PVEC'), ('CL_0002510', 'CD103-negative, langerin-positive lymph node dendritic cell', 57, 'Pulmonary vascular endothelial cells'), ('UBERON_0002048', 'lung', 57, 'Pulmonary'), ('UBERON_0001986', 'endothelium', 76, 'endothelial'), ('CL_0002358', 'pyrenocyte', 95, 'PVEC')]
PMC3577465	2/2013	S71-PMC3577465	['fresh Rat Lungs were sliced and then incubated with collagenase a.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 6, 'rat'), ('UBERON_0002048', 'lung', 10, 'lungs')]
PMC3577465	2/2013	S114-PMC3577465	['Pulmonary histological changes in 1-day, 6-week, hypoxia-treated Rats\nthe percentage of medial thickness in small Pulmonary Arteries of 50–150 μm diameter was analyzed.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rats'), ('UBERON_0002012', 'pulmonary artery', 114, 'pulmonary arteries')]
PMC3577465	2/2013	S117-PMC3577465	['significant histological changes compatible with Pulmonary Vascular Remodeling were observed in hypoxia-treated Rats, especially in iugr Rats.']	N/A	N/A	[('UBERON_0002048', 'lung', 49, 'pulmonary'), ('GO_0006903', 'vesicle targeting', 59, 'vascular remodeling'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 112, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 137, 'rats')]
PMC3577465	2/2013	S121-PMC3577465	['caption (fig): figure 3\n\nimmunohistochemical staining for A-Sma in Lung Tissue sections.']	N/A	N/A	[('PR_000003609', 'Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3', 58, 'a-SMA'), ('UBERON_0002048', 'lung', 67, 'lung'), ('UBERON_0000479', 'tissue', 72, 'tissue')]
PMC3577465	2/2013	S122-PMC3577465	['representative Lung histological sections of control d1 ( a ), iugr d1 ( b ), control 6wks ( c ), iugr 6wks ( d ), control hypoxia ( e ), and iugr hypoxia ( f ) are shown demonstrating hypertrophy of the Arterial medial Wall induced by hypoxia.']	N/A	N/A	[('UBERON_0002048', 'lung', 15, 'lung'), ('UBERON_0001399', 'deep brachial artery', 204, 'arterial ... wall')]
PMC3577465	2/2013	S127-PMC3577465	['Lung Tissue Α-Sma levels\nLung Tissue Α-Sma protein Expression levels reflecting Pulmonary Vascular Remodeling in iugr hypoxia and control hypoxia groups were significantly increased (figure4a).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 12, 'α-SMA'), ('UBERON_0002048', 'lung', 25, 'Lung'), ('UBERON_0000479', 'tissue', 30, 'tissue'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 37, 'α-SMA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('UBERON_0002048', 'lung', 80, 'pulmonary'), ('GO_0006903', 'vesicle targeting', 90, 'vascular remodeling')]
PMC3577465	2/2013	S131-PMC3577465	['Lung Tissue protein extractions were used for Α-Sma Expression analysis ( a ).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 46, 'α-SMA'), ('GO_0010467', 'gene expression', 52, 'expression')]
PMC3577465	2/2013	S190-PMC3577465	['maternal Nutrient restriction increased the Histone Acetylation and transcription factor Hif-1Α binding levels in the Et-1 Gene Promoter of Pulmonary Vascular Endothelial Cells (pvec) in iugr Rats.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 9, 'nutrient'), ('CHEBI_15358', 'histone', 44, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 44, 'histone acetylation'), ('PR_000043452', 'core histone', 44, 'histone'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 89, 'HIF-1α'), ('PR_000007222', 'protein C-ets-2', 118, 'ET-1'), ('SO_0000704', 'gene', 123, 'gene'), ('SO_0000167', 'promoter', 128, 'promoter'), ('CL_1001568', 'pulmonary artery endothelial cell', 140, 'pulmonary vascular endothelial cells'), ('UBERON_0002048', 'lung', 140, 'pulmonary'), ('UBERON_0004823', 'intrahepatic bile duct epithelium', 150, 'vascular endothelial'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 192, 'rats')]
PMC3577465	2/2013	S191-PMC3577465	['these epigenetic changes would induce iugr Individual in later Life to be highly sensitive to hypoxia, resulting in more significant Pulmonary hypertension ( b ).']	N/A	N/A	[('NCBITaxon_1', 'root', 43, 'individual'), ('UBERON_0000104', 'life cycle', 63, 'life'), ('UBERON_0002048', 'lung', 133, 'pulmonary')]
PMC3599191	1/2013	S35-PMC3599191	['exposure to these Drugs after the 20th week of Gestation increased six-fold the newborn’s risk (rr\u2009=\u20096.1) of persistent Pulmonary hypertension.']	N/A	N/A	[('CHEBI_23888', 'drug', 18, 'drugs'), ('GO_0007565', 'female pregnancy', 47, 'gestation'), ('UBERON_0002048', 'lung', 120, 'pulmonary')]
PMC3599191	1/2013	S87-PMC3599191	['the presence of 3 or more of these factors increases the risk of developing Adult chronic Lung disease or obstructive Pulmonary disease (copd) sixfold for males (rr\u2009=\u20096.3) and sevenfold for females (rr\u2009=\u20097.2) [39].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 76, 'adult'), ('UBERON_0002048', 'lung', 90, 'lung'), ('UBERON_0002048', 'lung', 118, 'pulmonary')]
PMC3613945	2/2013	S166-PMC3613945	['chronic obstructive Pulmonary disease\nchronic obstructive Pulmonary disease (copd) is characterized by decreased Pulmonary elastic recoil, expiratory obstruction and hyperinflation secondary to inflammation of peripheral airways89.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'pulmonary'), ('UBERON_0002048', 'lung', 58, 'pulmonary'), ('UBERON_0002048', 'lung', 113, 'pulmonary')]
PMC3616124	4/2013	S68-PMC3616124	['severe preeclampsia was defined as preeclampsia with either severe pah or Protein Excretion35 g/24 hours, or as mild pah with oliguria (<500 ml Urine/24 hours), Pulmonary edema (confirmed by radiography), or thrombocytopenia (<100,000 Platelets/mm3).']	N/A	N/A	[('GO_0030254', 'protein secretion by the type III secretion system', 74, 'protein excretion35'), ('UBERON_0001088', 'urine', 144, 'urine'), ('UBERON_0002048', 'lung', 161, 'pulmonary'), ('CL_0000233', 'platelet', 235, 'platelets')]
PMC3622346	3/2013	S39-PMC3622346	['however, Chest radiograph showed bilateral small to moderate Pleural effusion with mild Pulmonary congestion.']	N/A	N/A	[('UBERON_0001443', 'chest', 9, 'chest'), ('UBERON_2000660', 'epural', 61, 'pleural'), ('UBERON_0002048', 'lung', 88, 'pulmonary')]
PMC3622346	3/2013	S61-PMC3622346	['Magnesium Sulfate infusion was continued for 24 hours and discontinued once her hypertension and Pulmonary edema improved.']	N/A	N/A	[('CHEBI_31795', 'magnesium sulfate heptahydrate', 0, 'Magnesium sulfate'), ('UBERON_0002048', 'lung', 97, 'pulmonary')]
PMC3622346	3/2013	S62-PMC3622346	['after 3 days of diuresis, her short of Breath resolved, and Chest radiograph showed resolution of Pulmonary congestion (seefigure 2).']	N/A	N/A	[('UBERON_0000310', 'breast', 39, 'breath'), ('UBERON_0001443', 'chest', 60, 'chest'), ('UBERON_0002048', 'lung', 98, 'pulmonary')]
PMC3622346	3/2013	S73-PMC3622346	['examples of noncardiogenic Pulmonary edema are iatrogenic Fluid overload, Thyroid disease, Drug-induced Pulmonary edema (e.g., Tocolytic therapy and Oxytocin), acute Respiratory distress syndrome (ards), and preeclampsia-related Pulmonary edema.']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'pulmonary'), ('UBERON_0006314', 'bodily fluid', 58, 'fluid'), ('UBERON_0002046', 'thyroid gland', 74, 'thyroid'), ('CHEBI_23888', 'drug', 91, 'drug'), ('UBERON_0002048', 'lung', 104, 'pulmonary'), ('GO_0034390', 'smooth muscle cell apoptotic process', 127, 'tocolytic'), ('CHEBI_7872', 'oxytocin', 149, 'oxytocin'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory'), ('UBERON_0002048', 'lung', 229, 'pulmonary')]
PMC3622346	3/2013	S123-PMC3622346	['due to increasing dyspnea from Pulmonary edema, patient was admitted to the Intensive care unit, and Furosemide was used which significantly improved her symptoms.']	N/A	N/A	[('UBERON_0002048', 'lung', 31, 'pulmonary'), ('UBERON_0010210', 'blood clot', 76, 'intensive'), ('CHEBI_47426', 'furosemide', 101, 'furosemide')]
PMC3622346	3/2013	S126-PMC3622346	['these include increased Plasma volume, decreased Plasma oncotic pressure, increased Capillary permeability, and increased Pulmonary Capillary hydrostatic pressures [6].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 24, 'plasma'), ('UBERON_0001969', 'blood plasma', 49, 'plasma'), ('UBERON_0001982', 'capillary', 84, 'capillary'), ('UBERON_0002048', 'lung', 122, 'pulmonary'), ('UBERON_0001982', 'capillary', 132, 'capillary')]
PMC3622346	3/2013	S127-PMC3622346	['Cardiac functions during Pulmonary edema found to be varied [6].']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cardiac'), ('UBERON_0002048', 'lung', 25, 'pulmonary')]
PMC3662163	3/2013	S47-PMC3662163	['Cardiac disease, Lung disease), (otc-)Medication use during Pregnancy and socio-demographic characteristics.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'cardiac'), ('UBERON_0002048', 'lung', 17, 'lung'), ('CHEBI_60211', 'compound Z', 38, 'medication'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy')]
PMC3679768	5/2013	S28-PMC3679768	['Lungs were clear to auscultation bilaterally without wheezes, rhonchi, or rales.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lungs')]
PMC3691177	6/2013	S11-PMC3691177	['there was no significant difference in atopy, eczema risk, Lung function or exhaled Nitric Oxide between supplemented groups and controls.']	N/A	N/A	[('UBERON_0002048', 'lung', 59, 'lung'), ('CHEBI_16480', 'nitric oxide', 84, 'nitric oxide')]
PMC3691177	6/2013	S18-PMC3691177	['Developmental Programming Of Lung function and Immune Responses occurs during Pregnancy[10],[11].']	N/A	N/A	[('GO_0006880', 'intracellular sequestering of iron ion', 0, 'Developmental programming of ... immune responses'), ('UBERON_0002048', 'lung', 29, 'lung'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC3691177	6/2013	S95-PMC3691177	['effect of Prenatal Vitamin D supplementation on Lung function and bronchodilator responsiveness\nfifty-one of 180 (28%) children provided acceptable ios data for analyses.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('UBERON_0002048', 'lung', 48, 'Lung')]
PMC3710934	7/2013	S376-PMC3710934	['in a cohort of 34,708 Postmenopausal women followed for 16 years, 700 Lung cancer cases were identified.']	N/A	N/A	[('GO_0007595', 'lactation', 22, 'postmenopausal'), ('UBERON_0002048', 'lung', 70, 'lung')]
PMC3710934	7/2013	S377-PMC3710934	['the authors report no association between total Iron intake (dietary Iron plus supplements) and Lung cancer.']	N/A	N/A	[('CHEBI_24870', 'ion', 48, 'iron'), ('CHEBI_24870', 'ion', 69, 'iron'), ('UBERON_0002048', 'lung', 96, 'lung')]
PMC3710934	7/2013	S379-PMC3710934	['those with the highest Heme iron intake (≥2.44 mg/day) and the highest Vitamin C supplement intake (>700 mg/day) had rr=8.97 (95% ci: 1.29–62.51) for Lung cancer compared to those with lowest Heme Iron intake (≤0.77 mg/day).']	N/A	N/A	[('CHEBI_30413', 'heme', 23, 'heme'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('UBERON_0002048', 'lung', 150, 'lung'), ('CHEBI_36084', 'dihydroxybenzoate', 192, 'heme iron')]
PMC3710934	7/2013	S382-PMC3710934	['in a case-control (study quality b) study, zhou and co-workers identified 923 cases of Lung cancer at massachusetts general hospital over an 8-year period (63).']	N/A	N/A	[('UBERON_0002048', 'lung', 87, 'lung')]
PMC3710934	7/2013	S386-PMC3710934	['furthermore, when compared with subjects in the lowest tertile of iron intake (<11.70 mg/day) and the highest tertile of zinc intake (>11.69 mg/day), subjects who had the highest intake of iron (>14.32 mg/day) and lowest intake of zinc (<9.70 mg/day) had a higher risk of Lung cancer (or=2.01; 95% ci: 0.96–4.2; ptrend<0.0001).']	N/A	N/A	[('UBERON_0002048', 'lung', 272, 'lung')]
PMC3710934	7/2013	S390-PMC3710934	['the complementary search yielded one additional article on Iron Intake and Lung cancer (64).']	N/A	N/A	[('CHEBI_24870', 'ion', 59, 'iron'), ('GO_0007631', 'feeding behavior', 64, 'intake'), ('UBERON_0002048', 'lung', 75, 'lung')]
PMC3710934	7/2013	S393-PMC3710934	['after up to 8 years of follow-up 782 incident Lung cancers (454 male, 328 female) were identified.']	N/A	N/A	[('UBERON_0002048', 'lung', 46, 'lung')]
PMC3710934	7/2013	S394-PMC3710934	['Heme Iron Intake had no effect on the risk of Lung cancer.']	N/A	N/A	[('CHEBI_5603', 'Halazepam', 0, 'Heme iron'), ('GO_0007631', 'feeding behavior', 10, 'intake'), ('UBERON_0002048', 'lung', 46, 'lung')]
PMC3717170	5/2013	S101-PMC3717170	['today, in addition to Lung function impairment, copd is recognized as a systemic disease with multiple comorbidities, such as osteoporosis, Cardiovascular disease, Renal impairment, and psychological disorders.']	N/A	N/A	[('UBERON_0002048', 'lung', 22, 'lung'), ('UBERON_0004535', 'cardiovascular system', 140, 'cardiovascular'), ('UBERON_0002113', 'kidney', 164, 'renal')]
PMC3717170	5/2013	S106-PMC3717170	['Plasma 25(Oh)D3Levels, body mass index (bmi; weight in kg/(height in m)2), and Lung function parameters (Forced Expiratory volume in 1s (fev1), forced vital capacity (fvc), and diffusing capacity of the Lung (dlco)) were measured.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 7, '25(OH)D3levels'), ('PR_000001895', 'natural cytotoxicity triggering receptor 3', 7, '25(OH)D3levels'), ('UBERON_0002048', 'lung', 79, 'lung'), ('GO_0007629', 'flight behavior', 105, 'forced expiratory'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC3717170	5/2013	S113-PMC3717170	['caption (fig): figure 3\n\nLung function and Plasma Vitamin D levels in a group of 151 copd patients.']	N/A	N/A	[('UBERON_0002048', 'lung', 25, 'Lung'), ('UBERON_0001969', 'blood plasma', 43, 'plasma'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3749995	8/2013	S84-PMC3749995	['Organ explant culture\nfemale Mice (outbred icr strain) were time Mated between 09.00 hrs and 13.00 hrs and at Embryonic day 12 dams were euthanized and the fetal Kidneys/Lungs were removed and cultured on Polyethylene Terephthalate Tissue culture plate inserts (millipore corporation, usa).']	N/A	N/A	[('UBERON_0000033', 'head', 0, 'Organ'), ('NCBITaxon_10088', 'Mus <genus>', 29, 'mice'), ('GO_0007618', 'mating', 65, 'mated'), ('UBERON_0000922', 'embryo', 110, 'embryonic'), ('UBERON_0002113', 'kidney', 162, 'kidneys'), ('UBERON_0002048', 'lung', 170, 'lungs'), ('CHEBI_34922', 'picloram', 205, 'polyethylene terephthalate'), ('UBERON_0000479', 'tissue', 232, 'tissue')]
PMC3749995	8/2013	S86-PMC3749995	['cultured Lungs were maintained in bgjb medium fitton-jackson modification (invitrogen, paisley, uk) containing 25 mg/dl Ascorbic Acid and 1% heat inactivated fetal Bovine Serum (invitrogen, paisley, uk).']	N/A	N/A	[('UBERON_0002048', 'lung', 9, 'lungs'), ('CHEBI_22652', 'ascorbic acid', 120, 'ascorbic acid'), ('NCBITaxon_33208', 'Metazoa', 164, 'bovine'), ('UBERON_0001977', 'blood serum', 171, 'serum')]
PMC3749995	8/2013	S116-PMC3749995	['elevated Sodium Chloride in culture media significantly impedes Branching Morphogenesis in the Kidney, but not Lung\nusing an Organ explant culture system, Murine e12 fetal Kidneys and Lungs were Grown in the presence or absence of varying concentrations of Nacl or alternative Osmolytes known to cross (e.g.']	N/A	N/A	[('CHEBI_26710', 'sodium chloride', 9, 'sodium chloride'), ('GO_0001763', 'morphogenesis of a branching structure', 64, 'branching morphogenesis'), ('UBERON_0002113', 'kidney', 95, 'kidney'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0000062', 'organ', 125, 'organ'), ('NCBITaxon_39107', 'Murinae', 155, 'murine'), ('UBERON_0002113', 'kidney', 172, 'kidneys'), ('UBERON_0002048', 'lung', 184, 'lungs'), ('GO_0040007', 'growth', 195, 'grown'), ('CHEBI_26710', 'sodium chloride', 257, 'NaCl'), ('CHEBI_25671', 'oligoglycosylglucoses', 277, 'osmolytes')]
PMC3749995	8/2013	S126-PMC3749995	['25–50 mosmoles Nacl) Branching Morphogenesis Of the Lung was not obviously affected (figures, s1d–i).']	N/A	N/A	[('CHEBI_26710', 'sodium chloride', 15, 'NaCl'), ('GO_0001658', 'branching involved in ureteric bud morphogenesis', 21, 'branching morphogenesis of ... lung'), ('UBERON_0002048', 'lung', 52, 'lung')]
PMC3749995	8/2013	S130-PMC3749995	['k : growth (fold-increase in normalised Surface area) of cultured Kidneys or Lungs ( l ).']	N/A	N/A	[('GO_0009986', 'cell surface', 40, 'surface'), ('UBERON_0002113', 'kidney', 66, 'kidneys'), ('UBERON_0002048', 'lung', 77, 'lungs')]
PMC3749995	8/2013	S285-PMC3749995	['supporting information\n\ncaption (supplementary-material): figure s1\n\nincreased Extracellular Salt has no effect onin vitrolung growth.a–r : representative images of Lungs (n\u200a=\u200a4–6 replicates) cultured for 3 days in media with varying osmolality, generated using Nacl, Mannitol or Urea, at concentrations indicated on y -axes.']	N/A	N/A	[('GO_0005576', 'extracellular region', 79, 'extracellular'), ('CHEBI_24866', 'salt', 93, 'salt'), ('UBERON_0002048', 'lung', 165, 'lungs'), ('CHEBI_26710', 'sodium chloride', 262, 'NaCl'), ('CHEBI_25169', 'mannoside', 268, 'mannitol'), ('CHEBI_16199', 'urea', 280, 'urea')]
PMC3814422	10/2013	S34-PMC3814422	['Pulmonary function was measured at the 8-year clinic at mean age 8.7 years (sd: 0.27) using a vitalograph 2120 electronic spirometer with a computer-based on-screen incentive (vitalograph, maids moreton, uk).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary')]
PMC3814422	10/2013	S106-PMC3814422	['3\n\nminimally adjusted and adjusted mean difference in Pulmonary function outcomes at 8 years (sd units) between quintiles of maternal 25(Oh)D (min to 38 nmol/l (reference class); 38 to 52; 52 to 67; 67 to 89; 89 to max).']	N/A	N/A	[('UBERON_0002048', 'lung', 54, 'pulmonary'), ('CHEBI_71657', 'versiconol acetate', 134, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 134, '25(OH)D')]
PMC3850030	9/2013	S300-PMC3850030	[')- functional assessments (behavior, treadmill, Learning, Cognition, Renal function studies, Lung function studies, grip strength, etc.']	N/A	N/A	[('GO_0007612', 'learning', 48, 'learning'), ('GO_0050890', 'cognition', 58, 'cognition'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0002048', 'lung', 93, 'lung')]
PMC3914197	7/2012	S16-PMC3914197	['her Cardiac and Pulmonary examination was also normal.']	N/A	N/A	[('UBERON_0000948', 'heart', 4, 'cardiac'), ('UBERON_0002048', 'lung', 16, 'pulmonary')]
PMC3915248	2/2014	S23-PMC3915248	['the team analyzed 96 confirmed cancer cases from the new mexico tumor registry, 32 Lung cancer cases and 64 cases of other cancers.']	N/A	N/A	[('UBERON_0002048', 'lung', 83, 'lung')]
PMC3915248	2/2014	S24-PMC3915248	['of the 32 navajo men who developed Lung cancer, 72% had worked as uranium miners, compared with none of the controls.']	N/A	N/A	[('UBERON_0002048', 'lung', 35, 'lung')]
PMC4065350	12/2013	S31-PMC4065350	['at the Aortic-Pulmonary plan, around 80–85% of the poorly saturated Blood (50% oxygen) ejected by the Right Ventricle (Rv) into the main Pulmonary Artery passes through the Ductus Arteriosus to the Descending Aorta (around 75 ml/min), and as a result will mix with the Blood coming from the Left Ventricle (Lv).']	N/A	N/A	[('UBERON_0000947', 'aorta', 7, 'aortic'), ('UBERON_0002048', 'lung', 14, 'pulmonary'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0002080', 'heart right ventricle', 102, 'right ventricle'), ('UBERON_0005404', 'frontonasal suture', 119, 'RV'), ('UBERON_0002012', 'pulmonary artery', 137, 'pulmonary artery'), ('UBERON_0002254', 'thyroglossal duct', 173, 'ductus arteriosus'), ('UBERON_0001514', 'descending aorta', 198, 'descending aorta'), ('UBERON_0000178', 'blood', 269, 'blood'), ('UBERON_0002084', 'heart left ventricle', 291, 'left ventricle'), ('UBERON_0004621', 'lumbar vertebra 5', 307, 'LV')]
PMC4065350	12/2013	S45-PMC4065350	['hemodynamic alterations during the immediate neonatal period occur at the moment of cessation of placentary Blood Circulation, Lung insufflation, Pulmonary Vasodilation, and Foramen Ovale closure.']	N/A	N/A	[('GO_0008015', 'blood circulation', 108, 'blood circulation'), ('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0002048', 'lung', 127, 'lung'), ('UBERON_0002048', 'lung', 146, 'pulmonary'), ('GO_0042311', 'vasodilation', 156, 'vasodilation'), ('UBERON_0006699', 'foramen cecum of tongue', 174, 'foramen ovale')]
PMC4065350	12/2013	S46-PMC4065350	['the sudden increase in systemic vascular resistance and the decrease in Pulmonary vascular resistance generate a reverse flow through the Ductus Arteriosus and an abrupt increase in Pulmonary flow.']	N/A	N/A	[('UBERON_0002048', 'lung', 72, 'pulmonary'), ('UBERON_0002254', 'thyroglossal duct', 138, 'ductus arteriosus'), ('UBERON_0002048', 'lung', 182, 'pulmonary')]
PMC4065350	12/2013	S48-PMC4065350	['with the decrease in Pulmonary vascular resistance there is an increase in Pulmonary Blood flow, which culminates with ductal occlusion (obladen,2011; hong et al.,2013).']	N/A	N/A	[('UBERON_0002048', 'lung', 21, 'pulmonary'), ('UBERON_0002048', 'lung', 75, 'pulmonary'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC4065350	12/2013	S109-PMC4065350	['as a result, there is dilation of the Pulmonary Artery, Right Atrium, and Rv, right to left bulging of the Interventricular Septum, Tricuspid, and Pulmonary insufficiency, and systolic and diastolic Ventricular dysfunction (mushiake et al.,2002; paladini et al.,2005).']	N/A	N/A	[('UBERON_0002012', 'pulmonary artery', 38, 'pulmonary artery'), ('UBERON_0002078', 'right cardiac atrium', 56, 'right atrium'), ('UBERON_0005404', 'frontonasal suture', 74, 'RV'), ('UBERON_0002094', 'interventricular septum', 107, 'interventricular septum'), ('UBERON_0002445', 'ulnare', 132, 'tricuspid'), ('UBERON_0002048', 'lung', 147, 'pulmonary'), ('UBERON_0002082', 'cardiac ventricle', 199, 'ventricular')]
PMC4065350	12/2013	S119-PMC4065350	['in a classical study, administration of Indomethacin to fetal lambs was followed by fetal Ductal constriction and Pulmonary hypertension (levin et al.,1979).']	N/A	N/A	[('CHEBI_42068', 'idarubicin', 40, 'indomethacin'), ('UBERON_0001505', 'coracobrachialis muscle', 90, 'ductal'), ('UBERON_0002048', 'lung', 114, 'pulmonary')]
PMC4065350	12/2013	S159-PMC4065350	['right: three-Vessel view, demonstrating a Pulmonary to Aorta diameters disproportion.']	N/A	N/A	[('UBERON_0000055', 'vessel', 13, 'vessel'), ('UBERON_0002048', 'lung', 42, 'pulmonary'), ('UBERON_0000947', 'aorta', 55, 'aorta')]
PMC4065350	12/2013	S161-PMC4065350	['the hemodynamic compromise is considered mild when there is mild or no tricuspid and/or Pulmonary regurgitation, with normal Chambers diameters; moderate in the presence of tricuspid regurgitation with Right Ventricular dilation without hypertrophy and/or impaired contractility (fig.']	N/A	N/A	[('UBERON_0002048', 'lung', 88, 'pulmonary'), ('UBERON_0004151', 'cardiac chamber', 125, 'chambers'), ('UBERON_0002080', 'heart right ventricle', 202, 'right ventricular')]
PMC4065350	12/2013	S178-PMC4065350	['in fetal Lambs, mechanical occlusion of the fetal Ductus Arteriosus reproduces the hemodynamic and structural features of persistent Pulmonary hypertension of the newborn.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 9, 'lambs'), ('UBERON_0002254', 'thyroglossal duct', 50, 'ductus arteriosus'), ('UBERON_0002048', 'lung', 133, 'pulmonary')]
PMC4065350	12/2013	S308-PMC4065350	['immediately after Birth, there was Pulmonary hypertension by echocardiogram with ductal complete closure, severe Right Ventricular hypertrophy and dysfunction, and marked right-to-Left Atrial shunting.']	N/A	N/A	[('GO_0007567', 'parturition', 18, 'birth'), ('UBERON_0002048', 'lung', 35, 'pulmonary'), ('UBERON_0002080', 'heart right ventricle', 113, 'right ventricular'), ('UBERON_0002079', 'left cardiac atrium', 180, 'left atrial')]
PMC4065350	12/2013	S320-PMC4065350	['color flow doppler echocardiography depicted no flow signal documented into the dilated Pulmonary Trunk, indicating functional Pulmonary atresia.']	N/A	N/A	[('UBERON_0002333', 'pulmonary trunk', 88, 'pulmonary trunk'), ('UBERON_0002048', 'lung', 127, 'pulmonary')]
PMC4090565	6/2014	S52-PMC4090565	['women who consumed Alcohol, smoked, Nicotine, or any medication such as Ritodrine and Corticosteroids (except for fetal Lung Maturation) were excluded, such as amniotic Fluid disorders and Placental abnormalities.']	N/A	N/A	[('CHEBI_30879', 'alcohol', 19, 'alcohol'), ('CHEBI_25501', 'neoxanthin', 36, 'nicotine'), ('CHEBI_8874', 'rivastigmine', 72, 'ritodrine'), ('CHEBI_50850', 'etabonate ester', 86, 'corticosteroids'), ('GO_0060424', 'lung field specification', 120, 'lung maturation'), ('UBERON_0002048', 'lung', 120, 'lung'), ('UBERON_0006314', 'bodily fluid', 169, 'fluid'), ('UBERON_0001987', 'placenta', 189, 'placental')]
PMC4099383	7/2014	S221-PMC4099383	['Bronchial hyperresponsiveness (bhr) and Lung-function measurements\nPulmonary functions are assessed via various measures appropriate for the participant’s ability and age.']	N/A	N/A	[('UBERON_0002186', 'bronchiole', 0, 'Bronchial'), ('UBERON_0002048', 'lung', 40, 'lung'), ('UBERON_0002048', 'lung', 67, 'Pulmonary')]
PMC4099383	7/2014	S223-PMC4099383	['all subjects undergo Pulmonary function tests at the age of 7via conventional spirometry.']	N/A	N/A	[('UBERON_0002048', 'lung', 21, 'pulmonary')]
PMC4113768	7/2014	S477-PMC4113768	['rcts of Retinyl Palmitate increased Lung cancer risk in the large caret trial.']	N/A	N/A	[('CHEBI_84054', 'resveratrol glucuronide sulfate 2', 8, 'retinyl palmitate'), ('UBERON_0002048', 'lung', 36, 'lung')]
PMC4113768	7/2014	S490-PMC4113768	['Lung function (fev1 and fvc) was measured by spirometry at baseline and follow-up.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung')]
PMC4113768	7/2014	S1340-PMC4113768	['two Lung cancer patient are still alive and have survived 43 and 8 months so far.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung')]
PMC4113768	7/2014	S1660-PMC4113768	['participants diagnosed with Pulmonary tb in 2007-9 were invited to attend a follow-up visit in 2012-3.']	N/A	N/A	[('UBERON_0002048', 'lung', 28, 'pulmonary')]
PMC4113768	7/2014	S1680-PMC4113768	['method: Serum 25-Hydroxy Vitamin D3Level was measured in 180 Pulmonary tb patients with no co-morbidity.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 8, 'Serum'), ('CHEBI_68829', '[alpha-D-GalNAc-(1->4)]4-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tritrans,heptacis-undecaprenyl diphosphate', 14, '25-hydroxy vitamin D3level'), ('PR_000006844', 'dihydrofolate reductase', 33, 'D3level'), ('UBERON_0002048', 'lung', 61, 'pulmonary')]
PMC4113768	7/2014	S1775-PMC4113768	['background: the suffering from Lung cancer as the disease becoming the usual cause of cancer mortality has been on the rise rapidly in the world since the 20th century.']	N/A	N/A	[('UBERON_0002048', 'lung', 31, 'lung')]
PMC4113768	7/2014	S1779-PMC4113768	['the suffering from Lung cancer as the disease becoming the usual cause of cancer mortality has been on the rise rapidly in the world since the 20th century.']	N/A	N/A	[('UBERON_0002048', 'lung', 19, 'lung')]
PMC4113768	7/2014	S2910-PMC4113768	['Vitamin D sufficiency slows the progression of premalignant dysplasic lesions in the ntcu Mouse model of Lung Squamous Cell carcinoma\n\nmazzilli, s.a.; bogner, p.n.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 90, 'Mouse'), ('CL_0000173', 'pancreatic D cell', 105, 'Lung Squamous Cell'), ('UBERON_0002048', 'lung', 105, 'Lung')]
PMC4113768	7/2014	S2922-PMC4113768	['disease was evaluated by enumerating the percentage of hgd lesions, per the total area in serial H&e sections of the Lung.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 97, 'H'), ('UBERON_0002048', 'lung', 117, 'lung')]
PMC4113768	7/2014	S3090-PMC4113768	['there was no significant difference in atopy, eczema risk, Lung function or exhaled Nitric Oxide between supplemented groups and controls.']	N/A	N/A	[('UBERON_0002048', 'lung', 59, 'lung'), ('CHEBI_16480', 'nitric oxide', 84, 'nitric oxide')]
PMC4113768	7/2014	S3401-PMC4113768	['usa\njohnson, g., sighthill health centre, 380 calder road, edinburgh eh11 4au, scotland, uk\njohnson, n., department of clinical science and technology, ucl, uk\njohnston, s.l., national Heart and Lung institute, imperial college london, w2 1pg, uk\njolliffe, d.a., centre for primary care and public health, barts and the london school of medicine and dentistry, queen mary university of london, london e1 2ab, uk\njones, b., department of medicine, university of otago wellington, po box 7343 wellington south, wellington 6242, new zealand\njones, k.s., mrc Human nutrition research, elsie widdowson laboratory, fulbourn rd, cambridge, cb1 9nl, uk\njones, s.l., clinical biochemistry department, king george’s hospital, barking, havering and redbrige university hospitals nhs trust, essex, ig3 8yb, uk\njorde, r., division of internal medicine, university hospital of north norway, tromsø, norway\njorde, r., tromsø Endocrine research group, department of clinical medicine, the arctic university of norway, tromsø, norway\njorde, r., tromsø Endocrine research group, department of clinical medicine, university of tromsø, 9037 tromsø, norway\njørgensen, t., research centre for prevention and health, glostrup hospital, university of copenhagen, glostrup, denmark\njubulis, j., maine medical center/tufts university, pediatrics, portland, me, usa\njudkins, a.m., newtown union health service, 14 hall avenue, newtown, wellington 6021, new zealand\njunaid, k., department of microbiology and molecular genetics, university of the punjab, lahore, pakistan.']	N/A	N/A	[('UBERON_0000948', 'heart', 185, 'Heart'), ('UBERON_0002048', 'lung', 195, 'Lung'), ('NCBITaxon_10088', 'Mus <genus>', 555, 'Human'), ('GO_0009790', 'embryo development', 910, 'Endocrine'), ('GO_0009790', 'embryo development', 1035, 'Endocrine')]
PMC4155824	8/2014	S253-PMC4155824	['moreover, in cystic fibrosis patients colonized with p. aeruginosa , long-term lgg treatment (6×109cfu daily, in oral rehydration Solution) significantly decreased the incidence of Pulmonary exacerbations and increased body weight [119].']	N/A	N/A	[('CHEBI_75958', 'solution', 130, 'solution'), ('UBERON_0002048', 'lung', 181, 'pulmonary')]
PMC4160672	7/2014	S14-PMC4160672	['conclusion:\nfev6requires a short exhalation time and can effectively be used in place of fvc in evaluation of Lung function test during Pregnancy.']	N/A	N/A	[('UBERON_0002048', 'lung', 110, 'lung'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy')]
PMC4160672	7/2014	S16-PMC4160672	['introduction\nspirometry is the most widely used Pulmonary function test.']	N/A	N/A	[('UBERON_0002048', 'lung', 48, 'pulmonary')]
PMC4160672	7/2014	S46-PMC4160672	['those previously or currently treated for Pulmonary tuberculosis, Upper and Lower Respiratory Tract infections, Medications that alter Lung function (e.g., bronchodilators and constrictors), acute malaria in Pregnancy, Preeclampsia, diabetes in Pregnancy, febrile conditions, multiple Pregnancy, chronic Renal disease, Sickle Cell anemia, hiv positive patients, and other Pregnancy complications (threatened abortion, antepartum hemorrhage, etc.)']	N/A	N/A	[('UBERON_0002048', 'lung', 42, 'pulmonary'), ('UBERON_0002027', 'stratum corneum of epidermis', 66, 'upper ...'), ('UBERON_0004905', 'articulation', 76, 'lower respiratory tract'), ('CHEBI_25441', 'mycothiols', 112, 'medications'), ('UBERON_0002048', 'lung', 135, 'lung'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 219, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy'), ('GO_0007565', 'female pregnancy', 285, 'pregnancy'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('CL_0000129', 'microglial cell', 319, 'sickle cell'), ('GO_0007565', 'female pregnancy', 372, 'pregnancy')]
PMC4160672	7/2014	S69-PMC4160672	['the principal investigator, who was trained in the Pulmonary medicine unit of the unth on the use of spirometer, was in charge of the equipment and the method.']	N/A	N/A	[('UBERON_0002048', 'lung', 51, 'pulmonary')]
PMC4160672	7/2014	S81-PMC4160672	['the d’agostino and pearson omnibus normality tests were performed, and the Lung function data did not obey gaussian distribution (not normally distributed).']	N/A	N/A	[('UBERON_0002048', 'lung', 75, 'lung')]
PMC4172064	9/2014	S141-PMC4172064	['the most overt manifestations of this process are asthma exacerbation events, particularly those occasioning physician visits, and the decrement in ensuing Lung function after each episode reflects their intensity and duration (125).']	N/A	N/A	[('UBERON_0002048', 'lung', 156, 'lung')]
PMC4172064	9/2014	S248-PMC4172064	['the predictor set contains 45 different predictors, including measures of Respiratory infections, Immune function, Lung function, and maternal and environmental factors.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 74, 'respiratory'), ('UBERON_0002405', 'immune system', 98, 'immune'), ('UBERON_0002048', 'lung', 115, 'lung')]
PMC4208652	6/2014	S148-PMC4208652	['loss of adamts proteases in nonsmall‐cell Lung carcinomas is caused by hypermethylation in the Adamts Genes Promoters (dunn et al.2004).']	N/A	N/A	[('UBERON_0002048', 'lung', 42, 'lung'), ('PR_000003719', 'disintegrin and metalloproteinase domain-containing protein 23', 95, 'ADAMTS'), ('SO_0000704', 'gene', 102, 'genes'), ('SO_0000167', 'promoter', 108, 'promoters')]
PMC4233040	11/2014	S4-PMC4233040	['results\nmaternal Nutrient restriction increased Histone Acetylation levels of the Endothelin-1 (Et-1) Gene Promoter in Lung Tissue of offspring, but did not cause significant alterations of Dna Methylation.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 17, 'nutrient'), ('CHEBI_15358', 'histone', 48, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 48, 'histone acetylation'), ('PR_000043452', 'core histone', 48, 'histone'), ('PR_000007122', 'ephrin type-A receptor 2', 82, 'endothelin-1'), ('PR_000007222', 'protein C-ets-2', 96, 'ET-1'), ('SO_0000704', 'gene', 102, 'gene'), ('SO_0000167', 'promoter', 107, 'promoter'), ('UBERON_0002048', 'lung', 119, 'lung'), ('UBERON_0000479', 'tissue', 124, 'tissue'), ('GO_0006306', 'DNA methylation', 190, 'DNA methylation')]
PMC4233040	11/2014	S26-PMC4233040	['these epigenetic changes resulted in an iugr Rat being highly sensitive to hypoxia later in Life, causing more significant Pulmonary Arterial hypertension or Pulmonary Vascular Remodeling [18,20].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 45, 'rat'), ('UBERON_0000104', 'life cycle', 92, 'life'), ('UBERON_0002012', 'pulmonary artery', 123, 'pulmonary arterial'), ('UBERON_0002048', 'lung', 158, 'pulmonary'), ('GO_0006903', 'vesicle targeting', 168, 'vascular remodeling')]
PMC4233040	11/2014	S56-PMC4233040	['the Serum Ige level and Hematoxylin and eosin (H&e)-stained Lung Tissue were used to evaluate Rat asthma model.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 10, 'IgE'), ('CHEBI_51686', 'haematoxylin', 24, 'hematoxylin'), ('CHEBI_51686', 'haematoxylin', 47, 'H'), ('UBERON_0002048', 'lung', 60, 'lung'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 94, 'rat')]
PMC4233040	11/2014	S58-PMC4233040	['in H&e-stained Lung sections, the number of Eosinophils per square millimeter in the Peribronchial and Perivascular Tissue was assessed using image pro plus software (media cybernetics).']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 3, 'H'), ('UBERON_0002048', 'lung', 15, 'lung'), ('CL_0000771', 'eosinophil', 44, 'eosinophils'), ('UBERON_0014683', 'parasymphisial tooth whorl', 85, 'peribronchial ...'), ('GO_0043204', 'perikaryon', 103, 'perivascular'), ('UBERON_0014930', 'perivascular space', 103, 'perivascular'), ('UBERON_0000479', 'tissue', 116, 'tissue')]
PMC4233040	11/2014	S59-PMC4233040	['more than eight Bronchioles and Pulmonary Arteriole in a minimum of 10 high-power fields per Lung Tissue were randomly examined in a blinded fashion [27].']	N/A	N/A	[('UBERON_0002186', 'bronchiole', 16, 'bronchioles'), ('UBERON_0002012', 'pulmonary artery', 32, 'pulmonary arteriole'), ('UBERON_0002048', 'lung', 93, 'lung'), ('UBERON_0000479', 'tissue', 98, 'tissue')]
PMC4233040	11/2014	S61-PMC4233040	['total protein extracts were prepared from Lung Tissues in a Ripa Lysis buffer (50\xa0mm Tris, 150\xa0mm Nacl, 1% Np-40, 0.5% Sodium Deoxycholate, 0.1% Sds) containing protease inhibitors.']	N/A	N/A	[('UBERON_0002048', 'lung', 42, 'lung'), ('UBERON_0000479', 'tissue', 47, 'tissues'), ('GO_0055007', 'cardiac muscle cell differentiation', 60, 'RIPA'), ('GO_0019835', 'cytolysis', 65, 'lysis'), ('CHEBI_9754', 'tris', 85, 'Tris'), ('CHEBI_26710', 'sodium chloride', 98, 'NaCl'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 107, 'NP-40'), ('CHEBI_9177', 'sodium deoxycholate', 119, 'sodium deoxycholate'), ('CHEBI_8984', 'sodium dodecyl sulfate', 145, 'SDS')]
PMC4233040	11/2014	S68-PMC4233040	['Lung Tissue histological and immunohistochemistry assessment\nLung Tissue was fixed in Formaldehyde Solution and embedded in paraffin.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('UBERON_0002048', 'lung', 61, 'Lung'), ('UBERON_0000479', 'tissue', 66, 'tissue'), ('CHEBI_16842', 'formaldehyde', 86, 'formaldehyde'), ('CHEBI_75958', 'solution', 99, 'solution')]
PMC4233040	11/2014	S76-PMC4233040	['at least eight slides from each Lung were taken and analyzed.']	N/A	N/A	[('UBERON_0002048', 'lung', 32, 'lung')]
PMC4233040	11/2014	S77-PMC4233040	['quantitative real-time pcr for Et-1\ntotal rna was isolated from Lung Tissues according to the rneasy protocol (Axygen).']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 31, 'ET-1'), ('UBERON_0002048', 'lung', 64, 'lung'), ('UBERON_0000479', 'tissue', 69, 'tissues'), ('CHEBI_33310', 'neon atom', 111, 'Axygen')]
PMC4233040	11/2014	S84-PMC4233040	['Genomic dna was extracted from Lung Tissue and treated with 3\xa0m Sodium Bisulfite as described previously.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('CHEBI_86477', 'sodium sulfite', 64, 'sodium bisulfite')]
PMC4233040	11/2014	S94-PMC4233040	['a 100\xa0mg sample of Lung Tissue was ground in liquid nitrogen, and fixed with Formaldehyde.']	N/A	N/A	[('UBERON_0002048', 'lung', 19, 'lung'), ('UBERON_0000479', 'tissue', 24, 'tissue'), ('CHEBI_16842', 'formaldehyde', 77, 'formaldehyde')]
PMC4233040	11/2014	S116-PMC4233040	['a marked infiltration of Inflammatory Cells into Peribronchiolar and Perivascular lesions in the Lung Tissue sections from the ova-exposed Rats was observed compared with the non-ova-exposed groups.']	N/A	N/A	[('CL_0000902', 'induced T-regulatory cell', 25, 'inflammatory cells'), ('UBERON_0001297', 'serosa of uterus', 49, 'peribronchiolar'), ('UBERON_0014930', 'perivascular space', 69, 'perivascular'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0000479', 'tissue', 102, 'tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats')]
PMC4233040	11/2014	S119-PMC4233040	['this phenomenon was observed mainly in the Perivascular regions of the Lung (figure\xa02g, h).']	N/A	N/A	[('UBERON_0014930', 'perivascular space', 43, 'perivascular'), ('UBERON_0002048', 'lung', 71, 'lung')]
PMC4233040	11/2014	S120-PMC4233040	['caption (fig): figure 2\n\nrepresentative immunohistochemical staining for Et-1 (brown) and H&e staining in Lung Tissues from control 10\xa0weeks (a, e), iugr 10\xa0weeks (b, f), control ova (c, g), and iugr ova (d, h) groups (×200).']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 73, 'ET-1'), ('CHEBI_51686', 'haematoxylin', 90, 'H'), ('UBERON_0002048', 'lung', 106, 'lung'), ('UBERON_0000479', 'tissue', 111, 'tissues')]
PMC4233040	11/2014	S127-PMC4233040	['Lung Tissue Endothelin-1 (Et-1) levels and pathological changes\nthe Et-1 protein level of the iugr d1 group was similar to that of the control d1 group ( p \u2009=\u20090.524).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000007122', 'ephrin type-A receptor 2', 12, 'endothelin-1'), ('PR_000007222', 'protein C-ets-2', 26, 'ET-1'), ('PR_000007222', 'protein C-ets-2', 68, 'ET-1')]
PMC4233040	11/2014	S130-PMC4233040	['Lung Tissue Et-1 protein Expression levels in iugr ova and control ova-exposed groups were significantly higher than other non-ova-exposed groups ( p<0.05).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000007222', 'protein C-ets-2', 12, 'ET-1'), ('GO_0010467', 'gene expression', 25, 'expression')]
PMC4233040	11/2014	S132-PMC4233040	['caption (fig): figure 3\n\nExpression of Lung Tissue Et-1 proteins was measured using western blot analysis.']	N/A	N/A	[('GO_0010467', 'gene expression', 25, 'Expression'), ('UBERON_0002048', 'lung', 39, 'lung'), ('UBERON_0000479', 'tissue', 44, 'tissue'), ('PR_000007222', 'protein C-ets-2', 51, 'ET-1')]
PMC4233040	11/2014	S136-PMC4233040	['Lung Tissue Et-1 mrna levels in iugr and control ova-exposed groups were significantly higher than in non-ova-exposed groups ( p<0.05).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000007222', 'protein C-ets-2', 12, 'ET-1')]
PMC4233040	11/2014	S146-PMC4233040	['moreover, there was significant Inflammatory Cell infiltration in the Lung Tissue from iugr ova group (figure\xa02h).']	N/A	N/A	[('CL_0009002', 'inflammatory cell', 32, 'inflammatory cell'), ('UBERON_0002048', 'lung', 70, 'lung'), ('UBERON_0000479', 'tissue', 75, 'tissue')]
PMC4233040	11/2014	S147-PMC4233040	['methylation status of cpgs in the Et-1 core Promoter of Lung Tissue\nnineteen Cpg Sites within the proximal Promoter of the Rat Et-1 Gene were analyzed for methylation status.']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 34, 'ET-1'), ('SO_0000167', 'promoter', 44, 'promoter'), ('UBERON_0002048', 'lung', 56, 'lung'), ('UBERON_0000479', 'tissue', 61, 'tissue'), ('SO_0000036', 'matrix_attachment_site', 77, 'CpG sites'), ('SO_0000167', 'promoter', 107, 'promoter'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 123, 'rat'), ('PR_000007222', 'protein C-ets-2', 127, 'ET-1'), ('SO_0000704', 'gene', 132, 'gene')]
PMC4233040	11/2014	S154-PMC4233040	['caption (fig): figure 5\n\nmethylation profiles of theet-1core Promoter in Lung Tissue from iugr and control Rats are shown.']	N/A	N/A	[('SO_0000167', 'promoter', 61, 'promoter'), ('UBERON_0002048', 'lung', 73, 'lung'), ('UBERON_0000479', 'tissue', 78, 'tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 107, 'rats')]
PMC4233040	11/2014	S162-PMC4233040	['the Et-1 Gene Promoter Histone code in Lung Tissue\ntwo sites in the Et-1 Gene Promoter were analyzed for acetylated Histone H3, h3k9, and H4.']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 4, 'ET-1'), ('SO_0000704', 'gene', 9, 'gene'), ('SO_0000167', 'promoter', 14, 'promoter'), ('CHEBI_15358', 'histone', 23, 'histone'), ('PR_000043452', 'core histone', 23, 'histone'), ('UBERON_0002048', 'lung', 39, 'lung'), ('UBERON_0000479', 'tissue', 44, 'tissue'), ('PR_000007222', 'protein C-ets-2', 68, 'ET-1'), ('SO_0000138', 'gene_rearranged_at_DNA_level', 73, 'gene promoter'), ('CHEBI_15358', 'histone', 116, 'histone'), ('PR_000027594', 'histone H3', 116, 'histone H3'), ('PR_000027547', 'histone H2A', 138, 'H4')]
PMC4233040	11/2014	S164-PMC4233040	['the levels of acetylated Histone H3 in the Et-1 Promoter a1 region of Lung Tissue from iugr d1, iugr 10wks, and iugr ova groups were significantly higher than those from the age-matched control groups ( p \u2009=\u20090.039, 0.025, and 0.008, respectively).']	N/A	N/A	[('CHEBI_15358', 'histone', 25, 'histone'), ('PR_000027594', 'histone H3', 25, 'histone H3'), ('PR_000007222', 'protein C-ets-2', 43, 'ET-1'), ('SO_0000167', 'promoter', 48, 'promoter'), ('UBERON_0002048', 'lung', 70, 'lung'), ('UBERON_0000479', 'tissue', 75, 'tissue')]
PMC4233040	11/2014	S171-PMC4233040	['note that the levels of acetylated Histone H3 and h3k9 in the Et-1 Promoter a1 region of Lung Tissue from iugr groups were significantly higher than those from the age-matched control groups; while in the Et-1 Promoter a2 region there was no significant statistical difference between iugr and control groups.']	N/A	N/A	[('CHEBI_15358', 'histone', 35, 'histone'), ('PR_000027594', 'histone H3', 35, 'histone H3'), ('PR_000007222', 'protein C-ets-2', 62, 'ET-1'), ('SO_0000167', 'promoter', 67, 'promoter'), ('UBERON_0002048', 'lung', 89, 'lung'), ('UBERON_0000479', 'tissue', 94, 'tissue'), ('PR_000007222', 'protein C-ets-2', 205, 'ET-1'), ('SO_0000167', 'promoter', 210, 'promoter')]
PMC4233040	11/2014	S193-PMC4233040	['the Lung has the highest levels of Et-1 Secreted by Endothelium, Smooth Muscle, and Airway Epithelium.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung'), ('PR_000007222', 'protein C-ets-2', 35, 'ET-1'), ('GO_0046903', 'secretion', 40, 'secreted'), ('UBERON_0001986', 'endothelium', 52, 'endothelium'), ('UBERON_0001135', 'smooth muscle tissue', 65, 'smooth muscle'), ('UBERON_0010305', 'subdivision of conjunctiva', 84, 'airway epithelium')]
PMC4249952	12/2014	S15-PMC4249952	['lead is absorbed and spread through the Blood, resulting in long-term accumulation in the Liver, Kidney, Spleen, Lung, and Brain.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002106', 'spleen', 105, 'spleen'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000955', 'brain', 123, 'brain')]
PMC4251419	12/2014	S89-PMC4251419	['Antimicrobial proteins are Expressed at common Epithelial surfaces, including the Gut, skin, Urinary Tract and Lung [55].']	N/A	N/A	[('CHEBI_80959', 'N-Hydroxyl-tryptamine', 0, 'Antimicrobial'), ('GO_0010467', 'gene expression', 27, 'expressed'), ('UBERON_0000483', 'epithelium', 47, 'epithelial'), ('UBERON_0001555', 'digestive tract', 82, 'gut'), ('UBERON_0001553', 'medial tarsal artery', 93, 'urinary tract'), ('UBERON_0002048', 'lung', 111, 'lung')]
PMC4271720	12/2014	S203-PMC4271720	['other clinical manifestations involve Parenchymal Organs such as the Kidney, Lung, and Liver (mavragani and moutsopoulos, 2014).']	N/A	N/A	[('UBERON_0001804', 'capsule of lens', 38, 'parenchymal'), ('UBERON_0000062', 'organ', 50, 'organs'), ('UBERON_0002113', 'kidney', 69, 'kidney'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4284764	12/2014	S82-PMC4284764	['Egr1 encodes for Early Growth Response-1, a zinc-finger transcription factor that can be activated by oxidative stress to promote atherosclerosis, diabetes, and Pulmonary hypertension [27].']	N/A	N/A	[('PR_000006903', 'elongation factor 1-alpha 1', 0, 'Egr1'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 17, 'early growth response-1'), ('UBERON_0002048', 'lung', 161, 'pulmonary')]
PMC4292819	1/2015	S89-PMC4292819	['predicted Lung gas volume was used to calculate body composition, and body fat percent was calculated with the siri equation [19], assuming fm density of 0.9000\xa0kg/l and ffm density of 1.1000\xa0kg/l.']	N/A	N/A	[('UBERON_0002048', 'lung', 10, 'lung')]
PMC4302429	1/2015	S11-PMC4302429	['escherichia coli is a gram-negative bacillus causing local infections in the Urinary Tract, Abdomen, and Lungs.']	N/A	N/A	[('UBERON_0001553', 'medial tarsal artery', 77, 'urinary tract'), ('UBERON_0000916', 'abdomen', 92, 'abdomen'), ('UBERON_0002048', 'lung', 105, 'lungs')]
PMC4329404	10/2014	S4-PMC4329404	['results\nneonatal Mice that had in utero and early-Life Vitamin D deficiency had significantly increased Pulmonary cd3+Cd4+T1St2+cells and reduced Cd4+il-10+cells.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 17, 'mice'), ('UBERON_0000104', 'life cycle', 50, 'life'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0002048', 'lung', 104, 'pulmonary'), ('PR_000001204', 'C-C chemokine receptor type 8', 118, 'CD4'), ('PR_000016585', 'tripeptidyl-peptidase 1', 122, 'T1ST2'), ('PR_000001204', 'C-C chemokine receptor type 8', 146, 'CD4')]
PMC4329404	10/2014	S7-PMC4329404	['introduction of Vitamin D into the diet at weaning resulted in a significant reduction in Serum Ige levels, reduced Pulmonary Eosinophilia and Peri-Bronchiolar collagen deposition.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 90, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 96, 'IgE'), ('UBERON_0002048', 'lung', 116, 'pulmonary'), ('CL_0000771', 'eosinophil', 126, 'eosinophilia'), ('UBERON_0001789', 'outer nuclear layer of retina', 143, 'peri'), ('UBERON_0002186', 'bronchiole', 148, 'bronchiolar')]
PMC4329404	10/2014	S45-PMC4329404	['at 6\xa0weeks of age, Lung function was measured by the forced oscillation technique 4\xa0h after last challenge of pbs (b) or hdm (c).']	N/A	N/A	[('UBERON_0002048', 'lung', 19, 'lung')]
PMC4329404	10/2014	S50-PMC4329404	['one Lobe of Lung Tissue was mechanically chopped and incubated at 37°c for 1\xa0h in complete media containing 0.15\xa0mg/ml collagenase (type d; roche diagnostics, west sussex, uk) and 25\xa0μg/ml dnase (type 1; roche diagnostics).']	N/A	N/A	[('UBERON_0009912', 'anatomical lobe', 4, 'lobe'), ('UBERON_0002048', 'lung', 12, 'lung'), ('UBERON_0000479', 'tissue', 17, 'tissue')]
PMC4329404	10/2014	S58-PMC4329404	['cytokines and Immunoglobulins\nLung Tissue was homogenized at 50\xa0mg/ml in hbss (gibco, life technologies, paisley, uk) containing protease inhibitor tablets (roche diagnostics) and centrifuged at 800\xa0 g for 20\xa0min, and supernatants were collected.']	N/A	N/A	[('GO_0019814', 'immunoglobulin complex', 14, 'immunoglobulins'), ('UBERON_0002048', 'lung', 30, 'Lung'), ('UBERON_0000479', 'tissue', 35, 'tissue')]
PMC4329404	10/2014	S59-PMC4329404	['cytokines were analysed in Lung homogenate supernatants and Antibodies in Serum.']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'lung'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibodies'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4329404	10/2014	S63-PMC4329404	["Lung collagen quantification\ntotal Lung collagen was measured in Lung homogenates using the sircol assay (biocolor Life science assays, county antrim, uk) as per manufacturer's instructions."]	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0002048', 'lung', 35, 'lung'), ('UBERON_0002048', 'lung', 65, 'lung'), ('UBERON_0000104', 'life cycle', 115, 'Life')]
PMC4329404	10/2014	S68-PMC4329404	['results\n\nVitamin D insufficiency skews towards a Pulmonary th2 phenotype and reduces Il-10+T Regulatory Cells in Pregnant females\nPregnant female balb/c Mice received a Vitamin D-deficient diet from day-16 Gestation and throughout Lactation for a total of 4\xa0weeks to induce Vitamin D insufficiency (fig.1a) (29).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0002048', 'lung', 49, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 85, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 91, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 93, 'regulatory'), ('GO_0007565', 'female pregnancy', 113, 'pregnant'), ('GO_0007565', 'female pregnancy', 130, 'Pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 153, 'mice'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'gestation'), ('GO_0007595', 'lactation', 231, 'lactation'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4329404	10/2014	S69-PMC4329404	['Vitamin D insufficiency did not affect total Lung or Bronchoalveolar Lavage (Bal) Cells (fig.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002048', 'lung', 45, 'lung'), ('CL_1001566', 'bronchioalveolar stem cells', 53, 'bronchoalveolar lavage ... cells'), ('UBERON_0006182', 'mesonephric glomerular mesangium', 53, 'bronchoalveolar lavage'), ('UBERON_0006378', 'strand of vibrissa hair', 77, 'BAL')]
PMC4329404	10/2014	S70-PMC4329404	['s1a), but did result in a significant increase in Pulmonary cd3+Cd4+t1st2+Th2 cells and a reduction in Cd4+Il-10+t Regulatory Cells (fig.']	N/A	N/A	[('UBERON_0002048', 'lung', 50, 'pulmonary'), ('PR_000001204', 'C-C chemokine receptor type 8', 64, 'CD4'), ('CL_0002061', 'T-helper 9 cell', 74, 'Th2'), ('PR_000001204', 'C-C chemokine receptor type 8', 103, 'CD4'), ('PR_000001470', 'interleukin-28B', 107, 'IL-10'), ('CL_0000232', 'erythrocyte', 115, 'regulatory cells'), ('GO_0065007', 'biological regulation', 115, 'regulatory')]
PMC4329404	10/2014	S73-PMC4329404	['Lung compliance was also unaffected by Vitamin D status (data not shown).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4329404	10/2014	S74-PMC4329404	['Vitamin D supplementation after weaning reduces Pulmonary Eosinophilia\ninflammation was determined in Mice following 6\xa0weeks of Allergen exposure and Ingestion of either a normal or Vitamin D-deficient diet.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002048', 'lung', 48, 'pulmonary'), ('CL_0000771', 'eosinophil', 58, 'eosinophilia'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice'), ('CHEBI_50904', 'allergen', 128, 'allergen'), ('GO_0007631', 'feeding behavior', 150, 'ingestion'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4329404	10/2014	S75-PMC4329404	['Lung eosinophilia was highest in pups after in utero and early-Life insufficiency, and this was significantly reduced when pups were supplemented with Vitamin D at weaning (fig.2b).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000104', 'life cycle', 63, 'life'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC4329404	10/2014	S77-PMC4329404	['Eosinophils in the Bal (fig.2a) and total numbers of Inflammatory Cells in both the Bal and Lung were unaffected by Vitamin D status (fig.2a,b).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0006378', 'strand of vibrissa hair', 19, 'BAL'), ('CL_0000902', 'induced T-regulatory cell', 53, 'inflammatory cells'), ('UBERON_0006378', 'strand of vibrissa hair', 84, 'BAL'), ('UBERON_0002048', 'lung', 92, 'lung'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4329404	10/2014	S81-PMC4329404	['at 6\xa0weeks of age, both total and Eosinophil numbers in the bal (a) and Lung (b) were counted.']	N/A	N/A	[('CL_0000771', 'eosinophil', 34, 'eosinophil'), ('UBERON_0002048', 'lung', 72, 'lung')]
PMC4329404	10/2014	S82-PMC4329404	['+ represents Vitamin D intake; - represents a lack of Vitamin D. Lung sections stained with Haematoxylin and eosin from hdm-exposed pups with in utero vitamin d insufficiency (c).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002048', 'lung', 65, 'Lung'), ('CHEBI_51686', 'haematoxylin', 92, 'haematoxylin')]
PMC4329404	10/2014	S93-PMC4329404	['caption (fig): figure 3\n\nin utero and early-Life Vitamin D insufficiency skews towards a th2 environment and reduces T Regulatory Cells in the Lungs of pups.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 44, 'life'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 117, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 119, 'regulatory'), ('UBERON_0002048', 'lung', 143, 'lungs')]
PMC4329404	10/2014	S97-PMC4329404	['Lung Cells were harvested 4\xa0h after last challenge and analysed by flow cytometry.']	N/A	N/A	[('CL_0000178', 'Leydig cell', 0, 'Lung cells'), ('UBERON_0002048', 'lung', 0, 'Lung')]
PMC4329404	10/2014	S110-PMC4329404	['the cytokines Il-13, Il-5, Il-10 and Il-4 (b) were measured in the Lung of pups by elisa.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 14, 'IL-13'), ('PR_000001470', 'interleukin-28B', 21, 'IL-5'), ('PR_000001470', 'interleukin-28B', 27, 'IL-10'), ('PR_000001470', 'interleukin-28B', 37, 'IL-4'), ('UBERON_0002048', 'lung', 67, 'lung')]
PMC4329404	10/2014	S114-PMC4329404	['the skew in numbers of Th2 Cells in pups exposed to in utero and early-Life Vitamin D insufficiency was not evident in the level of Pulmonary th2 cytokines Il-13, Il-5 or Il-4 (fig.4b).']	N/A	N/A	[('CL_0000546', 'T-helper 2 cell', 23, 'Th2 cells'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002048', 'lung', 132, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 156, 'IL-13'), ('PR_000001470', 'interleukin-28B', 163, 'IL-5'), ('PR_000001470', 'interleukin-28B', 171, 'IL-4')]
PMC4329404	10/2014	S120-PMC4329404	['in utero and early-Life Vitamin D insufficiency did not alter Lung collagen content in hdm-exposed pups.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 19, 'life'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung')]
PMC4329404	10/2014	S123-PMC4329404	['caption (fig): figure 5\n\nintroduction of dietary Vitamin D after an in utero and early-Life insufficiency reduces house dust mite (hdm)-induced Lung collagen.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life'), ('UBERON_0002048', 'lung', 144, 'lung')]
PMC4329404	10/2014	S128-PMC4329404	['Periodic Acid–schiff (pas) staining was used to determine Goblet Cell hyperplasia in the Lungs using a semiquantitative scoring system (a).']	N/A	N/A	[('CHEBI_29019', 'nonanoic acid', 0, 'Periodic acid'), ('CL_0000160', 'goblet cell', 58, 'goblet cell'), ('UBERON_0002048', 'lung', 89, 'lungs')]
PMC4329404	10/2014	S130-PMC4329404	['Lung sections stained with Sirius Red (d); + represents Vitamin D intake; - represents a lack of Vitamin D. data are expressed as box and whisker plots; horizontal bar represents median, n \xa0=\xa09–16 combined from 2 experiments.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_34957', 'S-(1,2-Dichlorovinyl)glutathione', 27, 'Sirius red'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4329404	10/2014	S134-PMC4329404	['moreover, offspring from Vitamin D insufficient females exposed to hdm and Fed a Vitamin D-deficient diet had increased Pulmonary Eosinophilia, Th2 Cells and reduced Cd4+Il-10+Regulatory Cells.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007631', 'feeding behavior', 75, 'fed'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0002048', 'lung', 120, 'pulmonary'), ('CL_0000771', 'eosinophil', 130, 'eosinophilia'), ('CL_0000546', 'T-helper 2 cell', 144, 'Th2 cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 166, 'CD4'), ('PR_000001470', 'interleukin-28B', 170, 'IL-10'), ('CL_0000232', 'erythrocyte', 176, 'regulatory cells'), ('GO_0065007', 'biological regulation', 176, 'regulatory')]
PMC4329404	10/2014	S142-PMC4329404	['despite establishment of Vitamin D-replete and Vitamin D-deficient Mice through 5\xa0weeks of dietary manipulation of parent Mice before breeding, and from Birth of offspring until Adulthood, Ovalbumin exposure did not impact Lung function in offspring.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 67, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'mice'), ('GO_0007567', 'parturition', 153, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('CHEBI_83268', 'oxathiapiprolin', 189, 'ovalbumin'), ('PR_000012086', 'homeobox protein OTX2', 189, 'ovalbumin'), ('UBERON_0002048', 'lung', 223, 'lung')]
PMC4377870	3/2015	S64-PMC4377870	['oxidative stress caused by Reactive Oxygen Species (Ros), is generated in the Lungs due to various exposures, such as air pollution, airborne Irritants and typical Airway Inflammatory Cell Responses [51].']	N/A	N/A	[('CHEBI_26523', 'reactive oxygen species', 27, 'reactive oxygen species'), ('CHEBI_8756', 'RNA (poly(A))', 52, 'ROS'), ('UBERON_0002048', 'lung', 78, 'lungs'), ('CHEBI_33280', 'molecular messenger', 142, 'irritants'), ('UBERON_0001005', 'respiratory airway', 164, 'airway'), ('CL_0009002', 'inflammatory cell', 171, 'inflammatory cell'), ('GO_0002024', 'diet induced thermogenesis', 171, 'inflammatory cell responses')]
PMC4377870	3/2015	S91-PMC4377870	['[67] reported that in knock out Mice unable to synthesize Vitamin C, Vitamin C supplementation was able to prevent smoke induced emphysema and also to restore damaged Lung Tissue and decrease oxidative stress caused by smoke induced emphysema.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 32, 'mice'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('UBERON_0002048', 'lung', 167, 'lung'), ('UBERON_0000479', 'tissue', 172, 'tissue')]
PMC4377870	3/2015	S107-PMC4377870	['in the women’s health study ( n = 38,597), the risk of developing chronic Lung disease over a 10 year supplementation period was reduced by 10% in women using Vitamin E supplements (600 iu on alternate days) [87].']	N/A	N/A	[('UBERON_0002048', 'lung', 74, 'lung'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E')]
PMC4377870	3/2015	S205-PMC4377870	['there is an alteration in the Oligomerisation Of Adiponectin in copd resulting in increased concentrations of the Anti-inflammatory higher-molecular weight Isoform [164], and the Expression of adiponectin receptors in the Lung is also altered in comparison to healthy subjects [165].']	N/A	N/A	[('GO_0007279', 'pole cell formation', 30, 'oligomerisation of adiponectin'), ('CHEBI_67437', 'Euparin', 114, 'anti-'), ('SO_0001060', 'sequence_variant', 156, 'isoform'), ('GO_0010467', 'gene expression', 179, 'expression'), ('UBERON_0002048', 'lung', 222, 'lung')]
PMC4377870	3/2015	S215-PMC4377870	['amongst the obstructive Lung diseases, undernutrition is most commonly recognised as a feature of copd.']	N/A	N/A	[('UBERON_0002048', 'lung', 24, 'lung')]
PMC4379362	3/2015	S164-PMC4379362	['complications included: anemia (23%), septicemia (17%), transient Renal dysfunction (2%), and Pulmonary insufficiency (7%).']	N/A	N/A	[('UBERON_0002113', 'kidney', 66, 'renal'), ('UBERON_0002048', 'lung', 94, 'pulmonary')]
PMC4380381	3/2015	S62-PMC4380381	['Corticosteroids can be given to accelerate fetal Lung maturity if <34 weeks ga.11\n\nCerebral Venous Thrombosis\nthe risk of Cerebral Venous Thrombosis (cvt) is increased in the Prothrombotic Pregnant state.']	N/A	N/A	[('CHEBI_36961', 'chalcocarbonic acid', 0, 'Corticosteroids'), ('UBERON_0002048', 'lung', 49, 'lung'), ('UBERON_0008488', 'cremaster muscle', 83, 'Cerebral venous'), ('GO_0046755', 'viral budding', 92, 'venous thrombosis'), ('GO_0072584', 'caveolin-mediated endocytosis', 122, 'cerebral venous thrombosis'), ('UBERON_0008998', 'vasculature of brain', 122, 'cerebral venous'), ('GO_0006508', 'proteolysis', 175, 'prothrombotic'), ('GO_0007565', 'female pregnancy', 189, 'pregnant')]
PMC4405511	3/2015	S17-PMC4405511	['babies Born through cesarean are 5 times more in the risk of initial Pulmonary Blood pressure compared with the babies Born through Vaginal Delivery (2).']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'born'), ('UBERON_0002048', 'lung', 69, 'pulmonary'), ('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0007567', 'parturition', 119, 'born'), ('GO_0007601', 'visual perception', 132, 'vaginal'), ('UBERON_0001987', 'placenta', 132, 'vaginal'), ('GO_0007567', 'parturition', 140, 'delivery')]
PMC4448820	5/2015	S995-PMC4448820	['c. inflammation and nutrition in obstructive Lung diseases.']	N/A	N/A	[('UBERON_0002048', 'lung', 45, 'lung')]
PMC4448820	5/2015	S1004-PMC4448820	['inflammation occurs both locally in the Lungs but also in the Systemic Circulation (524).']	N/A	N/A	[('UBERON_0002048', 'lung', 40, 'lungs'), ('UBERON_0004341', 'primitive streak', 62, 'systemic'), ('UBERON_0009075', 'membrana tympaniformis', 71, 'circulation')]
PMC4448820	5/2015	S1007-PMC4448820	['chronic Lung inflammation in copd is followed by increased systemic inflammation, weight loss, and low muscle mass (526).']	N/A	N/A	[('UBERON_0002048', 'lung', 8, 'lung')]
PMC4466850	4/2015	S200-PMC4466850	['infants whose mothers Smoked early in Pregnancy and then stopped have better Pulmonary function because of their early Nicotine exposure.']	N/A	N/A	[('GO_0007601', 'visual perception', 22, 'smoked'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('UBERON_0002048', 'lung', 77, 'pulmonary'), ('CHEBI_25501', 'neoxanthin', 119, 'nicotine')]
PMC4494359	11/2013	S112-PMC4494359	['parturient vs. post-parturient mortality\nparturient mortality can be differentiated from post-parturient mortality by the farm personnel history or by evidence of Postnatal survival, e.g., the degree of Pulmonary atelectasis, Umbilical Thrombi or worn foetal Hooves.']	N/A	N/A	[('GO_0007567', 'parturition', 163, 'postnatal'), ('UBERON_0002048', 'lung', 203, 'pulmonary'), ('UBERON_0007118', 'umbilicus', 226, 'umbilical'), ('UBERON_0003113', 'dermatocranium', 236, 'thrombi'), ('UBERON_0007362', 'omasum', 259, 'hooves')]
PMC4494359	11/2013	S114-PMC4494359	['calves, which were Born alive have partially or fully inflated Lungs [55].']	N/A	N/A	[('GO_0007567', 'parturition', 19, 'born'), ('UBERON_0002048', 'lung', 63, 'lungs')]
PMC4494359	11/2013	S116-PMC4494359	['in most cases, the authors referred to ‘Lung expansion’, functional Lungs’, inflated Lungs’ or ‘the Lungs float in Water’ as the criteria for the presence or absence or degree of atelectasis.']	N/A	N/A	[('GO_0006412', 'translation', 40, 'lung'), ('UBERON_0002048', 'lung', 40, 'lung'), ('UBERON_0002048', 'lung', 68, 'lungs'), ('UBERON_0002048', 'lung', 85, 'lungs'), ('UBERON_0002048', 'lung', 100, 'lungs'), ('CHEBI_15377', 'water', 115, 'water')]
PMC4504131	7/2015	S7-PMC4504131	['the study identified Snails, Rats, hot Foods, and Animal Lungs as tabooed during Pregnancy.']	N/A	N/A	[('NCBITaxon_1', 'root', 21, 'snails'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 29, 'rats'), ('CHEBI_33290', 'food', 39, 'foods'), ('NCBITaxon_33208', 'Metazoa', 50, 'animal'), ('UBERON_0002048', 'lung', 57, 'lungs'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4504131	7/2015	S12-PMC4504131	['Pregnant women are forbidden from Eating snails, Rats, Snakes, hot Foods and Animal Lungs.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0051318', 'G1 phase', 34, 'eating'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 49, 'rats'), ('NCBITaxon_1', 'root', 55, 'snakes'), ('CHEBI_33290', 'food', 67, 'foods'), ('NCBITaxon_33208', 'Metazoa', 77, 'animal'), ('UBERON_0002048', 'lung', 84, 'lungs')]
PMC4504131	7/2015	S224-PMC4504131	['Pregnant women are forbidden from Eating various Foods including snails, Rats, Snakes, hot Foods and Animal Lungs.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0051318', 'G1 phase', 34, 'eating'), ('CHEBI_33290', 'food', 49, 'foods'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rats'), ('NCBITaxon_1', 'root', 79, 'snakes'), ('CHEBI_33290', 'food', 91, 'foods'), ('NCBITaxon_33208', 'Metazoa', 101, 'animal'), ('UBERON_0002048', 'lung', 108, 'lungs')]
PMC4509429	7/2015	S41-PMC4509429	['additionally, maternal (cesarean section or preeclampsia) and fetal (Birth weight, macrosomia, admission to a Neonatal Intensive Care Unit (nicu), fetal hypoglycemia, Lung complications, congenital anomalies, still Births, and neonatal deaths) outcomes were not significantly different between the groups [7].']	N/A	N/A	[('GO_0007567', 'parturition', 69, 'birth'), ('UBERON_0001759', 'vagus nerve', 110, 'neonatal'), ('UBERON_0011933', 'vibrissa unit', 119, 'intensive care unit'), ('UBERON_0002048', 'lung', 167, 'lung'), ('GO_0007567', 'parturition', 215, 'births')]
PMC4516488	9/2009	S78-PMC4516488	['a549 (Lung carcinoma) Cells (2 × 105) were plated in 96-well plates (triplicates), stimulated with ligands and incubated at 37°c (at 5% Co2).']	N/A	N/A	[('UBERON_0002048', 'lung', 6, 'lung'), ('CL_0000573', 'retinal cone cell', 22, 'cells'), ('CHEBI_16526', 'carbon dioxide', 136, 'CO2')]
PMC4530571	4/2015	S20-PMC4530571	['early-onset asthma in obese presents before the age of 12\xa0years, has no gender preference, and is characterized by severely decreased Pulmonary function, significant Airway hyperresponsiveness, and poor asthma Control.']	N/A	N/A	[('UBERON_0002048', 'lung', 134, 'pulmonary'), ('UBERON_0001005', 'respiratory airway', 166, 'airway'), ('GO_0065007', 'biological regulation', 210, 'control')]
PMC4539876	7/2015	S252-PMC4539876	['[116] reis and källén[117] reported 1 case of major malformation (Anal atresia along with Pulmonary malformation) in 51 Risperidone exposed Pregnancies.']	N/A	N/A	[('UBERON_0001245', 'anus', 66, 'anal'), ('UBERON_0002048', 'lung', 90, 'pulmonary'), ('CHEBI_8871', 'risperidone', 120, 'risperidone'), ('GO_0007565', 'female pregnancy', 140, 'pregnancies')]
PMC4661480	10/2015	S49-PMC4661480	['two of these, pallister-hall syndrome and smith-lemli-opitz syndrome, also demonstrate Cardiac, Pulmonary, Genitourinary, and multiple Skeletal abnormalities[3],[4].']	N/A	N/A	[('UBERON_0000948', 'heart', 87, 'cardiac'), ('UBERON_0002048', 'lung', 96, 'pulmonary'), ('UBERON_0002315', 'gray matter of spinal cord', 107, 'genitourinary'), ('UBERON_0004288', 'skeleton', 135, 'skeletal')]
PMC4666222	11/2015	S5-PMC4666222	['case presentation\na 37\xa0year-old caucasian female presents with four post-Partum days of unexplained Sinus tachycardia and absence of fever, Uterine tenderness, or Vaginal discharge, which elicits an extensive Cardiac and Pulmonary workup in multiple emergency rooms.']	N/A	N/A	[('GO_0007567', 'parturition', 73, 'partum'), ('UBERON_0001825', 'paranasal sinus', 100, 'sinus'), ('UBERON_0000995', 'uterus', 140, 'uterine'), ('UBERON_0001987', 'placenta', 163, 'vaginal'), ('UBERON_0000948', 'heart', 209, 'cardiac'), ('UBERON_0002048', 'lung', 221, 'pulmonary')]
PMC4666222	11/2015	S34-PMC4666222	['this prompted a Chest x-ray and Pulmonary computed tomography (ct) scan, both of which were negative for an acute process or Pulmonary embolus.']	N/A	N/A	[('UBERON_0001443', 'chest', 16, 'chest'), ('UBERON_0002048', 'lung', 32, 'pulmonary'), ('UBERON_0002048', 'lung', 125, 'pulmonary')]
PMC4666222	11/2015	S111-PMC4666222	['this complaint fueled an extensive Cardiac and Pulmonary evaluation at multiple facilities.']	N/A	N/A	[('UBERON_0000948', 'heart', 35, 'cardiac'), ('UBERON_0002048', 'lung', 47, 'pulmonary')]
PMC4673623	11/2015	S79-PMC4673623	['caption (table-wrap): table 1\n\nPlacental and fetal morphometric characteristics at cesarean section (0.9\xa0Gestation) in control ( n \xa0=\xa020–22) and hf-hed ( n \xa0=\xa05) group*controlhf-hedplacenta measures\u2003weight (g)210\xa0±\xa09214\xa0±\xa09\u2003efficiency (g fetus/g Placenta)3.9\xa0±\xa00.13.2\xa0±\xa00.2†\u2003volume (cm3)159\xa0±\xa018111\xa0±\xa026fetal measures\u2003body weight (g)806\xa0±\xa024675\xa0±\xa036†\u2003length (cm)38\xa0±\xa00.637\xa0±\xa01\u2003bmi (kg/m2)5.7\xa0±\xa00.15.1\xa0±\xa00.4‡\u2003ponderal index (kg/m3)15\xa0±\xa00.514\xa0±\xa01\u2003Brain (g)82\xa0±\xa0280\xa0±\xa02\u2003Heart (g)4.9\xa0±\xa00.24.2\xa0±\xa00.2\u2003Kidneys (g)4.5\xa0±\xa00.24.0\xa0±\xa00.2\u2003Liver (g)24\xa0±\xa00.920\xa0±\xa01.2‡\u2003Lung (g)17\xa0±\xa00.617\xa0±\xa01.5\u2003Pancreas (g)0.56\xa0±\xa00.060.44\xa0±\xa00.05\u2003Thymus (g)3.4\xa0±\xa00.203.4\xa0±\xa00.46fetal measures as percent fetal weight\u2003Placenta26\xa0±\xa00.832\xa0±\xa02.5†\u2003Brain11\xa0±\xa00.312\xa0±\xa00.6†\u2003Heart0.61\xa0±\xa00.020.63\xa0±\xa00.04\u2003Kidneys0.56\xa0±\xa00.020.59\xa0±\xa00.03\u2003Liver3.0\xa0±\xa00.063.0\xa0±\xa00.125\u2003Lungs2.2\xa0±\xa00.072.4\xa0±\xa00.12‡\u2003Pancreas0.07\xa0±\xa00.010.07\xa0±\xa00.01\u2003Thymus0.42\xa0±\xa00.020.52\xa0±\xa00.05†fetal measures as percent maternal weight\u2003fetal weight4.3\xa0±\xa00.13.5\xa0±\xa00.2†\u2003Placenta1.13\xa0±\xa00.041.09\xa0±\xa00.05\ndata are mean\xa0±\xa0sem.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'Placental'), ('GO_0007565', 'female pregnancy', 105, 'gestation'), ('UBERON_0001987', 'placenta', 246, 'placenta'), ('UBERON_0000955', 'brain', 445, 'Brain'), ('UBERON_0000948', 'heart', 467, 'Heart'), ('UBERON_0002113', 'kidney', 495, 'Kidneys'), ('UBERON_0002107', 'liver', 525, 'Liver'), ('UBERON_0002048', 'lung', 552, 'Lung'), ('UBERON_0001264', 'pancreas', 577, 'Pancreas'), ('UBERON_0002370', 'thymus', 612, 'Thymus'), ('UBERON_0001950', 'neocortex', 681, 'Placenta26'), ('UBERON_0009747', 'tail fold of embryonic disc', 707, 'Brain11'), ('UBERON_0000948', 'heart', 730, 'Heart0'), ('UBERON_0000975', 'sternum', 758, 'Kidneys0'), ('UBERON_0006009', 'cusp of cardiac valve', 788, 'Liver3'), ('UBERON_0000170', 'pair of lungs', 815, 'Lungs2'), ('UBERON_0001272', 'innominate bone', 842, 'Pancreas0'), ('UBERON_0002370', 'thymus', 873, 'Thymus0'), ('UBERON_0001987', 'placenta', 976, 'Placenta1')]
PMC4685088	12/2015	S7-PMC4685088	['Lung Development progresses in five distinct stages: Embryonic, pseudoglandular, canalicular, Saccular, and Alveolar (2,3).']	N/A	N/A	[('GO_0030324', 'lung development', 0, 'Lung development'), ('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000922', 'embryo', 53, 'embryonic'), ('UBERON_0000116', 'lung saccule', 94, 'saccular'), ('UBERON_0003215', 'alveolus', 108, 'alveolar')]
PMC4685088	12/2015	S8-PMC4685088	['Human preterm babies who develop bpd are Born in the late canalicular or early Saccular stage of Lung Development.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('GO_0007567', 'parturition', 41, 'born'), ('UBERON_0000116', 'lung saccule', 79, 'saccular'), ('GO_0030324', 'lung development', 97, 'lung development'), ('UBERON_0002048', 'lung', 97, 'lung')]
PMC4685088	12/2015	S10-PMC4685088	['the early Saccular stage is marked by initiation of Surfactant Production, Pulmonary Vascularization, and enlargement of terminal Airways (2–5).']	N/A	N/A	[('UBERON_0000116', 'lung saccule', 10, 'saccular'), ('CHEBI_35195', 'surfactant', 52, 'surfactant'), ('GO_0007268', 'chemical synaptic transmission', 52, 'surfactant production'), ('UBERON_0002048', 'lung', 75, 'pulmonary'), ('GO_0001944', 'vasculature development', 85, 'vascularization'), ('UBERON_0001005', 'respiratory airway', 130, 'airways')]
PMC4685088	12/2015	S20-PMC4685088	['this on top of Genetic susceptibility and prematurity leads to persistent inflammation leading to Lung remodeling and evolution of bpd.']	N/A	N/A	[('SO_0000704', 'gene', 15, 'genetic'), ('UBERON_0002048', 'lung', 98, 'lung')]
PMC4685088	12/2015	S27-PMC4685088	['Pulmonary inflammation in bpd is characterized by the presence of Inflammatory Cells like Neutrophils and Monocytes, pro-inflammatory cytokines, and other Mediators, including soluble adhesion Molecules.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('CL_0000902', 'induced T-regulatory cell', 66, 'inflammatory cells'), ('CL_0000775', 'neutrophil', 90, 'neutrophils'), ('CL_0000576', 'monocyte', 106, 'monocytes'), ('CHEBI_35222', 'inhibitor', 155, 'mediators'), ('CHEBI_36357', 'polyatomic entity', 193, 'molecules')]
PMC4685088	12/2015	S36-PMC4685088	['the premature Lung is exposed to ongoing oxidative and Cellular damage.']	N/A	N/A	[('UBERON_0002048', 'lung', 14, 'lung'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 55, 'cellular')]
PMC4685088	12/2015	S37-PMC4685088	['damaged Lung Tissue releases Chemotactic factors and inflammatory cytokines, such as Interleukin (Il)-1, Il-8 (Cxcl-8), and tumor Necrosis factor alpha (Tnf-Α).']	N/A	N/A	[('UBERON_0002048', 'lung', 8, 'lung'), ('UBERON_0000479', 'tissue', 13, 'tissue'), ('GO_0000090', 'mitotic anaphase', 29, 'chemotactic'), ('PR_000001470', 'interleukin-28B', 85, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 98, 'IL)-1'), ('PR_000001470', 'interleukin-28B', 105, 'IL-8'), ('PR_000001208', 'C-X-C chemokine receptor type 4', 111, 'CXCL-8'), ('PR_000001244', 'long-wave-sensitive opsin 1', 130, 'necrosis'), ('PR_000000134', 'tumor necrosis factor alpha', 153, 'TNF-α')]
PMC4685088	12/2015	S44-PMC4685088	['caption (table-wrap): table 1\n\nselected mediators of inflammation, their role, and corresponding Expression in bpd .mediators of inflammationroleexpression in bpd inflammatory cytokines interleukins: anti-inflammatory\u2003il-10suppresses inflammatory response by inhibiting Nf-Κb↓/↔\u2003Il-4, Il-13Suppresses inflammation by inhibiting pro-inflammatory cytokine production↔interleukins: pro-inflammatory\u2003Il-1, Il-6Acute Phase inflammatory response↑\u2003Il-8 (Cxcl-8)main chemoattractant for Neutrophils↑cc chemokines\u2003Monocyte Chemoattractant Protein (Mcp)-1, 1α, 1β, 2, 3recruit Inflammatory Cells to area of injury↑Macrophage Migration Inhibitory Factor (Mif)upstream regulator of Innate Immune Response↓Tumor Necrosis Factor Alpha (Tnf-Α)enhances Expression of other pro-inflammatory cytokines↑Transforming Growth Factor-Beta 1 (Tgf-Β1)pro-inflammatory↑ Matrix proteins Matrix Metalloproteinase-8Disordered Pulmonary remodeling after inflammation↑Matrix Metalloproteinase-9Pro-inflammatory, interferon-gamma (Ifn-Γ) Signaling↑ growth factors Endothelin-1Pro-inflammatory↑Vascular Endothelial growth factorpro-inflammatory↑/↓Connective Tissue growth factor (Ctgf)pro-inflammatory↑bombesin-like peptide (blp)increases Mast Cells in the Lung↑Breast Regression Protein-39 (Human analog is ykl-40)anti-inflammatory↓Pulmonary Hepatocyte Growth Factor (Hgf)Alveolar septation, Repair↓Keratinocyte Growth Factor (Kgf)Regulates Proliferation Of Alveolar Epithelial Cells↓ miscellaneous Interferon-Inducible Protein 9 (Ip-9\u2009–\u2009also known as Cxcl11)pro-inflammatory, Ifn-Γ Signaling↑Cyclooxygenase-2 (Cox-2)pro-inflammatory, Ifn-Γ Signaling↑Ccaat/Enhancer-Binding Protein (C/Ebp)pro-inflammatory, ifn-Γ Signaling↑endoglinpro-inflammatory↑periostinpro-inflammatory↑Clara Cell secretory proteinmodulates acute Pulmonary inflammation↓Parathyroid Hormone-Related Protein (Pthrp)Alveolar growth↓Angiopoietin-2Pro-inflammatory↑lactoferrinanti-inflammatory↓\n↑\u2009–\u2009increase; ↔\u2009–\u2009no change; ↓\u2009–\u2009decrease .']	N/A	N/A	[('GO_0010467', 'gene expression', 97, 'expression'), ('GO_0071159', 'NF-kappaB complex', 270, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 270, 'NF-κB'), ('PR_000001470', 'interleukin-28B', 279, 'IL-4'), ('PR_000029553', 'interferon-induced protein with tetratricopeptide repeats 5', 285, 'IL-13Suppresses'), ('PR_000001470', 'interleukin-28B', 396, 'IL-1'), ('PR_000001364', 'interleukin-1 receptor type II', 402, 'IL-6Acute'), ('GO_0051324', 'prophase', 412, 'phase'), ('PR_000001470', 'interleukin-28B', 441, 'IL-8'), ('PR_000001208', 'C-X-C chemokine receptor type 4', 447, 'CXCL-8'), ('CL_0000775', 'neutrophil', 479, 'neutrophils'), ('CL_0000576', 'monocyte', 505, 'Monocyte'), ('PR_000010704', 'metallothionein-2', 505, 'Monocyte chemoattractant protein ...'), ('PR_000010220', 'mannose-binding protein C', 539, 'MCP)-1'), ('CL_0000902', 'induced T-regulatory cell', 567, 'inflammatory cells'), ('CL_0000235', 'macrophage', 604, 'Macrophage'), ('GO_0003138', 'primary heart field specification', 604, 'Macrophage migration'), ('PR_000010193', 'mannan-binding lectin serine protease 1', 604, 'Macrophage migration inhibitory factor'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 644, 'MIF'), ('GO_0002244', 'hematopoietic progenitor cell differentiation', 670, 'innate immune response↓'), ('UBERON_0002405', 'immune system', 677, 'immune'), ('PR_000016190', 'trichohyalin-like protein 1', 693, 'Tumor necrosis factor alpha'), ('PR_000000134', 'tumor necrosis factor alpha', 722, 'TNF-α'), ('GO_0010467', 'gene expression', 737, 'expression'), ('PR_000001933', 'signal transducer and transcription activator STAT', 784, 'Transforming growth factor'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 811, 'beta 1'), ('PR_000000183', 'TGF-beta 2', 819, 'TGF-β1'), ('GO_0031430', 'M band', 844, 'Matrix'), ('GO_0031430', 'M band', 860, 'Matrix'), ('PR_000015455', 'sperm-associated antigen 16 protein', 860, 'Matrix metalloproteinase-8Disordered'), ('UBERON_0002048', 'lung', 897, 'pulmonary'), ('GO_0031430', 'M band', 937, 'Matrix'), ('PR_000010755', 'metaxin-1', 937, 'Matrix metalloproteinase-9Pro'), ('GO_0038171', 'cannabinoid signaling pathway', 999, 'IFN- ... signaling'), ('PR_000008920', 'interferon alpha-7', 999, 'IFN-γ'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 1032, 'Endothelin-1Pro'), ('UBERON_0006849', 'scapula', 1061, 'Vascular'), ('UBERON_0001986', 'endothelium', 1070, 'endothelial'), ('UBERON_0003588', 'forelimb connective tissue', 1114, 'Connective tissue'), ('PR_000006022', 'lysosomal protective protein', 1147, 'CTGF'), ('CL_0000097', 'mast cell', 1206, 'mast cells'), ('UBERON_0002048', 'lung', 1224, 'lung'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 1229, 'Breast regression protein-39'), ('UBERON_0000310', 'breast', 1229, 'Breast'), ('GO_0060033', 'anatomical structure regression', 1236, 'regression'), ('NCBITaxon_9606', 'Homo sapiens', 1259, 'human'), ('CL_0002241', 'pulmonary interstitial fibroblast', 1300, 'Pulmonary hepatocyte'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 1300, 'Pulmonary hepatocyte growth factor'), ('UBERON_0002048', 'lung', 1300, 'Pulmonary'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 1336, 'HGF'), ('UBERON_0003215', 'alveolus', 1340, 'Alveolar'), ('GO_0006281', 'DNA repair', 1360, 'repair'), ('GO_0007567', 'parturition', 1366, '↓'), ('CL_0000312', 'keratinocyte', 1367, 'Keratinocyte'), ('PR_000009266', 'calcium-activated potassium channel subunit beta-1', 1367, 'Keratinocyte growth factor'), ('PR_000009311', 'kinesin-like protein KIF3A', 1395, 'KGF'), ('GO_0065007', 'biological regulation', 1399, 'Regulates'), ('GO_0006626', 'protein targeting to mitochondrion', 1409, 'proliferation of ... epithelial cells↓'), ('CL_0000322', 'pneumocyte', 1426, 'alveolar epithelial cells↓'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 1426, 'alveolar epithelial'), ('PR_000029559', 'interleukin-36 beta', 1467, 'Interferon-inducible protein 9'), ('PR_000008989', 'interleukin-1 family member 7', 1499, 'IP-9'), ('PR_000006079', 'cytochrome b5 type B', 1520, 'CXCL11'), ('GO_0038043', 'interleukin-5-mediated signaling pathway', 1545, 'IFN-γ signaling'), ('PR_000008920', 'interferon alpha-7', 1545, 'IFN-γ'), ('PR_000005806', 'cytoplasmic polyadenylation element-binding protein 2', 1561, 'Cyclooxygenase-2'), ('PR_000003266', 'collagen type II alpha chain', 1579, 'Cox-2'), ('GO_0038043', 'interleukin-5-mediated signaling pathway', 1603, 'IFN-γ signaling'), ('PR_000008920', 'interferon alpha-7', 1603, 'IFN-'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 1619, 'CCAAT/enhancer-binding protein'), ('SO_0000165', 'enhancer', 1625, 'enhancer'), ('PR_000005309', 'CCAAT/enhancer-binding protein delta', 1651, 'C/EBP'), ('GO_0007229', 'integrin-mediated signaling pathway', 1679, 'γ signaling'), ('CL_0000574', 'erythrophore', 1742, 'Clara cell'), ('UBERON_0002048', 'lung', 1786, 'pulmonary'), ('PR_000013535', 'putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase', 1809, 'Parathyroid hormone-related protein'), ('UBERON_0001132', 'parathyroid gland', 1809, 'Parathyroid'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1846, 'PTHrP'), ('UBERON_0003215', 'alveolus', 1852, 'Alveolar'), ('PR_000004009', 'alpha-amylase 2B', 1868, 'Angiopoietin-2Pro')]
PMC4685088	12/2015	S60-PMC4685088	['to summarize, in experimental Animals, Antenatal inflammation causes Lung maturation and some degrees of Lung injury, which is modified by the not fully developed innate Immune response, exposure to Antenatal Steroids, and noxious Postnatal factors.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 30, 'animals'), ('GO_0007567', 'parturition', 39, 'antenatal'), ('UBERON_0002048', 'lung', 69, 'lung'), ('UBERON_0002048', 'lung', 105, 'lung'), ('GO_0007566', 'embryo implantation', 170, 'immune'), ('UBERON_0002405', 'immune system', 170, 'immune'), ('GO_0007567', 'parturition', 199, 'antenatal'), ('CHEBI_35341', 'steroid', 209, 'steroids'), ('GO_0007567', 'parturition', 231, 'postnatal')]
PMC4685088	12/2015	S79-PMC4685088	['Lung injury from mv results due to volutrauma, barotrauma, or atelectrauma (57).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung')]
PMC4685088	12/2015	S80-PMC4685088	['when Lungs are exposed to high tidal volumes, over distension leads to production of pro-inflammatory cytokines like Il-6, Il-8, and tnfα and reduced Expression of anti-inflammatory cytokines like Il-10 (58).']	N/A	N/A	[('UBERON_0002048', 'lung', 5, 'lungs'), ('PR_000001470', 'interleukin-28B', 117, 'IL-6'), ('PR_000001470', 'interleukin-28B', 123, 'IL-8'), ('GO_0010467', 'gene expression', 150, 'expression'), ('PR_000001470', 'interleukin-28B', 197, 'IL-10')]
PMC4685088	12/2015	S84-PMC4685088	['in neonatal Rats (7- to 14-day-old\u2009–\u2009in the Alveolar phase of Lung Development), high tidal volume ventilation increased Il-6 mrna and upregulated the Tgf-Β Signaling Molecule, ctgf mrna, and protein Expression compared to controls (61).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 12, 'rats'), ('UBERON_0003215', 'alveolus', 44, 'alveolar'), ('GO_0030324', 'lung development', 62, 'lung development'), ('UBERON_0002048', 'lung', 62, 'lung'), ('PR_000001470', 'interleukin-28B', 121, 'IL-6'), ('GO_0007179', 'transforming growth factor beta receptor signaling pathway', 151, 'TGF-β signaling'), ('PR_000000046', 'TGF-beta', 151, 'TGF-β'), ('CHEBI_62488', 'signalling molecule', 157, 'signaling molecule'), ('GO_0010467', 'gene expression', 200, 'expression')]
PMC4685088	12/2015	S87-PMC4685088	['in an invasive mv model in 2-week-old Mice (well into the Alveolar phase of Lung Development) for 1\u2009h, Il-6 Lung levels were increased in the high tidal volume ventilation group (64).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 38, 'mice'), ('UBERON_0003215', 'alveolus', 58, 'alveolar'), ('GO_0030324', 'lung development', 76, 'lung development'), ('UBERON_0002048', 'lung', 76, 'lung'), ('PR_000001470', 'interleukin-28B', 103, 'IL-6'), ('UBERON_0002048', 'lung', 108, 'lung')]
PMC4685088	12/2015	S88-PMC4685088	['studies conducted in 2- to 6-day-old Mice (late Saccular to early Alveolar phase of Lung Development) ventilated for 8–24\u2009h with room air or 40% o2revealed Dysregulated Elastin (eln) Assembly, a threefold to fivefold increase in Cell Death, Tgf-Β Activation, and a decrease in Vegf-R2 Expression (65,66).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 37, 'mice'), ('UBERON_0000116', 'lung saccule', 48, 'saccular'), ('UBERON_0003215', 'alveolus', 66, 'alveolar'), ('GO_0030324', 'lung development', 84, 'lung development'), ('UBERON_0002048', 'lung', 84, 'lung'), ('GO_0060203', 'clathrin-sculpted glutamate transport vesicle membrane', 156, 'dysregulated'), ('GO_0048251', 'elastic fiber assembly', 169, 'elastin ... assembly'), ('GO_0008219', 'cell death', 229, 'cell death'), ('PR_000000046', 'TGF-beta', 241, 'TGF-β'), ('GO_0032726', 'positive regulation of hepatocyte growth factor production', 244, '-β activation'), ('PR_000001980', 'ATP-sensitive inward rectifier potassium channel 11', 277, 'VEGF-R2'), ('GO_0010467', 'gene expression', 285, 'expression')]
PMC4685088	12/2015	S89-PMC4685088	['inhibiting Lung elastase activity by using recombinant Human elafin or Genetically modified Mice that Expressed elafin in the Vascular Endothelium was protective of the Lung injury (67,68).']	N/A	N/A	[('UBERON_0002048', 'lung', 11, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 55, 'human'), ('SO_0000704', 'gene', 71, 'genetically'), ('NCBITaxon_10088', 'Mus <genus>', 92, 'mice'), ('GO_0010467', 'gene expression', 102, 'expressed'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 126, 'vascular endothelium'), ('UBERON_0002048', 'lung', 169, 'lung')]
PMC4685088	12/2015	S95-PMC4685088	['this stretch injury also increases Expression of Granulocyte/Macrophage colony-stimulating factor mrna leading to Maturation Of Lung Monocytes to Alveolar Macrophages (57).']	N/A	N/A	[('GO_0010467', 'gene expression', 35, 'expression'), ('CL_0000120', 'granule cell', 49, 'granulocyte ...'), ('CL_0000235', 'macrophage', 61, 'macrophage'), ('GO_0002001', 'renin secretion into blood stream', 114, 'maturation of ... monocytes'), ('CL_0002140', 'acinar cell of sebaceous gland', 128, 'lung monocytes'), ('UBERON_0002048', 'lung', 128, 'lung'), ('UBERON_0003215', 'alveolus', 146, 'alveolar'), ('GO_0042637', 'catagen', 155, 'macrophages')]
PMC4685088	12/2015	S102-PMC4685088	['alteration of vegf was also noted in the Lungs of various Baboon models (75,76).']	N/A	N/A	[('UBERON_0002048', 'lung', 41, 'lungs'), ('NCBITaxon_33208', 'Metazoa', 58, 'baboon')]
PMC4685088	12/2015	S124-PMC4685088	['acute Lung injury caused by hyperoxia (figure2) occurs secondary to an inflammatory response, which causes destruction of the Alveolar–Capillary barrier, vascular leak, influx of Inflammatory Mediators, Pulmonary edema, and ultimately Cell Death (96).']	N/A	N/A	[('UBERON_0002048', 'lung', 6, 'lung'), ('UBERON_0003215', 'alveolus', 126, 'alveolar'), ('UBERON_0001982', 'capillary', 135, 'capillary'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 179, 'inflammatory mediators'), ('UBERON_0002048', 'lung', 203, 'pulmonary'), ('GO_0008219', 'cell death', 235, 'cell death')]
PMC4685088	12/2015	S126-PMC4685088	['at the cellular level, Alveolar or Interstitial Macrophages Express early response cytokines when exposed to Hyperoxia, which in turn attract Inflammatory Cells to the Lungs (19).']	N/A	N/A	[('CL_0002337', 'keratinocyte stem cell', 23, 'alveolar ... macrophages'), ('UBERON_0003215', 'alveolus', 23, 'alveolar'), ('UBERON_0005169', 'interstitial tissue', 35, 'interstitial'), ('GO_0010467', 'gene expression', 60, 'express'), ('CHEBI_35291', 'all-trans-retinoate', 109, 'hyperoxia'), ('CL_0000902', 'induced T-regulatory cell', 142, 'inflammatory cells'), ('UBERON_0002048', 'lung', 168, 'lungs')]
PMC4685088	12/2015	S127-PMC4685088	['caption (fig): figure 2\n\nphotomicrographs (×10, upper panel; ×20 lower panel; Hematoxylin and eosin stain) of neonatal Lung injury noted in newborn Mice at Postnatal day 2, after 100% O2Exposure since Birth .']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 78, 'hematoxylin'), ('UBERON_0002048', 'lung', 119, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'mice'), ('GO_0007567', 'parturition', 156, 'postnatal'), ('CHEBI_7716', 'Obtusifolin 2-glucoside', 184, 'O2exposure'), ('GO_0007567', 'parturition', 201, 'birth')]
PMC4685088	12/2015	S128-PMC4685088	['note the Alveolar exudates and presence of Inflammatory Cells in the hyperoxia-exposed Lungs compared with litter-mate controls in room air.']	N/A	N/A	[('UBERON_0003215', 'alveolus', 9, 'alveolar'), ('CL_0000902', 'induced T-regulatory cell', 43, 'inflammatory cells'), ('UBERON_0002048', 'lung', 87, 'lungs')]
PMC4685088	12/2015	S140-PMC4685088	['Lung mrna for Il-1Β also increases in neonatal Mice exposed to hyperoxia (103).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('PR_000001383', 'interleukin-22', 14, 'IL-1β'), ('NCBITaxon_10088', 'Mus <genus>', 47, 'mice')]
PMC4685088	12/2015	S144-PMC4685088	['Cinc-1 in premature Rat Lungs (105) and newborn Rabbits (104) exposed to hyperoxia was upregulated.']	N/A	N/A	[('PR_000005438', 'charged multivesicular body protein 4c', 0, 'CINC-1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rat'), ('UBERON_0002048', 'lung', 24, 'lungs'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 48, 'rabbits')]
PMC4685088	12/2015	S146-PMC4685088	['the Lungs of Hyperoxia-exposed neonatal Mice had no change in Il-10 mrna Expression (103).']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lungs'), ('CHEBI_35291', 'all-trans-retinoate', 13, 'hyperoxia'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('PR_000001470', 'interleukin-28B', 62, 'IL-10'), ('GO_0010467', 'gene expression', 73, 'expression')]
PMC4685088	12/2015	S160-PMC4685088	['among the Inflammatory Mediators of Hyperoxia-induced Lung injury that can mimic the bpd phenotype in room air, the well-defined ones are Il-1Β, Tgf-Β1, Ctgf, Ifn-Γ, and mif.']	N/A	N/A	[('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 10, 'inflammatory mediators'), ('CHEBI_35291', 'all-trans-retinoate', 36, 'hyperoxia'), ('UBERON_0002048', 'lung', 54, 'lung'), ('PR_000001383', 'interleukin-22', 138, 'IL-1β'), ('PR_000000183', 'TGF-beta 2', 145, 'TGF-β1'), ('PR_000006022', 'lysosomal protective protein', 153, 'CTGF'), ('PR_000008920', 'interferon alpha-7', 159, 'IFN-γ')]
PMC4685088	12/2015	S163-PMC4685088	['for the chorioamnionitis Rodent models, the exposure to Lps is over a few days in the late canalicular/early Saccular stage of Lung Development.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 25, 'rodent'), ('CHEBI_16412', 'lipopolysaccharide', 56, 'LPS'), ('UBERON_0000116', 'lung saccule', 109, 'saccular'), ('GO_0030324', 'lung development', 127, 'lung development'), ('UBERON_0002048', 'lung', 127, 'lung')]
PMC4685088	12/2015	S164-PMC4685088	['for the relative short duration of exposure to invasive mv and hyperoxia in Rodent models, 1 Postnatal day in the Saccular stage of Lung Development is equivalent to 3–4\u2009weeks in a Human preterm infant.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 76, 'rodent'), ('GO_0007567', 'parturition', 93, 'postnatal'), ('UBERON_0000116', 'lung saccule', 114, 'saccular'), ('GO_0030324', 'lung development', 132, 'lung development'), ('UBERON_0002048', 'lung', 132, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 181, 'human')]
PMC4685088	12/2015	S169-PMC4685088	['in concordance, preterm neonates with bpd have Anatomical and functional Pulmonary deficits well into childhood and as Adults (114–116).']	N/A	N/A	[('UBERON_0001062', 'anatomical entity', 47, 'anatomical'), ('UBERON_0002048', 'lung', 73, 'pulmonary'), ('UBERON_0007023', 'adult organism', 119, 'adults')]
PMC4689556	12/2015	S146-PMC4689556	['strength is lent to this conclusion when the healthcare utilisation data are contextualised within the other clinical data obtained from this trial in which supplementation did not influence odds of Respiratory or allergic symptoms, or measures of Lung Function/inflammation and Immune Development [14].']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 199, 'respiratory'), ('GO_0060432', 'lung pattern specification process', 248, 'lung function'), ('UBERON_0002048', 'lung', 248, 'lung'), ('GO_0001822', 'kidney development', 279, 'immune development'), ('UBERON_0002405', 'immune system', 279, 'immune')]
PMC4739392	2/2016	S6-PMC4739392	['at study start and end, Lung function parameters, specific Ige, in vitro Allergen-induced Cytokine Production in Peripheral Blood Mononuclear Cells (Pbmc), Plasma ecp, Urinary 8-Oxodg as marker of oxidation, Fatty Acid profiles of Erythrocytes, and routine Haematological parameters were determined.']	N/A	N/A	[('UBERON_0002048', 'lung', 24, 'lung'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 59, 'IgE'), ('CHEBI_50904', 'allergen', 73, 'allergen'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 90, 'cytokine production'), ('CL_0000111', 'peripheral neuron', 113, 'peripheral blood mononuclear cells'), ('UBERON_0012101', 'perinatal stage', 113, 'peripheral blood'), ('GO_0031097', 'medial cortex', 130, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 149, 'PBMC'), ('UBERON_0001969', 'blood plasma', 156, 'plasma'), ('UBERON_0001088', 'urine', 168, 'urinary'), ('CHEBI_82778', 'citrate-coated silver nanoparticle', 176, '8-oxodG'), ('CHEBI_35366', 'fatty acid', 208, 'fatty acid'), ('CL_0000232', 'erythrocyte', 231, 'erythrocytes'), ('UBERON_0000178', 'blood', 257, 'haematological')]
PMC4739392	2/2016	S50-PMC4739392	['combined gc-fid and silver-ion hplc analysisafatty Acid (common name)claplacebo oilc14:0 (Myristic Acid)00.1c16:0 (Palmitic Acid)0.18.2c18:0 (Stearic Acid)0.53.4c18:1 c 9 (Oleic Acid)1.819.9c18:1 c 11 (Vaccenic Acid)0.30c18:2 N -6 (Linoleic Acid)3.164.5c18:3 n -3 (Alpha-Linolenic Acid)0.21.0c20:0 (Arachidic Acid)0.10.5c20:1 (eicosenoic acid)0.50.3c20:5 N -3 (Eicosapentaenoic Acid)00other6.82.3∑ cla86.60 c 9, t 11b66.1 c 9, c 1119.2 t 9, t 11c0.9 t 10, c 120.1\nafor detailed information, please refer to [11]\nbcorrected for co-eluting t 8, c 10\nccorrected for co-eluting t 8, t 10\nat the beginning and at the end of the study, dietary records on the three preceding days were requested, Lung function parameters were assessed by Whole Body plethysmography and spirometry, and Venous Blood and 24\xa0h-Urine samples were collected for further analyses.']	N/A	N/A	[('CHEBI_37527', 'acid', 51, 'acid'), ('CHEBI_25459', 'myrtenic acid', 90, 'myristic acid'), ('CHEBI_15756', 'hexadecanoic acid', 115, 'palmitic acid'), ('CHEBI_28842', 'octadecanoic acid', 142, 'stearic acid'), ('CHEBI_30814', 'digallic acid', 172, 'oleic acid'), ('CHEBI_17418', 'valeric acid', 202, 'vaccenic acid'), ('CHEBI_70674', 'erythro-carolignan E', 226, 'n -'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 232, 'linoleic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 262, '3 ('), ('CHEBI_27432', 'alpha-linolenic acid', 265, 'alpha-linolenic acid'), ('CHEBI_28822', 'icosanoic acid', 299, 'arachidic acid'), ('CHEBI_76331', 'N-acetoxy-2-acetamidofluorene', 355, 'n -3 (eicosapentaenoic acid'), ('UBERON_0002048', 'lung', 690, 'lung'), ('UBERON_0000468', 'multicellular organism', 732, 'whole body'), ('UBERON_0001638', 'vein', 779, 'venous'), ('UBERON_0000178', 'blood', 786, 'blood'), ('UBERON_0001088', 'urine', 801, 'urine')]
PMC4739392	2/2016	S96-PMC4739392	['for the Pulmonary function and immunological readouts such as in vitro cytokines, the type of allergy (seasonal vs. all-year) was additionally included as third fixed effect and the extent of Pollination was entered as covariate.']	N/A	N/A	[('UBERON_0002048', 'lung', 8, 'pulmonary'), ('GO_0009856', 'pollination', 192, 'pollination')]
PMC4739392	2/2016	S128-PMC4739392	['Pulmonary function parameters\n\nvolume parameters\nthe vital capacity (vc) is the maximum amount of air that can be expelled from the Lungs after a maximum inspiration.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('UBERON_0002048', 'lung', 132, 'lungs')]
PMC4739392	2/2016	S129-PMC4739392	['the addition of vc with the residual volume (rv) results in the total Lung capacity (tlc).']	N/A	N/A	[('UBERON_0002048', 'lung', 70, 'lung')]
PMC4739392	2/2016	S130-PMC4739392	['the rv is the gas volume that remains in the Lung after maximal expiration, thereby preventing Alveolar collapse.']	N/A	N/A	[('UBERON_0002048', 'lung', 45, 'lung'), ('UBERON_0003215', 'alveolus', 95, 'alveolar')]
PMC4739392	2/2016	S131-PMC4739392	['in obstructive Respiratory disorders rv is elevated by air trapping, which causes Pulmonary hyper-inflation [21].']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 15, 'respiratory'), ('UBERON_0002048', 'lung', 82, 'pulmonary')]
PMC4739392	2/2016	S133-PMC4739392	['caption (table-wrap): table 5\n\nPulmonary function parametersparameter (% predicted)placebocla p valuepost-hocstartendstartendgr\u2009×\u2009ti\u2009×\u2009allati\u2009×\u2009allballcfvc 0.4450.680 \u2003phl p197/94101/9696/9597/97\u2003Der P1/fel d197/9998/10090/9092/90rv 0.7610.402 \u2003phl p1106/109105/120114/104109/97\u2003Der P1/fel d1108/111123/123101/95111/114fev1 0.7930.041 \u2003Phl P193/91101/9595/9799/96 0.039 \u2003Der P1/fel d1104/112105/11497/9595/95mmef 0.8870.080 \u2003Phl P169/6676/7073/6977/77\u2003Der P1/fel d192/9391/9087/8781/84\ndata are expressed as mean/median;astudy group (placebo/cla)\u2009×\u2009study time point (start/end)\u2009×\u2009type of allergy (seasonal/all-year);bstudy time point (start/end)\u2009×\u2009type of allergy (seasonal/all-year);Cseasonal (Phl P1) vs. all-year (Der P1/Fel D1)\n\nflow parameters\nthe forced Expiratory volume in 1\xa0s (fev1) is the volume exhaled during the first second of a forced expiration and is given as %fev predicted, with references adapted for age, body height and gender.']	N/A	N/A	[('UBERON_0002048', 'lung', 31, 'Pulmonary'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 196, 'Der p1'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 279, 'Der p1'), ('PR_000013504', 'periodic tryptophan protein 1', 336, 'Phl p193'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 371, 'Der p1'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 425, 'Phl p169'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 452, 'Der p1'), ('UBERON_0001450', 'calcaneus', 684, 'cseasonal'), ('PR_000013509', 'peroxisomal membrane protein 2', 695, 'Phl p1'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 717, 'Der p1'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 724, 'Fel d1'), ('GO_0010467', 'gene expression', 760, 'expiratory')]
PMC4763449	2/2016	S22-PMC4763449	['she had had a history of unprovoked Pulmonary embolism 4\xa0years after the Renal transplant and had been treated with oral Anticoagulation for 2\xa0years.']	N/A	N/A	[('UBERON_0002048', 'lung', 36, 'pulmonary'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0051648', 'vesicle localization', 121, 'anticoagulation')]
PMC4763449	2/2016	S31-PMC4763449	['per hour on dialysis to prevent dialyzer clotting (dialyzer utilized was fx 800 fresenius medical care dialyzer), and Tinzaparin for prophylaxis against Pulmonary embolism.']	N/A	N/A	[('CHEBI_35020', 'tributyrin', 118, 'tinzaparin'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC4764298	2/2016	S39-PMC4764298	['pe was defined as a Blood pressure greater than 140/90 mmhg on two occasions six hours apart and proteinuria greater than 2+ on dipstick or greater than 300 mg in 24 hour Urine collection, supplemented by clinical symptoms and lab test results such as hellp (hemolysis, elevated Liver enzymes, and low Platelet count), thrombocytopenia, Renal insufficiency, impaired Liver function, Pulmonary edema, Cerebral or Visual symptoms, and elevated Uric Acid levels, in the absence of proteinuria.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0001088', 'urine', 171, 'urine'), ('UBERON_0002107', 'liver', 279, 'liver'), ('CL_0000233', 'platelet', 302, 'platelet'), ('UBERON_0002113', 'kidney', 337, 'renal'), ('UBERON_0002107', 'liver', 367, 'liver'), ('UBERON_0002048', 'lung', 383, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 400, 'cerebral'), ('GO_0007601', 'visual perception', 412, 'visual'), ('CHEBI_27226', 'uric acid', 442, 'uric acid')]
PMC4794442	3/2016	S60-PMC4794442	['signs of impending herniation include seizures, neurogenic Pulmonary edema, hypercapnic Respiratory failure, obtundation, hyperemesis, dilated Pupils, and decorticate or decerebrate posturing.']	N/A	N/A	[('UBERON_0002048', 'lung', 59, 'pulmonary'), ('UBERON_0001004', 'respiratory system', 88, 'respiratory'), ('UBERON_0001771', 'pupil', 143, 'pupils')]
PMC4811441	3/2016	S20-PMC4811441	['Pulmonary edema, eclampsia, Renal or Liver failure and stroke [3].']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'pulmonary'), ('UBERON_0002113', 'kidney', 28, 'renal'), ('UBERON_0002107', 'liver', 37, 'liver')]
PMC4825102	2/2016	S116-PMC4825102	['Curcumin treatment Modulates the Expression profile of several Mirna, including up-regulation of Mirna-26A in a549 Human Lung adenocarcinoma cell line (Curcumin: 15 µmfor 48 h)(103)and Mir-181A in bxpc-3 Human Pancreatic Carcinoma cell line (Curcumin: 10 µmfor 72 h)(104).']	N/A	N/A	[('CHEBI_3962', 'curcumin', 0, 'Curcumin'), ('GO_0065007', 'biological regulation', 19, 'modulates'), ('GO_0010467', 'gene expression', 33, 'expression'), ('SO_0000276', 'miRNA', 63, 'miRNA'), ('PR_000010220', 'mannose-binding protein C', 97, 'miRNA-26a'), ('NCBITaxon_9606', 'Homo sapiens', 115, 'human'), ('UBERON_0002048', 'lung', 121, 'lung'), ('CHEBI_3962', 'curcumin', 152, 'curcumin'), ('PR_000005450', 'chromatin accessibility complex protein 1', 185, 'miR-181a'), ('NCBITaxon_9606', 'Homo sapiens', 204, 'human'), ('UBERON_0001264', 'pancreas', 210, 'pancreatic'), ('CL_0010022', 'cardiac neuron', 221, 'carcinoma'), ('CHEBI_3962', 'curcumin', 242, 'curcumin')]
PMC4829879	2/2016	S19-PMC4829879	['in this model, we Fed dams with hfd or control diet (cd) during Pregnancy and Lactation and compared the consequences in their offspring in terms of metabolic profiles, inflammatory status, neurotrophic pathways, and Lung function in early vs. Adult Life.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 18, 'fed'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007595', 'lactation', 78, 'lactation'), ('UBERON_0002048', 'lung', 217, 'lung'), ('UBERON_0000113', 'post-juvenile adult stage', 244, 'adult life')]
PMC4829879	2/2016	S25-PMC4829879	['in newborns Delivered from hfd dams, Lung inflammation was driven by Interleukin (Il)-1Α, Il-1Β, Il-2, Il-5, Il-9, Eotaxin, tumor necrosis factor α (Tnf-Α), and Monocyte Chemoattractant Protein-1 (Mcp-1) ( table 2 ).']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'delivered'), ('UBERON_0002048', 'lung', 37, 'lung'), ('PR_000001470', 'interleukin-28B', 69, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 82, 'IL)-1α'), ('PR_000001383', 'interleukin-22', 90, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 97, 'IL-2'), ('PR_000001470', 'interleukin-28B', 103, 'IL-5'), ('PR_000001470', 'interleukin-28B', 109, 'IL-9'), ('PR_000007209', 'steroid hormone receptor ERR2', 115, 'eotaxin'), ('PR_000000134', 'tumor necrosis factor alpha', 149, 'TNF-α'), ('CL_0000576', 'monocyte', 161, 'monocyte'), ('PR_000010206', 'matrilin-2', 161, 'monocyte chemoattractant protein-1'), ('PR_000010439', 'myeloid leukemia factor 1', 197, 'MCP-1')]
PMC4829879	2/2016	S26-PMC4829879	['in weanlings Born to hfd dams, the most significant changes were an average 50-fold increase in Serum levels of Il-5 and a 5-fold increase in Mcp-1 ( table 3 ); the same cytokines were significantly increased in the Lung Tissues, and the latter also in Bronchoalveolar Lavage (bal) obtained from the same hfd weanlings ( table 4 ).']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'born'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('PR_000001470', 'interleukin-28B', 112, 'IL-5'), ('PR_000010439', 'myeloid leukemia factor 1', 142, 'MCP-1'), ('UBERON_0002048', 'lung', 216, 'lung'), ('UBERON_0000479', 'tissue', 221, 'tissues'), ('UBERON_0006182', 'mesonephric glomerular mesangium', 253, 'bronchoalveolar lavage')]
PMC4829879	2/2016	S34-PMC4829879	['following challenge with aerosolized Methacholine, significantly higher Airway resistance and lower Lung compliance were observed in hfd offspring with cumulative doses up to 8.75\u2009mg/ml.']	N/A	N/A	[('CHEBI_6805', 'methacycline', 37, 'methacholine'), ('UBERON_0001005', 'respiratory airway', 72, 'airway'), ('UBERON_0002048', 'lung', 100, 'lung')]
PMC4829879	2/2016	S36-PMC4829879	['response to Rsv\nafter 5 d of infection at 2\u2009wk of age, Rsv titers measured in Lung Tissues of weanlings Born to hfd dams were on average threefold higher than in age-matched controls Born to cd dams ( figure 3a ; n = 7 per group).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 12, 'RSV'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'RSV'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0000479', 'tissue', 83, 'tissues'), ('GO_0007567', 'parturition', 104, 'born'), ('GO_0007567', 'parturition', 183, 'born')]
PMC4829879	2/2016	S65-PMC4829879	['after the neonatal stage, high Il-5 and Mcp-1 concentrations persisted both systemically and locally in the Lungs during development of pups exposed to maternal hfd during Gestation.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 31, 'IL-5'), ('PR_000010439', 'myeloid leukemia factor 1', 40, 'MCP-1'), ('UBERON_0002048', 'lung', 108, 'lungs'), ('GO_0007565', 'female pregnancy', 172, 'gestation')]
PMC4829879	2/2016	S74-PMC4829879	['Neurotrophins\nGene Expression of Ngf, Bdnf, and their respective cognate receptors was significantly upregulated in the Lungs of pups Born to mothers Fed hfd during Pregnancy.']	N/A	N/A	[('PR_000021998', 'neurotrophin', 0, 'Neurotrophins'), ('GO_0010467', 'gene expression', 14, 'Gene expression'), ('SO_0000704', 'gene', 14, 'Gene'), ('PR_000011159', 'nexilin', 33, 'NGF'), ('PR_000004716', 'brain-derived neurotrophic factor', 38, 'BDNF'), ('UBERON_0002048', 'lung', 120, 'lungs'), ('GO_0007567', 'parturition', 134, 'born'), ('GO_0007631', 'feeding behavior', 150, 'fed'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC4829879	2/2016	S81-PMC4829879	['inoculation of Rsv in weanlings Born to hfd mothers resulted in more efficient Viral Replication in Lung Tissues compared with age-matched pups Born to dams Fed with a balanced diet and then inoculated with the same Virus suspension.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 15, 'RSV'), ('GO_0007567', 'parturition', 32, 'born'), ('NCBITaxon_1', 'root', 79, 'viral'), ('GO_0006260', 'DNA replication', 85, 'replication'), ('UBERON_0002048', 'lung', 100, 'lung tissues'), ('GO_0007567', 'parturition', 144, 'born'), ('GO_0007631', 'feeding behavior', 157, 'fed'), ('NCBITaxon_1', 'root', 216, 'virus')]
PMC4829879	2/2016	S99-PMC4829879	['Lung Tissues were dissected, snap-frozen in liquid nitrogen, and stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissues')]
PMC4829879	2/2016	S105-PMC4829879	['cytokines Expression\nthis analysis was performed on Serum, Bal Fluid, and Lung Tissue homogenates.']	N/A	N/A	[('GO_0010467', 'gene expression', 10, 'expression'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('UBERON_0006310', 'vitelline venous plexus', 59, 'BAL fluid'), ('UBERON_0002048', 'lung', 74, 'lung'), ('UBERON_0000479', 'tissue', 79, 'tissue')]
PMC4829879	2/2016	S109-PMC4829879	['Neurotrophins Expression\nLung Tissue Expression of Genes encoding for key neurotrophic factors and their cognate receptors was conducted as described previously (26).']	N/A	N/A	[('PR_000021998', 'neurotrophin', 0, 'Neurotrophins'), ('GO_0010467', 'gene expression', 14, 'expression'), ('UBERON_0002048', 'lung', 25, 'Lung'), ('UBERON_0000479', 'tissue', 30, 'tissue'), ('GO_0010467', 'gene expression', 37, 'expression'), ('SO_0000704', 'gene', 51, 'genes')]
PMC4829879	2/2016	S110-PMC4829879	['briefly, frozen Lung specimens were homogenized in rlt buffer (qiagen, valencia, ca).']	N/A	N/A	[('UBERON_0002048', 'lung', 16, 'lung')]
PMC4829879	2/2016	S115-PMC4829879	['Pulmonary function tests\nthe Trachea of weanling and Adult Rats under deep anesthesia was exposed through a Neck incision, a small cut was made below the Cricoid Cartilage, and an 18-gauge catheter was inserted and secured with sutures (23).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('UBERON_0003126', 'trachea', 29, 'trachea'), ('UBERON_0007023', 'adult organism', 53, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 59, 'rats'), ('UBERON_0000974', 'neck', 108, 'neck'), ('UBERON_0002375', 'cricoid cartilage', 154, 'cricoid cartilage')]
PMC4829879	2/2016	S120-PMC4829879	['Pulmonary function tests were performed as described above at 5 d post-inoculation, and the Lungs were dissected immediately after for measurements of Rsv titer and Ngf expression.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('UBERON_0002048', 'lung', 92, 'lungs'), ('NCBITaxon_10088', 'Mus <genus>', 151, 'RSV'), ('PR_000011159', 'nexilin', 165, 'NGF')]
PMC4829879	2/2016	S121-PMC4829879	["Rsv copy number in the Lungs was measured using a one-step Rsv-a quantitation kit (primer design, southampton, uk) as per manufacturer's instructions."]	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'RSV'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 0, 'RSV'), ('UBERON_0002048', 'lung', 23, 'lungs'), ('NCBITaxon_10088', 'Mus <genus>', 59, 'RSV')]
PMC4829879	2/2016	S126-PMC4829879	['statement of financial support\nthis study was funded in part by a grant from the us national institutes of health, national Heart, Lung, and Blood institute (bethesda, md) grant ro1 hl-61007 to g.p.']	N/A	N/A	[('UBERON_0000948', 'heart', 124, 'Heart'), ('UBERON_0002048', 'lung', 131, 'Lung'), ('UBERON_0000178', 'blood', 141, 'Blood')]
PMC4848989	4/2016	S1-PMC4848989	['Glucocorticoids are frequently used Prenatally to accelerate the maturation of the Lungs of premature infants.']	N/A	N/A	[('CHEBI_5439', 'Glutethimide', 0, 'Glucocorticoids'), ('GO_0019230', 'proprioception', 36, 'prenatally'), ('UBERON_0002048', 'lung', 83, 'lungs')]
PMC4857329	12/2015	S14-PMC4857329	['we present a case of 32-year-old female who presented with recurrent hemorrhagic Pleural Effusions and was diagnosed with Lung sarcoma.']	N/A	N/A	[('UBERON_0002735', 'transverse pontine fibers', 81, 'pleural effusions'), ('UBERON_0002048', 'lung', 122, 'lung')]
PMC4857329	12/2015	S67-PMC4857329	['H&e staining of Lung biopsy specimen showing myxoid background, poorly differentiated cells and high mitotic figures.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 0, 'H'), ('UBERON_0002048', 'lung', 16, 'lung')]
PMC4857329	12/2015	S91-PMC4857329	['differential diagnosis of primary Lung sarcoma included sarcomatoid carcinoma of the Lung, which are poorly differentiated non-small-cell cancers that contain a sarcoma or sarcoma-like component.']	N/A	N/A	[('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0002048', 'lung', 85, 'lung')]
PMC4857329	12/2015	S97-PMC4857329	['repeat ct Chest showed progression of sarcoma with involvement of Pleura and Heart, thus revealing a highly malignant nature of primary Lung sarcoma.']	N/A	N/A	[('UBERON_0001443', 'chest', 10, 'chest'), ('UBERON_0000977', 'pleura', 66, 'pleura'), ('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002048', 'lung', 136, 'lung')]
PMC4896250	4/2016	S16-PMC4896250	['jue seong lee, sun-ho kee, sewon kim, young yoo, heung sik na, seung keun back\na414 comparison between the impulse oscillometry system, spirometry, feno, Lung clearance index and asthma Control and exacerbation status.']	N/A	N/A	[('UBERON_0002048', 'lung', 154, 'Lung'), ('GO_0065007', 'biological regulation', 186, 'Control')]
PMC4896250	4/2016	S61-PMC4896250	['in the second part, we concentrated on the site of the inflammation, and determined the composition of Lymphocyte infiltration in Labial Salivary Gland (Lsg) biopsies with special emphasis on tfhcells.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 103, 'lymphocyte'), ('UBERON_0006330', 'anterior lingual gland', 130, 'labial salivary gland'), ('UBERON_0002048', 'lung', 153, 'LSG')]
PMC4896250	4/2016	S241-PMC4896250	['using one whole Lung Tissue from each Mouse, we performed microarray analysis and real-time pcr.']	N/A	N/A	[('UBERON_0002048', 'lung', 16, 'lung'), ('UBERON_0000479', 'tissue', 21, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 38, 'mouse')]
PMC4896250	4/2016	S730-PMC4896250	['the Lung function test, biochemical, molecular, histopathological and ultrastructural changes were analyzed in Lung and Bronchoalveolar Lavage Fluid (Balf) after 14 and 28 days after the Drug treatment.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0004212', 'glomerular capillary', 120, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 150, 'BALF'), ('CHEBI_23888', 'drug', 187, 'drug')]
PMC4896250	4/2016	S731-PMC4896250	['results: treatment with sfse-g significantly restored the blm induced alteration in body weight, Lung index, Lung function test and hematology.']	N/A	N/A	[('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0002048', 'lung', 109, 'lung')]
PMC4896250	4/2016	S734-PMC4896250	['sfse-g significantly enhanced the Balf and Lung antioxidant status, through Modulating the sod, Gsh, t-aoc, Mda, no level and nrf2, Ho-1 mrna Expression.']	N/A	N/A	[('UBERON_0001348', 'brown adipose tissue', 34, 'BALF'), ('UBERON_0002048', 'lung', 43, 'lung'), ('GO_0065007', 'biological regulation', 76, 'modulating'), ('CHEBI_16856', 'glutathione', 96, 'GSH'), ('CHEBI_34840', 'methyl methacrylate', 108, 'MDA'), ('PR_000005086', 'chromobox protein homolog 5', 132, 'HO-1'), ('GO_0010467', 'gene expression', 142, 'expression')]
PMC4896250	4/2016	S735-PMC4896250	['there was a significant reduction in Lung 5-Ht level by sfse-g treatment.']	N/A	N/A	[('UBERON_0002048', 'lung', 37, 'lung'), ('CHEBI_61485', 'thiopental(1-)', 42, '5-HT'), ('PR_000008443', 'huntingtin-associated protein 1', 44, 'HT')]
PMC4896250	4/2016	S736-PMC4896250	['the altered mrna Expression of Lung inflammatory markers (Tnf-Α, Il-1Β, Il-6 and Il-8), fibrotic markers (Tgf-β, Collagen-1, Et-1, Muc5Ac, Nf-Kb, Vegf, Smad-3) and apoptotic markers (Bax, Bcl-2 and Caspase-3) were significantly restored by sfse-g treatment.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expression'), ('UBERON_0002048', 'lung', 31, 'lung'), ('PR_000000134', 'tumor necrosis factor alpha', 58, 'TNF-α'), ('PR_000001383', 'interleukin-22', 65, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 72, 'IL-6'), ('PR_000001470', 'interleukin-28B', 81, 'IL-8'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 106, 'TGF'), ('PR_000003266', 'collagen type II alpha chain', 113, 'collagen-1'), ('PR_000007222', 'protein C-ets-2', 125, 'ET-1'), ('PR_000010830', 'myosin-7', 131, 'Muc5ac'), ('GO_0005883', 'neurofilament', 139, 'NF'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 139, 'NF-kB'), ('PR_000017279', 'testis-specific basic protein Y 1', 146, 'VEGF'), ('PR_000000364', 'smad2', 152, 'Smad-3'), ('PR_000002193', 'apoptosis regulator BAX', 183, 'Bax'), ('PR_000004687', '2-oxoisovalerate dehydrogenase subunit beta, mitochondrial', 188, 'Bcl'), ('PR_000002319', 'catenin beta-1 isoform 1', 198, 'Caspase-3')]
PMC4896250	4/2016	S737-PMC4896250	['blm induced histological inflammatory, and fibrotic and ultrastructural changes of Lungs were reversed by sfse-g treatment.']	N/A	N/A	[('UBERON_0002048', 'lung', 83, 'lungs')]
PMC4896250	4/2016	S741-PMC4896250	['long-term treatment with Fasudil improves Bleomycin-induced Pulmonary fibrosis and Pulmonary hypertension via inhibition of Smad2/3Phosphorylation.']	N/A	N/A	[('CHEBI_31598', 'Felbinac ethyl', 25, 'fasudil'), ('CHEBI_22907', 'bleomycin', 42, 'bleomycin'), ('UBERON_0002048', 'lung', 60, 'pulmonary'), ('UBERON_0002048', 'lung', 83, 'pulmonary'), ('PR_000000364', 'smad2', 124, 'Smad2'), ('GO_0006754', 'ATP biosynthetic process', 130, '3phosphorylation')]
PMC4896250	4/2016	S742-PMC4896250	['Pulmonary pharmacol therap 2013; 26: 635-643.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary')]
PMC4896250	4/2016	S744-PMC4896250	['chitra p, saiprasad g, manikandan r, sudhandiran g. Berberine attenuates Bleomycin-induced Pulmonary toxicity and fibrosis via suppressing Nf-Κb dependant Tgf-β activation: a biphasic experimental study.']	N/A	N/A	[('CHEBI_16118', 'berberine', 52, 'Berberine'), ('CHEBI_22907', 'bleomycin', 73, 'bleomycin'), ('UBERON_0002048', 'lung', 91, 'pulmonary'), ('GO_0071159', 'NF-kappaB complex', 139, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 139, 'NF-κB'), ('PR_000000046', 'TGF-beta', 155, 'TGF-')]
PMC4896250	4/2016	S845-PMC4896250	['a61 allergic bronchopulmonary aspergillosis in asthma and Lung tuberculosis\n\njuwita soekarno1, sarie ratnasari2, e. alwi datau2, eko surachmanto2, jc matheos2\n\n1medical faculty of univesity of sam ratulangi, indonesia;2samratulangi university manado, indonesia\n\ncorrespondence: juwita soekarno – medical faculty of univesity of sam ratulangi, indonesia\nbackground: allergic bronchopulmonary aspergillosis (abpa) is a Lung disease that is caused by hypersensitivity reaction to the Fungus aspergillus fumigatus, where its colonization often found in chronic Respiratory disease, either in bronchial asthma and Lung tuberculosis.']	N/A	N/A	[('UBERON_0002048', 'lung', 58, 'lung'), ('UBERON_0002048', 'lung', 417, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 481, 'fungus'), ('UBERON_0001004', 'respiratory system', 557, 'respiratory'), ('UBERON_0002048', 'lung', 609, 'lung')]
PMC4896250	4/2016	S850-PMC4896250	['total 75 samples from 3 groups, each 25 samples: moderate-severe persistent asthma, Acid-fast Bacilli (afb) positive Lung tb and afb negative Lung tb.']	N/A	N/A	[('CHEBI_37527', 'acid', 84, 'Acid'), ('CHEBI_3015', 'benomyl', 94, 'Bacilli'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0002048', 'lung', 142, 'lung')]
PMC4896250	4/2016	S1012-PMC4896250	['Lung function parameters and Nasal Eosinophil counts (%) were measured.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000004', 'nose', 29, 'nasal'), ('CL_0000771', 'eosinophil', 35, 'eosinophil')]
PMC4896250	4/2016	S1082-PMC4896250	['a78 redox modulation for the treatment of Toluene Diisocyanates-induced Lung Inflammation\n\nli-ming chin, chi-chang shieh\n\nnational cheng kung university, taiwan\n\ncorrespondence: li-ming chin – national cheng kung university, taiwan\nToluene Diisocyanates (tdi) is a low-molecular-weight, high Reactive chemical that widely used in industry for the production of polyurethane foams, vanish, paint, and isolation material.']	N/A	N/A	[('CHEBI_26932', 'tetrapyrrole', 42, 'Toluene Diisocyanates'), ('UBERON_0002048', 'lung', 72, 'Lung'), ('GO_0006270', 'DNA replication initiation', 77, 'Inflammation'), ('CHEBI_26932', 'tetrapyrrole', 232, 'Toluene diisocyanates'), ('CHEBI_33893', 'reagent', 292, 'reactive')]
PMC4896250	4/2016	S1094-PMC4896250	['last, we measured Mice Lung resistance and compliance with finepointe resistance and compliance system.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('UBERON_0002048', 'lung', 23, 'lung')]
PMC4896250	4/2016	S1097-PMC4896250	['moreover, tdi-treated Mice with Nac treatment had better Lung function parameters than the group without Nac treatment.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 22, 'mice'), ('CHEBI_7421', 'NAC', 32, 'NAC'), ('UBERON_0002048', 'lung', 57, 'lung'), ('CHEBI_7421', 'NAC', 105, 'NAC')]
PMC4896250	4/2016	S1102-PMC4896250	['Leukocyte Nicotinamide Adenine Dinucleotide phosphate-reduced oxidase is required for Isocyanate-induced Lung inflammation.']	N/A	N/A	[('CL_0002084', 'Boettcher cell', 0, 'Leukocyte'), ('CHEBI_44264', 'nicotinamide guanine dinucleotide', 10, 'nicotinamide adenine dinucleotide'), ('CHEBI_53692', 'sodium amidotrizoate', 86, 'isocyanate'), ('UBERON_0002048', 'lung', 105, 'lung')]
PMC4896250	4/2016	S1199-PMC4896250	['variables including age, sex, body mass index, parental allergic history, income, maternal education level, ar treatment during the last 12 months, environmental tobacco smoking exposure, total Serum Ige levels, Eosinophil percentage, diagnosis of atopic dermatitis and asthma, Lung function tests, bhr to Methacholine and skin prick tests were used in the latent class analysis.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 194, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 200, 'IgE'), ('CL_0000771', 'eosinophil', 212, 'eosinophil'), ('UBERON_0002048', 'lung', 278, 'lung'), ('CHEBI_6805', 'methacycline', 306, 'methacholine')]
PMC4896250	4/2016	S1201-PMC4896250	['cluster types were characterized as "non-atopy with low socioeconomic status" (33% of sample, cluster 1), "atopy with normal Lung function" (39%, cluster 2), "atopy with impaired Lung function" (14%, cluster 3), and “non-atopy and high socioeconomic status" (15%, cluster 4).']	N/A	N/A	[('UBERON_0002048', 'lung', 125, 'lung'), ('UBERON_0002048', 'lung', 179, 'lung')]
PMC4896250	4/2016	S1410-PMC4896250	['methods: balb/c Mice were injected Intraperitoneally with ovalbumin (ova) followed by nebulized ova challenges, from which Bronchoalveolar Lavage Fluid (Balf) Cells and Lung Tissues were collected.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 16, 'mice'), ('UBERON_0000007', 'pituitary gland', 35, 'intraperitoneally'), ('CL_0002168', 'border cell of cochlea', 123, 'bronchoalveolar lavage fluid'), ('UBERON_0004212', 'glomerular capillary', 123, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 153, 'BALF'), ('CL_0000573', 'retinal cone cell', 159, 'cells'), ('UBERON_0002048', 'lung', 169, 'lung'), ('UBERON_0000479', 'tissue', 174, 'tissues')]
PMC4896250	4/2016	S1415-PMC4896250	['the Expressions of P2Y12R, Cyslt1R and Cyslt2R were significantly higher in the Lung Tissue of ova-sensitized Mice than in vehicle-treated Mice ( p = 0.047; p = 0.04; p =0.045, respectively).']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expressions'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 19, 'P2Y12R'), ('PR_000001204', 'C-C chemokine receptor type 8', 27, 'CysLT1R'), ('PR_000001204', 'C-C chemokine receptor type 8', 39, 'CysLT2R'), ('UBERON_0002048', 'lung', 80, 'lung'), ('UBERON_0000479', 'tissue', 85, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'mice')]
PMC4896250	4/2016	S1771-PMC4896250	['Lung function was examined by a portable spirometer and Airway hyper-resposiveness.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0001005', 'respiratory airway', 56, 'airway')]
PMC4896250	4/2016	S1911-PMC4896250	['patient’s information of demography, allergy and duration of onset were collected, infant Pulmonary function, bronchial dilation test and Serum total Ige were tested, and modified-tal score and length of hospitalization were also recorded at admission.']	N/A	N/A	[('UBERON_0002048', 'lung', 90, 'pulmonary'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 150, 'IgE')]
PMC4896250	4/2016	S2111-PMC4896250	['conclusion: maternal supplementation with scgos/lcfos during Lactation did down-regulate allergic inflammation in the Lungs.']	N/A	N/A	[('GO_0007595', 'lactation', 61, 'lactation'), ('UBERON_0002048', 'lung', 118, 'lungs')]
PMC4896250	4/2016	S2142-PMC4896250	['a152 Hydroclorothiazide-induced acute non-cardiogenic Pulmonary edema\n\nramon lleonart\n\nhospital universitari de bellvitge, spain\nHydroclorothiazide (Hctz) is widely used in the treatment of essential hypertension.']	N/A	N/A	[('CHEBI_5784', 'hydroflumethiazide', 5, 'Hydroclorothiazide'), ('UBERON_0002048', 'lung', 54, 'pulmonary'), ('CHEBI_5784', 'hydroflumethiazide', 129, 'Hydroclorothiazide'), ('CHEBI_15347', 'acetone', 149, 'HCTZ')]
PMC4896250	4/2016	S2146-PMC4896250	['we describe 5 patients that have suffered episodes of sudden-onset Pulmonary edema immediately after the ingestion of Hctz.']	N/A	N/A	[('UBERON_0002048', 'lung', 67, 'pulmonary'), ('CHEBI_15347', 'acetone', 118, 'HCTZ')]
PMC4896250	4/2016	S2150-PMC4896250	['common causes of shock and Pulmonary edema were ruled out in all cases.']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'pulmonary')]
PMC4896250	4/2016	S2153-PMC4896250	['the 5 patients were diagnosed in the allergy unit as having Hctz-induced non-cardiogenic Pulmonary edema.']	N/A	N/A	[('CHEBI_15347', 'acetone', 60, 'HCTZ'), ('UBERON_0002048', 'lung', 89, 'pulmonary')]
PMC4896250	4/2016	S2207-PMC4896250	['there is no evidence of Eosinophilic infiltration on Lung and Heart in Chest x-ray, Pulmonary function test and echocardiogram.']	N/A	N/A	[('CL_0000771', 'eosinophil', 24, 'eosinophilic'), ('UBERON_0002048', 'lung', 53, 'lung'), ('UBERON_0000948', 'heart', 62, 'heart'), ('UBERON_0001443', 'chest', 71, 'chest'), ('UBERON_0002048', 'lung', 84, 'pulmonary')]
PMC4896250	4/2016	S2235-PMC4896250	['Pulmonary function test was carried out, which yielded decreased Lung function with positive bronchodilator response.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('UBERON_0002048', 'lung', 65, 'lung')]
PMC4896250	4/2016	S2412-PMC4896250	['materials and methods: we reviewed medical records of 689 asthma patients who visited a tertiary referral hospital from may 2005 to jul 2012 and performed skin prick test and Pulmonary function test.']	N/A	N/A	[('UBERON_0002048', 'lung', 175, 'pulmonary')]
PMC4896250	4/2016	S2567-PMC4896250	['a180 the prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic korean Adults\n\njin-young lee1, kyoung won ha2, yun-jin jeung3, sehyo yune4, byung-jae lee4, dong-chull choi5, mi-jung oh6, young hee lim7\n\n1health promotion center, samsung medical center, south korea;2seoul samsung medical clinic;3clean medicine allergy clinic;4samsung medical center;5samsung medical center, sungkyunkwan university school of medicine;6bundang jesaeng hospital;7ansan sarang general hospital\n\ncorrespondence: jin-young lee – health promotion center, samsung medical center, south korea\npurpose: toxocariasis is the most common cause of peripheral Blood Eosinophilia in korea and produces Eosinophilic infiltration into various Organs, including the Lung.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 99, 'adults'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CL_0000771', 'eosinophil', 664, 'eosinophilia'), ('CL_0000771', 'eosinophil', 699, 'eosinophilic'), ('UBERON_0000062', 'organ', 738, 'organs'), ('UBERON_0002048', 'lung', 760, 'lung')]
PMC4896250	4/2016	S2612-PMC4896250	['ahr was measured using Methacholine and activity of Gsnor was measured in whole Lung lysate.']	N/A	N/A	[('CHEBI_6805', 'methacycline', 23, 'methacholine'), ('PR_000008240', 'glutamate receptor ionotropic, kainate 1', 52, 'GSNOR'), ('UBERON_0002048', 'lung', 80, 'lung')]
PMC4896250	4/2016	S2654-PMC4896250	['histopathologic changes and Expression of mir-21 were compared in Lung Tissues between antagomir treatment group and control groups.']	N/A	N/A	[('GO_0010467', 'gene expression', 28, 'expression'), ('UBERON_0002048', 'lung', 66, 'lung'), ('UBERON_0000479', 'tissue', 71, 'tissues')]
PMC4896250	4/2016	S2717-PMC4896250	['characteristics of asthma sub-phenotypes were analyzed by disease severity, Pulmonary function, Blood Eosinophil counts, total Ige levels in Serum, and specific Ige Antibody to environmental Allergens.']	N/A	N/A	[('UBERON_0002048', 'lung', 76, 'pulmonary'), ('UBERON_0000178', 'blood', 96, 'blood'), ('CL_0000771', 'eosinophil', 102, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 127, 'IgE'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 161, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody'), ('CHEBI_33663', 'cyclic hydrocarbon', 191, 'allergens')]
PMC4896250	4/2016	S2824-PMC4896250	['gross findings, functional study for skin barrier, Blood sampling, Bronchoalveolar lavage and biopsies of skin and Lung were done at 24 h after last treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0002183', 'lobar bronchus', 67, 'bronchoalveolar'), ('UBERON_0002048', 'lung', 115, 'lung')]
PMC4896250	4/2016	S2939-PMC4896250	['Hur ko Mice had significant decreases in Lung Neutrophils, Lymphocytes, Eosinophils and Il-13.']	N/A	N/A	[('PR_000008840', 'huntingtin', 0, 'HuR'), ('NCBITaxon_10088', 'Mus <genus>', 7, 'mice'), ('UBERON_0002048', 'lung', 41, 'lung'), ('CL_0000775', 'neutrophil', 46, 'neutrophils'), ('CL_0000542', 'lymphocyte', 59, 'lymphocytes'), ('CL_0000771', 'eosinophil', 72, 'eosinophils'), ('PR_000001470', 'interleukin-28B', 88, 'IL-13')]
PMC4896250	4/2016	S2943-PMC4896250	['furthermore, Hur ko in T Cells completely abrogates Allergen induced Lung inflammation.']	N/A	N/A	[('PR_000008840', 'huntingtin', 13, 'HuR'), ('CL_0000084', 'T cell', 23, 'T cells'), ('CHEBI_50904', 'allergen', 52, 'allergen'), ('UBERON_0002048', 'lung', 69, 'lung')]
PMC4896250	4/2016	S3064-PMC4896250	['the patients were visited at the baseline period and followed up every three months to assess asthma Control test (act), visual analog scale (vas) of asthma and rhinitis symptom and spirometry for Pulmonary function test.']	N/A	N/A	[('GO_0065007', 'biological regulation', 101, 'control'), ('UBERON_0002048', 'lung', 197, 'pulmonary')]
PMC4896250	4/2016	S3216-PMC4896250	['Mitochondrial translocation from subcellular fractionation of Human Bronchial Epithelial Cell line and Mouse Lung Tissue under oxidative stress were analyzed by immunoblotting.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('NCBITaxon_9606', 'Homo sapiens', 62, 'human'), ('CL_0002328', 'bronchial epithelial cell', 68, 'bronchial epithelial cell'), ('UBERON_0002031', 'epithelium of bronchus', 68, 'bronchial epithelial'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'mouse'), ('UBERON_0002048', 'lung', 109, 'lung'), ('UBERON_0000479', 'tissue', 114, 'tissue')]
PMC4896250	4/2016	S3229-PMC4896250	['we evaluated Airway hyper-responsiveness (ahr), Bronchoalveolar Lavage Fluid (Balf), cytokine levels, and histology of the Lungs.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 13, 'airway'), ('UBERON_0004212', 'glomerular capillary', 48, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 78, 'BALF'), ('UBERON_0002048', 'lung', 123, 'lungs')]
PMC4896250	4/2016	S3318-PMC4896250	['in addition, Lung histopathology was done to show Peribronchial and Perivascular inflammation.']	N/A	N/A	[('UBERON_0002048', 'lung', 13, 'lung'), ('UBERON_0002256', 'dorsal horn of spinal cord', 50, 'peribronchial'), ('GO_0043204', 'perikaryon', 68, 'perivascular'), ('UBERON_0014930', 'perivascular space', 68, 'perivascular')]
PMC4896250	4/2016	S3375-PMC4896250	['Leukocyte subtypes were analyzed in the Broncho-Alveolar Lavage (bal) and in Lung Cell suspensions.']	N/A	N/A	[('CL_0002084', 'Boettcher cell', 0, 'Leukocyte'), ('UBERON_0005681', 'right lung upper lobe bronchiole', 40, 'broncho-alveolar lavage'), ('CL_0000175', 'luteal cell', 77, 'lung cell'), ('UBERON_0002048', 'lung', 77, 'lung')]
PMC4896250	4/2016	S3376-PMC4896250	['Mucosal Mast Cell Protease-1 (mmcp-1) was measured in Serum and cytokines in Lung homogenates.']	N/A	N/A	[('CL_0000485', 'mucosal type mast cell', 0, 'Mucosal mast cell'), ('UBERON_0000912', 'mucus', 0, 'Mucosal'), ('PR_000010439', 'myeloid leukemia factor 1', 8, 'mast cell protease-1'), ('UBERON_0001977', 'blood serum', 54, 'serum'), ('UBERON_0002048', 'lung', 77, 'lung')]
PMC4896250	4/2016	S3409-PMC4896250	['we report a case of Lung cancer patient who experienced two near-fatal Anaphylactic reactions that resulted from paclitaxel and multivitamin, separately.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'lung'), ('GO_0006915', 'apoptotic process', 71, 'anaphylactic')]
PMC4896250	4/2016	S3525-PMC4896250	['spirometry and two forced oscillation technique (fot) tests (mostgraph® and master screen ios®) were performed to assess Lung function before and after treatment of obesity (diet and exercise).']	N/A	N/A	[('UBERON_0002048', 'lung', 121, 'lung')]
PMC4896250	4/2016	S3821-PMC4896250	['methods: we collected data from 146 patients with severe asthma for analysis of the following variables: asthma Control test (act) score, Pulmonary function, fractional exhaled Nitric Oxide (Feno), and sensitization to Fungi ( aspergillus, alternaria, cladosporium, penicillium, trichophyton, and schizophyllum commune ) and non-Fungal Antigen sources (house dust mites, Dogs, Cats, cockroaches, Moths, and Chironomids).']	N/A	N/A	[('GO_0065007', 'biological regulation', 112, 'control'), ('UBERON_0002048', 'lung', 138, 'pulmonary'), ('CHEBI_16480', 'nitric oxide', 177, 'nitric oxide'), ('CHEBI_32035', 'potassium hydroxide', 191, 'FeNO'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'fungi'), ('NCBITaxon_10088', 'Mus <genus>', 329, 'fungal'), ('CHEBI_59132', 'antigen', 336, 'antigen'), ('NCBITaxon_33208', 'Metazoa', 371, 'dogs'), ('NCBITaxon_33208', 'Metazoa', 377, 'cats'), ('NCBITaxon_10088', 'Mus <genus>', 396, 'moths'), ('NCBITaxon_10088', 'Mus <genus>', 407, 'chironomids')]
PMC4896250	4/2016	S3825-PMC4896250	['the sex distribution, Pulmonary function, and dose of inhaled Corticosteroid were not significantly different between the three groups; however, the act score was significantly lower for group f + n than for the other groups.']	N/A	N/A	[('UBERON_0002048', 'lung', 22, 'pulmonary'), ('CHEBI_36916', 'cation', 62, 'corticosteroid')]
PMC4896250	4/2016	S4014-PMC4896250	['we assess the severity of asthma by Pulmonary score (ps).']	N/A	N/A	[('UBERON_0002048', 'lung', 36, 'Pulmonary')]
PMC4896250	4/2016	S4078-PMC4896250	['their diagnoses were asthma (31.1%), allergic rhinitis (37.1%), non-allergic rhinitis (7.0%), chronic rhinosinusitis (18.9%), Eosinophilic bronchitis (7.5%), and chronic obstructive Pulmonary disease (1.2%).']	N/A	N/A	[('CL_0000771', 'eosinophil', 126, 'eosinophilic'), ('UBERON_0002048', 'lung', 182, 'pulmonary')]
PMC4896250	4/2016	S4130-PMC4896250	['Lung injury was observed histologically in Hematoxylin and eosin (he) stained Tissue sections, semi-quantified by Lung Tissue injury score, and the Lung Tissue mass alteration was measured by wet to dry weight ratio (w/d).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_51686', 'haematoxylin', 43, 'hematoxylin'), ('UBERON_0000479', 'tissue', 78, 'tissue'), ('UBERON_0002048', 'lung', 114, 'lung'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('UBERON_0002048', 'lung', 148, 'lung'), ('UBERON_0000479', 'tissue', 153, 'tissue')]
PMC4896250	4/2016	S4131-PMC4896250	['mrna levels of Tnf-Α, Shh, patched (ptc) and Gli1 in Lung Tissue were studied with real time quantitative pcr (rt-pcr), while the protein Expression of Shh and Gli1 was determined by western blot analysis.']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 15, 'TNF-α'), ('PR_000014841', 'sonic hedgehog protein', 22, 'SHH'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 45, 'GLI1'), ('UBERON_0002048', 'lung', 53, 'lung'), ('UBERON_0000479', 'tissue', 58, 'tissue'), ('GO_0010467', 'gene expression', 138, 'expression'), ('PR_000014841', 'sonic hedgehog protein', 152, 'SHH'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 160, 'GLI1')]
PMC4896250	4/2016	S4132-PMC4896250	['results: Lung Tissue injury score, w/d, and mrna Expression levels of Tnf-Α were significantly higher in the ali Mice than the normal Mice (p<0.05).']	N/A	N/A	[('UBERON_0002048', 'lung', 9, 'Lung'), ('UBERON_0000479', 'tissue', 14, 'tissue'), ('GO_0010467', 'gene expression', 49, 'expression'), ('PR_000000134', 'tumor necrosis factor alpha', 70, 'TNF-α'), ('NCBITaxon_10088', 'Mus <genus>', 113, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 134, 'mice')]
PMC4896250	4/2016	S4134-PMC4896250	['Protein Production of Shh and Gli1 at 6h, 12h, and 24h in the Lungs of ali Mice significantly increased, in a time-dependent manner, compared with that in normal Mice.']	N/A	N/A	[('GO_0006412', 'translation', 0, 'Protein production'), ('PR_000014841', 'sonic hedgehog protein', 22, 'SHH'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 30, 'GLI1'), ('UBERON_0002048', 'lung', 62, 'lungs'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 162, 'mice')]
PMC4896250	4/2016	S4172-PMC4896250	['(p=0.003)when the sarcopenia criteria of awgs was applied, the fev1(l) was 2.30±0.667 and 2.09±0.651, and the Pulmonary function of the sarcopenia group was low (p < 0.001).']	N/A	N/A	[('UBERON_0002048', 'lung', 110, 'pulmonary')]
PMC4896250	4/2016	S4215-PMC4896250	['bronchiolitis severity score (bss, general appearance, Lung sound, dyspnea, respiration rate, oxygen saturation by pulse oxymetry) was evaluated at admission and within 72 hrs after admission.']	N/A	N/A	[('UBERON_0002048', 'lung', 55, 'lung')]
PMC4896250	4/2016	S4249-PMC4896250	['Lc3 Expression in Lung homogenate was measured by western blot to evaluate the development of Autophagy.']	N/A	N/A	[('PR_000009691', 'protein LBH', 0, 'LC3'), ('GO_0010467', 'gene expression', 4, 'expression'), ('UBERON_0002048', 'lung', 18, 'lung'), ('GO_0006914', 'autophagy', 94, 'autophagy')]
PMC4896250	4/2016	S4255-PMC4896250	['anti-Il-5 Antibody treatment significantly reduced Eosinophil counts and Il-5 levels in Bal Fluid, as well as Lc3 Expression in the Lung Tissue homogenate.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-5'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody'), ('CL_0000771', 'eosinophil', 51, 'eosinophil'), ('PR_000001470', 'interleukin-28B', 73, 'IL-5'), ('UBERON_0006310', 'vitelline venous plexus', 88, 'BAL fluid'), ('PR_000009691', 'protein LBH', 110, 'LC3'), ('GO_0010467', 'gene expression', 114, 'expression'), ('UBERON_0002048', 'lung', 132, 'lung'), ('UBERON_0000479', 'tissue', 137, 'tissue')]
PMC4896250	4/2016	S4469-PMC4896250	['the material of history, Blood test, Lung function test, the concentrations of fraction of exhaled Nitric Oxide (Feno), vitro allergern test of asthmatic children were reserved.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002048', 'lung', 37, 'lung'), ('CHEBI_16480', 'nitric oxide', 99, 'nitric oxide'), ('CHEBI_32035', 'potassium hydroxide', 113, 'FeNO')]
PMC4896250	4/2016	S4475-PMC4896250	['there is no relationship between the level of Serum Il-13 or Il-17A and Lung function or feno.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 46, 'serum'), ('PR_000001470', 'interleukin-28B', 52, 'IL-13'), ('PR_000001139', 'interleukin-17B', 61, 'IL-17A'), ('UBERON_0002048', 'lung', 72, 'lung')]
PMC4896250	4/2016	S4526-PMC4896250	['Ovalbumin (ova)-induced allergic Lung inflammation) and in Human Lung Microvascular Endothelial Cells (hlmvec) and normal Human Bronchial Epithelial (nhbe) Cells.']	N/A	N/A	[('CHEBI_83268', 'oxathiapiprolin', 0, 'ovalbumin'), ('PR_000012086', 'homeobox protein OTX2', 0, 'ovalbumin'), ('UBERON_0002048', 'lung', 33, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_1001567', 'lung endothelial cell', 65, 'lung microvascular endothelial cells'), ('UBERON_0002048', 'lung', 65, 'lung'), ('UBERON_0011931', 'nasal hair', 70, 'microvascular'), ('UBERON_0001986', 'endothelium', 84, 'endothelial'), ('NCBITaxon_9606', 'Homo sapiens', 122, 'human'), ('CL_0002328', 'bronchial epithelial cell', 128, 'bronchial epithelial ... cells'), ('UBERON_0002031', 'epithelium of bronchus', 128, 'bronchial epithelial')]
PMC4896250	4/2016	S4528-PMC4896250	['Lung Cldn5 levels were assessed with qrt-pcr, elisa, immunoblotting, immunohistochemical stain, and confocal imaging.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('PR_000005563', 'C-type lectin domain family 18 member C', 5, 'CLDN5')]
PMC4896250	4/2016	S4540-PMC4896250	['results: Lung cldn4 Transcript and protein were significantly increased in ova Mice than in sham Mice.']	N/A	N/A	[('UBERON_0002048', 'lung', 9, 'Lung'), ('SO_0000673', 'transcript', 20, 'transcript'), ('NCBITaxon_10088', 'Mus <genus>', 79, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'mice')]
PMC4896250	4/2016	S4542-PMC4896250	['increased Lung cldn4 Transcript and protein in ova Mice were decreased in Acrolein exposed Mice.']	N/A	N/A	[('UBERON_0002048', 'lung', 10, 'lung'), ('SO_0000673', 'transcript', 21, 'transcript'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'mice'), ('CHEBI_15368', 'acrolein', 74, 'acrolein'), ('NCBITaxon_10088', 'Mus <genus>', 91, 'mice')]
PMC4896250	4/2016	S4573-PMC4896250	['then, Serum Igg Antibody against major bacteria derived Evs in dust were measured in 90 healthy control subjects, and 294 asthma, 242 copd, and 325 Lung cancer patients.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 6, 'Serum'), ('GO_0071735', 'IgG immunoglobulin complex', 12, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 16, 'antibody'), ('GO_0005793', 'endoplasmic reticulum-Golgi intermediate compartment', 56, 'EVs'), ('UBERON_0002048', 'lung', 148, 'lung')]
PMC4896250	4/2016	S4593-PMC4896250	['Pulmonary function testing in children older than 7 years old, and 4.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary')]
PMC4896250	4/2016	S4598-PMC4896250	['more than 80% of patients could demonstrate inhaler Drugs used correctly and >60% of them received Pulmonary function testing yearly.']	N/A	N/A	[('CHEBI_23888', 'drug', 52, 'drugs'), ('UBERON_0002048', 'lung', 99, 'pulmonary')]
PMC4896250	4/2016	S4738-PMC4896250	['the Lung ventilation function were defined fev1, fvc, pef, fvc/fev1parameters of spirometer test (spirostar usb, medikro oy, finland).']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung')]
PMC4896250	4/2016	S4740-PMC4896250	['results: we were interviewed 16-60 (average age 35±12) aged 283 subjects with asthma symptoms and normal Lung function by spirometer.']	N/A	N/A	[('UBERON_0002048', 'lung', 105, 'lung')]
PMC4896250	4/2016	S4850-PMC4896250	['the subjects were randomly assigned the bronchodilator tests of the two dosages without physician’s knowledge and performed the bdr tests using the spirometric and impulse oscillometric Lung function.']	N/A	N/A	[('UBERON_0002048', 'lung', 186, 'lung')]
PMC4896250	4/2016	S4898-PMC4896250	['the issac questionnaire, Serum total Ige level, Blood Eosinophil percentage, skin prick test, Pulmonary function test and Methacholine challenge test were done at age 7 for baseline and age 11 years after follow up.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 37, 'IgE'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CL_0000771', 'eosinophil', 54, 'eosinophil'), ('UBERON_0002048', 'lung', 94, 'pulmonary'), ('CHEBI_6805', 'methacycline', 122, 'methacholine')]
PMC4896250	4/2016	S4910-PMC4896250	['children with bhr new showed high sensitization and normal Lung function, but low Eosinophil at age 7 yrs.']	N/A	N/A	[('UBERON_0002048', 'lung', 59, 'lung'), ('CL_0000771', 'eosinophil', 82, 'eosinophil')]
PMC4896250	4/2016	S5048-PMC4896250	['one Lobe of the right Lung was taken for Viral rna (vrna), mrna-Il-33 evaluation by qpcr and the other Lobes was used for preparing of cell suspension by collagenase digestion.']	N/A	N/A	[('UBERON_0009912', 'anatomical lobe', 4, 'lobe'), ('UBERON_0002048', 'lung', 22, 'lung'), ('NCBITaxon_1', 'root', 41, 'viral'), ('PR_000001470', 'interleukin-28B', 64, 'IL-33'), ('UBERON_0009912', 'anatomical lobe', 103, 'lobes')]
PMC4896250	4/2016	S5050-PMC4896250	['results: Vrna copy number in Lung Tissue of Rsv-Infected Animals was 4.3-fold higher than in Mice treated with inactivated Virus.']	N/A	N/A	[('SO_0000403', 'U14_snoRNA', 9, 'vRNA'), ('UBERON_0002048', 'lung', 29, 'lung'), ('UBERON_0000479', 'tissue', 34, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'RSV'), ('GO_0007631', 'feeding behavior', 48, 'infected'), ('NCBITaxon_33208', 'Metazoa', 57, 'animals'), ('NCBITaxon_10088', 'Mus <genus>', 93, 'mice'), ('NCBITaxon_1', 'root', 123, 'virus')]
PMC4896250	4/2016	S5054-PMC4896250	['mrna-Il-33 Expression in Lungs was 2.5-fold up-regulated upon Rsv infection.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-33'), ('GO_0010467', 'gene expression', 11, 'expression'), ('UBERON_0002048', 'lung', 25, 'lungs'), ('NCBITaxon_10088', 'Mus <genus>', 62, 'RSV')]
PMC4896250	4/2016	S5080-PMC4896250	['Lung inflammation and immunologic parameters were evaluated 48 h after the final Allergen challenge and 6 h after Allergen challenge on day 21, respectively.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_50904', 'allergen', 81, 'allergen'), ('CHEBI_50904', 'allergen', 114, 'allergen')]
PMC4896250	4/2016	S5114-PMC4896250	['48 hours after the last challenge in all groups Blood was collected for differential cell count, Brochoalveolar Lavage Fluid (Balf) was sampled for the determination of inflammatory cells and Lungs were removed for histological analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0004212', 'glomerular capillary', 97, 'brochoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 126, 'BALF'), ('UBERON_0002048', 'lung', 192, 'lungs')]
PMC4896250	4/2016	S5122-PMC4896250	['histological picture of allergic inflammation in Lungs (Peribronchial and Perivascular infiltration with Inflammatory Cells) was the most expressive (according to score system) in group 3 in comparison with other experimental groups.']	N/A	N/A	[('UBERON_0002048', 'lung', 49, 'lungs'), ('UBERON_0002256', 'dorsal horn of spinal cord', 56, 'peribronchial'), ('GO_0043204', 'perikaryon', 74, 'perivascular'), ('UBERON_0014930', 'perivascular space', 74, 'perivascular'), ('CL_0000902', 'induced T-regulatory cell', 105, 'inflammatory cells')]
PMC4896250	4/2016	S5132-PMC4896250	['a Chest ct scan revealed profound Lung Tissue destruction in the right middle Lobe.']	N/A	N/A	[('UBERON_0001443', 'chest', 2, 'chest'), ('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0000479', 'tissue', 39, 'tissue'), ('UBERON_0009912', 'anatomical lobe', 78, 'lobe')]
PMC4896250	4/2016	S5137-PMC4896250	['he had recurrent pneumonia clinically and the Right Lung lesions were progress to be collapsed totally, called as destroyed Lung till 3 years of infection.']	N/A	N/A	[('UBERON_0002167', 'right lung', 46, 'right lung'), ('UBERON_0002048', 'lung', 124, 'lung')]
PMC4896250	4/2016	S5139-PMC4896250	['conclusions: we reported two cases of Necrotizing pneumonia and bronchiolitis obliterance followed by destroyed Lung after m ycoplasma pneumoniae pneumonia.']	N/A	N/A	[('GO_0008380', 'RNA splicing', 38, 'necrotizing'), ('UBERON_0002048', 'lung', 112, 'lung')]
PMC4896250	4/2016	S5158-PMC4896250	['Lung inflammation and immunologic parameters were evaluated 48 h after the final Allergen challenge and 6 h after Allergen challenge on day 21, respectively.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_50904', 'allergen', 81, 'allergen'), ('CHEBI_50904', 'allergen', 114, 'allergen')]
PMC4896250	4/2016	S5221-PMC4896250	['methods: the patients who were performed both Methacholine challenge tests and Pulmonary function tests with bronchodilator for suspected asthma from 2002 to 2013 were selected and the results of the tests from order communication system were reviewed.']	N/A	N/A	[('CHEBI_6805', 'methacycline', 46, 'methacholine'), ('UBERON_0002048', 'lung', 79, 'pulmonary')]
PMC4896250	4/2016	S5225-PMC4896250	['results: a total 2616 Pulmonary function tests with Salbutamol and 1496 Methacholine challenge tests in 1434 patients from 12 to 89 years old were analyzed.']	N/A	N/A	[('UBERON_0002048', 'lung', 22, 'pulmonary'), ('CHEBI_66163', 'samaderine Y', 52, 'salbutamol'), ('CHEBI_6805', 'methacycline', 72, 'methacholine')]
PMC4896250	4/2016	S5235-PMC4896250	['Pulmonary function tests including bdr and feno were serially measured 10 times or more over 2 years when subjects were not receiving controller Medications.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('CHEBI_25441', 'mycothiols', 145, 'medications')]
PMC4896250	4/2016	S5361-PMC4896250	['Pulmonary score and side effects (tachycardia and tremor) was evaluated at before and after nebulized at 20, 50 and 60 minutes.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary')]
PMC4896250	4/2016	S5363-PMC4896250	['results: the decreased Pulmonary score at time evaluation was significant than before nebulized in both groups (p<0.05).']	N/A	N/A	[('UBERON_0002048', 'lung', 23, 'pulmonary')]
PMC4896250	4/2016	S5364-PMC4896250	['the decreased Pulmonary score in treatment group was greater than control group (p <0.05).']	N/A	N/A	[('UBERON_0002048', 'lung', 14, 'pulmonary')]
PMC4896250	4/2016	S5382-PMC4896250	['clinical presentation of Abpa ranges from asymptomatic Mucus Plugs to severe asthmatic symptoms or destructive and fibrotic Lung disease.']	N/A	N/A	[('PR_000003581', 'target of Nesh-SH3', 25, 'ABPA'), ('UBERON_0000912', 'mucus', 55, 'mucus plugs'), ('UBERON_0002048', 'lung', 124, 'lung')]
PMC4896250	4/2016	S5508-PMC4896250	['idiopathic Pulmonary fibrosis (ipf) is another chronic, progressive and lethal fibrotic Lung disease.']	N/A	N/A	[('UBERON_0002048', 'lung', 11, 'pulmonary'), ('UBERON_0002048', 'lung', 88, 'lung')]
PMC4896250	4/2016	S5578-PMC4896250	['baseline assessment included demographics, Lung functions, comorbidities, and Serum total Ige and se-Ige levels.']	N/A	N/A	[('UBERON_0002048', 'lung', 43, 'lung'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 90, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 101, 'IgE')]
PMC4896250	4/2016	S5581-PMC4896250	['Lung functions were serially checked every 3 month for two years in elderly asthma patients, and their best fev1/fvc ratio was used to define fixed Airway obstruction (persistently fev1/fvc<0.7 during 2-year of asthma management).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0001005', 'respiratory airway', 148, 'airway')]
PMC4896250	4/2016	S5633-PMC4896250	['st-Mirccl22 treatment also induced an increase in ova-specific Ifn-Γ levels and in the frequency of Lung Inflammatory Monocytes.']	N/A	N/A	[('PR_000010477', 'matrix metalloproteinase-17', 3, 'miRCCL22'), ('PR_000008920', 'interferon alpha-7', 63, 'IFN-γ'), ('UBERON_0002048', 'lung', 100, 'lung'), ('CL_0000902', 'induced T-regulatory cell', 105, 'inflammatory monocytes')]
PMC4896250	4/2016	S5919-PMC4896250	['all subjects underwent skin prick test, Pulmonary function test, and Methacholine challenge test.']	N/A	N/A	[('UBERON_0002048', 'lung', 40, 'pulmonary'), ('CHEBI_6805', 'methacycline', 69, 'methacholine')]
PMC4896250	4/2016	S6019-PMC4896250	['there were no significant differences in sex, age, smoking habits, levels of Eosinophil of Serum and Sputum, and baseline Lung function.']	N/A	N/A	[('CL_0000771', 'eosinophil', 77, 'eosinophil'), ('UBERON_0001977', 'blood serum', 91, 'serum'), ('UBERON_0007311', 'sputum', 101, 'sputum'), ('UBERON_0002048', 'lung', 122, 'lung')]
PMC4896250	4/2016	S6070-PMC4896250	['Pulmonary function tets were performed: baseline, postbronchodilator inhalation and Mannitol inhalation.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Pulmonary'), ('CHEBI_25169', 'mannoside', 84, 'mannitol')]
PMC4896250	4/2016	S6133-PMC4896250	['a432 implication of inspiratory and Expiratory resistance and reactance in children with asthma\n\nin suk sol1, kyu-earn kim1, yoon hee kim1, min jung kim1, seo hee yoon1, yong ju lee2, kyung won kim1, young a park1, myung hyun sohn1\n\n1yonsei university college of medicine, south korea;2hallym sacred Heart kangnam hospital\n\ncorrespondence: in suk sol – yonsei university college of medicine, south korea\nbackground: impulse oscillometry (ios) was developed as a non-invasive method to evaluate Lung function by measuring Respiratory resistance and reactance.']	N/A	N/A	[('GO_0010467', 'gene expression', 36, 'Expiratory'), ('UBERON_0000948', 'heart', 300, 'Heart'), ('UBERON_0002048', 'lung', 494, 'lung'), ('UBERON_0001004', 'respiratory system', 521, 'respiratory')]
PMC4896250	4/2016	S6207-PMC4896250	['results: compound v can improve Lung fibrosis in physiology significantly by scireq.']	N/A	N/A	[('UBERON_0002048', 'lung', 32, 'lung')]
PMC4896250	4/2016	S6210-PMC4896250	['we will further figure out the mechanism of compound v on Pulmonary fibrosis.']	N/A	N/A	[('UBERON_0002048', 'lung', 58, 'pulmonary')]
PMC4896250	4/2016	S6330-PMC4896250	['therefore, open Lung biopsy was performed, and it showed diffuse Interstitial Lymphocyte infiltrate.']	N/A	N/A	[('UBERON_0002048', 'lung', 16, 'lung'), ('UBERON_0005169', 'interstitial tissue', 65, 'interstitial'), ('CL_0000542', 'lymphocyte', 78, 'lymphocyte')]
PMC4896250	4/2016	S6331-PMC4896250	['the Lung Tissue was negative for Ebv by dnapcr and Ebv serology showed all-negative.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung'), ('UBERON_0000479', 'tissue', 9, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'EBV')]
PMC4896250	4/2016	S6403-PMC4896250	['demographic, socioeconomic, Metabolic, comorbidities, allergic parameters, and Lung function were analyzed.']	N/A	N/A	[('GO_0008152', 'metabolic process', 28, 'metabolic'), ('UBERON_0002048', 'lung', 79, 'lung')]
PMC4896250	4/2016	S6483-PMC4896250	['outcomes were evaluated for Methacholine Airway hyperresponsiveness (ahr), Lung Inflammatory Cells, Lung cytokines, Serum Ige, and in vitro Der P-stimulated Splenocyte responses.']	N/A	N/A	[('CHEBI_6805', 'methacycline', 28, 'methacholine'), ('UBERON_0001005', 'respiratory airway', 41, 'airway'), ('CL_0011006', 'Lugaro cell', 75, 'lung inflammatory cells'), ('UBERON_0002048', 'lung', 75, 'lung'), ('UBERON_0002048', 'lung', 100, 'lung'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 122, 'IgE'), ('PR_000006266', 'dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1', 140, 'Der p'), ('CL_0000017', 'spermatocyte', 157, 'splenocyte')]
PMC4896250	4/2016	S6829-PMC4896250	['in previous experiments of Mice, a short-term exposure to staphylococcal enterotoxin b (seb) induced extensive inflammatory responses in Lungs, including Lymphocytes, Neutrophils and Eosinophils.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 27, 'mice'), ('UBERON_0002048', 'lung', 137, 'lungs'), ('CL_0000542', 'lymphocyte', 154, 'lymphocytes'), ('CL_0000775', 'neutrophil', 167, 'neutrophils'), ('CL_0000771', 'eosinophil', 183, 'eosinophils')]
PMC4896250	4/2016	S6833-PMC4896250	['at 8 weeks, Mice were sacrificed and assessed for histopathology, Bronchoalveolar Lavage Fluid (Balf) cell counts, Lung cytokines, Methacholine Airway hyper-responsiveness (ahr), and Serum Immunoglobulins.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 12, 'mice'), ('UBERON_0004212', 'glomerular capillary', 66, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 96, 'BALF'), ('UBERON_0002048', 'lung', 115, 'lung'), ('CHEBI_6805', 'methacycline', 131, 'methacholine'), ('UBERON_0001005', 'respiratory airway', 144, 'airway'), ('UBERON_0001977', 'blood serum', 183, 'serum'), ('GO_0019814', 'immunoglobulin complex', 189, 'immunoglobulins')]
PMC4896250	4/2016	S6834-PMC4896250	['results: Ova sensitization followed by repeated Ova exposure resulted in the development of th2 asthma and inflammation, including Balf cell counts, Lung cytokines, histopathology, ahr and Serum Immunoglobulins.']	N/A	N/A	[('CHEBI_33299', 'alkaline earth molecular entity', 9, 'OVA'), ('CHEBI_33299', 'alkaline earth molecular entity', 48, 'OVA'), ('UBERON_0001348', 'brown adipose tissue', 131, 'BALF'), ('UBERON_0002048', 'lung', 149, 'lung'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('GO_0019814', 'immunoglobulin complex', 195, 'immunoglobulins')]
PMC4896250	4/2016	S6861-PMC4896250	['and Bronchoalveolar Lavage Fluid (Balf) samples were obtained and Lung specimens were also harvested on days 5 after inoculation to assess Lung inflammation, cytokine Expression and brp-39 production.']	N/A	N/A	[('UBERON_0004212', 'glomerular capillary', 4, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 34, 'BALF'), ('UBERON_0002048', 'lung', 66, 'lung'), ('UBERON_0002048', 'lung', 139, 'lung'), ('GO_0010467', 'gene expression', 167, 'expression'), ('PR_000001009', 'integrin alpha-D', 185, '-39')]
PMC4896250	4/2016	S6915-PMC4896250	['asthma Control was obtained, Lung function was improved and treatment with montelukast was stopped.']	N/A	N/A	[('GO_0065007', 'biological regulation', 7, 'control'), ('UBERON_0002048', 'lung', 29, 'lung')]
PMC4896250	4/2016	S6998-PMC4896250	['demographic and disease related information was obtained via a detailed questionnaire, skin prick test, Pulmonary function test, and Methacholine challenge test.']	N/A	N/A	[('UBERON_0002048', 'lung', 104, 'pulmonary'), ('CHEBI_6805', 'methacycline', 133, 'methacholine')]
PMC4896250	4/2016	S7139-PMC4896250	['he was diagnosed as Pulmonary tb and has started combination anti-tb Drug therapy consisting of Isoniazid, Rifampicin, Ethambutol, and pyrazinamide for 10 days.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'pulmonary'), ('CHEBI_23888', 'drug', 69, 'drug'), ('CHEBI_63438', 'hexaric acid derivative', 96, 'isoniazid'), ('CHEBI_17015', 'riboflavin', 107, 'rifampicin'), ('CHEBI_4877', 'ethambutol', 119, 'ethambutol')]
PMC4896250	4/2016	S7332-PMC4896250	['we evaluated Airway hyperresponsiveness (ahr), the proportion of Eosinophils in Bronchoalveolar Lavage Fluid (Balf), Lung histology, Serum total and ova-specific Antibody, cytokine profile of Balf and Lung draining Lymph Nodes (Lln), and T Cell population of lln.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 13, 'airway'), ('CL_0000771', 'eosinophil', 65, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 80, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 110, 'BALF'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 162, 'antibody'), ('UBERON_0001348', 'brown adipose tissue', 192, 'BALF'), ('UBERON_0002048', 'lung', 201, 'lung'), ('UBERON_0000029', 'lymph node', 215, 'lymph nodes'), ('UBERON_2000120', 'lateral line ganglion', 228, 'LLN'), ('CL_0000084', 'T cell', 238, 'T cell')]
PMC4896250	4/2016	S7333-PMC4896250	['results: Ascs-derived secretome significantly inhibited Eosinophilic inflammation in the Lung.']	N/A	N/A	[('CL_0002561', 'outer root sheath cell', 9, 'ASCs'), ('CL_0000771', 'eosinophil', 56, 'eosinophilic'), ('UBERON_0002048', 'lung', 89, 'lung')]
PMC4896250	4/2016	S7338-PMC4896250	['conclusions: Ascs-derived Secretome ameliorated allergic Airway inflammation and improved Lung function through the induction of Tregs expansion.']	N/A	N/A	[('CL_0002561', 'outer root sheath cell', 13, 'ASCs'), ('GO_0030017', 'sarcomere', 26, 'secretome'), ('UBERON_0001005', 'respiratory airway', 57, 'airway'), ('UBERON_0002048', 'lung', 90, 'lung'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 129, 'Tregs')]
PMC4896250	4/2016	S7343-PMC4896250	['in these diseases, affected Vessels have changed with focal necrosis in pathologic findings and patients suffer from Pulmonary, Cerebral, Gastrointestinal, other hemorrhagic complication and also Renal dysfunction represented by crescentic glomerulonephritis.']	N/A	N/A	[('UBERON_0000055', 'vessel', 28, 'vessels'), ('UBERON_0002048', 'lung', 117, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 128, 'cerebral'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 138, 'gastrointestinal'), ('UBERON_0002113', 'kidney', 196, 'renal')]
PMC4896250	4/2016	S7345-PMC4896250	['her Chest ct scan showed diffuse consolidation and ground glass opacity in both Lungs, hemoglobin was 3.9g/dl, hematocrit 12%, so she was diagnosed as diffuse Alveolar hemorrhage.']	N/A	N/A	[('UBERON_0001443', 'chest', 4, 'chest'), ('UBERON_0002048', 'lung', 80, 'lungs'), ('UBERON_0003215', 'alveolus', 159, 'alveolar')]
PMC4896250	4/2016	S7600-PMC4896250	['Thiocyanate amount are gradually decreased in Lung lysates and Balf after Ozone exposure.']	N/A	N/A	[('CHEBI_18022', 'thiocyanate', 0, 'Thiocyanate'), ('UBERON_0002048', 'lung', 46, 'lung'), ('UBERON_0001348', 'brown adipose tissue', 63, 'BALF'), ('CHEBI_25812', 'ozone', 74, 'ozone')]
PMC4896250	4/2016	S7610-PMC4896250	['results: Airway hyperresponsiveness, total Ige Production, and Pulmonary inflammation were significantly suppressed by Nac and the Par2-antagonist in the Mouse model.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 9, 'Airway'), ('GO_0032631', 'interleukin-27 production', 43, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 43, 'IgE'), ('UBERON_0002048', 'lung', 63, 'pulmonary'), ('CHEBI_7421', 'NAC', 119, 'NAC'), ('PR_000012271', 'pappalysin-2', 131, 'PAR2'), ('NCBITaxon_10088', 'Mus <genus>', 154, 'mouse')]
PMC4896250	4/2016	S7611-PMC4896250	['th2-cytokines and Tslp in the Lung were suppressed by the Nac and Par-2 antagonist.']	N/A	N/A	[('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 18, 'TSLP'), ('UBERON_0002048', 'lung', 30, 'lung'), ('CHEBI_7421', 'NAC', 58, 'NAC'), ('PR_000012270', 'pappalysin-1', 66, 'PAR-2')]
PMC4896250	4/2016	S7612-PMC4896250	['tight junction protein, Claudin-1 was disturbed by gce and restored by Par2-antagonist and Nac in the Lung.']	N/A	N/A	[('PR_000005519', 'cyclin-dependent kinases regulatory subunit 2', 24, 'claudin-1'), ('PR_000012271', 'pappalysin-2', 71, 'PAR2'), ('CHEBI_7421', 'NAC', 91, 'NAC'), ('UBERON_0002048', 'lung', 102, 'lung')]
PMC4896250	4/2016	S7615-PMC4896250	['a538 novel anti-Il-4Ra nanocarrier approach for the efficient Control Of Lung Tissue Inflammation during asthma\n\nrabih halwani1, saleh al muhsen1, asma sultana2,3, achraf al-faraj4; rosan kanana2,3, sibtain afzal2, roaa al kufaidi2\n\n1prince naif center for immunology research and asthma research chair, department of pediatrics, college of medicine, king saud university, saudi arabia;2prince naif center for immunology research, college of medicine, king saud university;3pnhrc, king saud university;4department of radiological sciences, college of applied medical sciences, king saud university\n\ncorrespondence: rabih halwani – prince naif center for immunology research and asthma research chair, department of pediatrics, college of medicine, king saud university, saudi arabia\nbackground.']	N/A	N/A	[('PR_000001366', 'interleukin-11', 16, 'IL-4Ra'), ('GO_0061584', 'hypocretin secretion', 62, 'Control of Lung Tissue Inflammation'), ('UBERON_0002048', 'lung', 73, 'Lung Tissue')]
PMC4896250	4/2016	S7623-PMC4896250	['Particles distribution within the Lungs were then examined and their targeting of specific Il-4R+ Inflammatory Cells was investigated using mri and histological analysis (immunohistochemistry, immunofluorescence).']	N/A	N/A	[('GO_0044316', 'cone cell pedicle', 0, 'Particles'), ('UBERON_0002048', 'lung', 34, 'lungs'), ('PR_000001470', 'interleukin-28B', 91, 'IL-4R'), ('CL_0000902', 'induced T-regulatory cell', 98, 'inflammatory cells')]
PMC4896250	4/2016	S7624-PMC4896250	['multiple Gene Expression studies (rt-pcr), flow cytometry, cytokine arrays (luminex) and histological analyses were performed on treated asthmatic Lungs Tissue and cells to evaluate the anti-inflammatory responses of these nanocariers.']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'gene expression'), ('SO_0000704', 'gene', 9, 'gene'), ('UBERON_0002048', 'lung', 147, 'lungs'), ('UBERON_0000479', 'tissue', 153, 'tissue')]
PMC4896250	4/2016	S7626-PMC4896250	['targeting and localization of nanocarriers with perl’s (iron), Peg (anti-Peg Antibodies), immunofluorescence (spio nanocarriers with Fitc labelled Antibody) confirmed their localization with anti-Il-4R+ Lung Inflammatory Cells.']	N/A	N/A	[('CHEBI_61022', 'naproxol', 63, 'PEG'), ('CHEBI_61022', 'naproxol', 73, 'PEG'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 133, 'FITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 147, 'antibody'), ('PR_000001470', 'interleukin-28B', 196, 'IL-4R'), ('CL_0011006', 'Lugaro cell', 203, 'lung inflammatory cells'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC4896250	4/2016	S7629-PMC4896250	['Lung inflammation was significantly decreased as observed in histological analysis as well as Gene Expression of inflammatory cytokines (Genes).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('GO_0010467', 'gene expression', 94, 'gene expression'), ('SO_0000704', 'gene', 94, 'gene'), ('SO_0000704', 'gene', 137, 'genes')]
PMC4896250	4/2016	S7630-PMC4896250	['in addition, a significant decrease in Activation and functionality Of Lung Inflammatory Cells was observed suing facs analysis following treatment with the Il-4R-nanocarrier.']	N/A	N/A	[('GO_0001775', 'cell activation', 39, 'activation ... of ... cells'), ('CL_0011006', 'Lugaro cell', 71, 'lung inflammatory cells'), ('UBERON_0002048', 'lung', 71, 'lung'), ('PR_000001470', 'interleukin-28B', 157, 'IL-4R')]
PMC4896250	4/2016	S7757-PMC4896250	['the Lung status in these patients was rapidly recovered within days, and they were extubated at 31, 67 hours and 4 days after initiation of ecmo, respectively.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'lung')]
PMC4896250	4/2016	S7820-PMC4896250	['identification of Interleukin (Il)-17 Expression was performed by immunohistochemistry and real time pcr on skin and Lung specimens.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 18, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 31, 'IL)-17'), ('GO_0010467', 'gene expression', 38, 'expression'), ('UBERON_0002048', 'lung', 117, 'lung')]
PMC4896250	4/2016	S7824-PMC4896250	['furthermore, the skin and Lung Expressions of Il-17 were reduced after the treatment of anti-Fcεri Antibody.']	N/A	N/A	[('UBERON_0002048', 'lung', 26, 'lung'), ('GO_0010467', 'gene expression', 31, 'expressions'), ('PR_000001470', 'interleukin-28B', 46, 'IL-17'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 93, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibody')]
PMC4896250	4/2016	S7924-PMC4896250	['the levels were analyzed in terms of Airway obstruction (fev1%) and inflammation (Neutrophil % and Eosinophil % of induced Sputum) and exacerbation frequency and Lung function over 1 year or longer follow up.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 37, 'airway'), ('CL_0000775', 'neutrophil', 82, 'neutrophil'), ('CL_0000771', 'eosinophil', 99, 'eosinophil'), ('UBERON_0007311', 'sputum', 123, 'sputum'), ('UBERON_0002048', 'lung', 162, 'lung')]
PMC4896250	4/2016	S7940-PMC4896250	['the levels were analyzed in terms of Airway obstruction (fev1) and inflammation (Neutrophil and Eosinophil % of the Airway) and exacerbation frequency and Lung functions over 1 year or longer follow up.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 37, 'airway'), ('CL_0000775', 'neutrophil', 81, 'neutrophil'), ('CL_0000771', 'eosinophil', 96, 'eosinophil'), ('UBERON_0001005', 'respiratory airway', 116, 'airway'), ('UBERON_0002048', 'lung', 155, 'lung')]
PMC4896250	4/2016	S7952-PMC4896250	['ascs significantly inhibited th2 cytokines (Il-4, Il-5, and Il-13) and enhanced th1 cytokine (Ifn-Γ) and Regulatory cytokines (Il-10 and Tgf-Β) in the Balf and Lung draining Lymph Nodes (Llns).']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 44, 'IL-4'), ('PR_000001470', 'interleukin-28B', 50, 'IL-5'), ('PR_000001470', 'interleukin-28B', 60, 'IL-13'), ('PR_000008920', 'interferon alpha-7', 94, 'IFN-γ'), ('GO_0065007', 'biological regulation', 105, 'regulatory'), ('PR_000001470', 'interleukin-28B', 127, 'IL-10'), ('PR_000000046', 'TGF-beta', 137, 'TGF-β'), ('UBERON_0001348', 'brown adipose tissue', 151, 'BALF'), ('UBERON_0002048', 'lung', 160, 'lung'), ('UBERON_0000029', 'lymph node', 174, 'lymph nodes'), ('UBERON_0000029', 'lymph node', 187, 'LLNs')]
PMC4896250	4/2016	S7959-PMC4896250	['furthermore, several nanometer- to micrometer-sized tiny particulates, such as Particulate matter 2.5 (pm2.5) that is less than 2.5 micrometers in diameter, could enter into the Respiratory Tract and settle deep in Lungs, causing Pulmonary chronic inflammation such as asthma.']	N/A	N/A	[('CHEBI_62964', 'magnesium acetate', 79, 'particulate'), ('UBERON_0000065', 'respiratory tract', 178, 'respiratory tract'), ('UBERON_0002048', 'lung', 215, 'lungs'), ('UBERON_0002048', 'lung', 230, 'pulmonary')]
PMC4896250	4/2016	S7964-PMC4896250	['instillation and then we analyzed the Particulate-induced Lung inflammation.']	N/A	N/A	[('CHEBI_62964', 'magnesium acetate', 38, 'particulate'), ('UBERON_0002048', 'lung', 58, 'lung')]
PMC4896250	4/2016	S7965-PMC4896250	['a histological analysis showed that, in addition to the infiltration of Inflammatory Cells, many lymphoid clusters, with the size of 100-300 mm in diameter, were induced in the Lung.']	N/A	N/A	[('CL_0000902', 'induced T-regulatory cell', 72, 'inflammatory cells'), ('UBERON_0002048', 'lung', 177, 'lung')]
PMC4896250	4/2016	S7969-PMC4896250	['alum instillation induced Il-1Α released in the Lung by Alveolar Macrophage (Am) Cell Death, and the number of ibalt formation was clearly reduced in il-1R-deficient Mice.']	N/A	N/A	[('PR_000001388', 'interleukin-32', 26, 'IL-1α'), ('UBERON_0002048', 'lung', 48, 'lung'), ('CL_0000322', 'pneumocyte', 56, 'alveolar macrophage ...'), ('UBERON_0003215', 'alveolus', 56, 'alveolar'), ('CL_0002284', 'type X enteroendocrine cell', 77, 'AM ... cell'), ('GO_0008219', 'cell death', 81, 'cell death'), ('PR_000003035', 'cellular tumor antigen p53', 153, '1R'), ('NCBITaxon_10088', 'Mus <genus>', 166, 'mice')]
PMC4896250	4/2016	S7981-PMC4896250	['methods: Expression of S100A9, S100A8 mrna and protein levels and Activated Caspase-1 were measured in the Lung Tissues of the cfa/ova modelusing a rt-pcr, real-time pcr and western blot.']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'Expression'), ('PR_000014414', 'protein S100-A7', 23, 'S100A9'), ('PR_000014414', 'protein S100-A7', 31, 'S100A8'), ('PR_000004139', 'adipocyte plasma membrane-associated protein', 66, 'activated caspase-1'), ('UBERON_0002048', 'lung', 107, 'lung'), ('UBERON_0000479', 'tissue', 112, 'tissues')]
PMC4896250	4/2016	S7986-PMC4896250	['Intra-Tracheal instillation of S100A9 protein induced rapid increase of Activated Caspase-1 in the Lung Tissue from 2 hr, peaked at 8 hr, then progressively decreased till 80 hr with concomitantincrease of Neutrophilsin Bal Fluids.']	N/A	N/A	[('UBERON_0001273', 'ilium', 0, 'Intra'), ('UBERON_0003126', 'trachea', 6, 'tracheal'), ('PR_000014414', 'protein S100-A7', 31, 'S100A9'), ('PR_000004139', 'adipocyte plasma membrane-associated protein', 72, 'activated caspase-1'), ('UBERON_0002048', 'lung', 99, 'lung'), ('UBERON_0000479', 'tissue', 104, 'tissue'), ('CL_0000775', 'neutrophil', 206, 'neutrophilsin'), ('UBERON_0006314', 'bodily fluid', 220, 'BAL fluids')]
PMC4896250	4/2016	S8011-PMC4896250	['Lung Tissue was separated and he and pas stain were done to obseve pathologic changes and Goblet Cell hyperplasia under the optical microscope.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('CL_0000160', 'goblet cell', 90, 'goblet cell')]
PMC4896250	4/2016	S8013-PMC4896250	['percentages of Th17 Cells and Treg Cells in the Lung Tissue were determined by means of flow cytometry(fcm).']	N/A	N/A	[('CL_0000899', 'T-helper 17 cell', 15, 'Th17 cells'), ('CL_0000960', 'T3 B cell', 30, 'Treg cells'), ('UBERON_0002048', 'lung', 48, 'lung'), ('UBERON_0000479', 'tissue', 53, 'tissue')]
PMC4896250	4/2016	S8015-PMC4896250	['Treg Cell percentage in the Lung of the na group was higher than that of the naag group (each p<0.05).']	N/A	N/A	[('CL_0000960', 'T3 B cell', 0, 'Treg cell'), ('UBERON_0002048', 'lung', 28, 'lung')]
PMC4896250	4/2016	S8150-PMC4896250	['conclusions\nin preschool children, with the management of asthma after exacerbation, Lung function assessed by impulse oscillometry improved in different degrees.']	N/A	N/A	[('UBERON_0002048', 'lung', 85, 'lung')]
PMC4896250	4/2016	S8168-PMC4896250	['in children with higher exposure to Ozone and Sulfur Dioxide, Lung function measured as fev1 and fvc was significantly decreased.']	N/A	N/A	[('CHEBI_25812', 'ozone', 36, 'ozone'), ('CHEBI_18422', 'sulfur dioxide', 46, 'sulfur dioxide'), ('UBERON_0002048', 'lung', 62, 'lung')]
PMC4896250	4/2016	S8178-PMC4896250	['Lung Tissue stainning with he, concentration of Il-17 in Balf by elisa, Expression of Bcl-2 and Caspase-3 on Th17 Cells by flow cytometry were determined.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000001470', 'interleukin-28B', 48, 'IL-17'), ('UBERON_0001348', 'brown adipose tissue', 57, 'BALF'), ('GO_0010467', 'gene expression', 72, 'expression'), ('PR_000002304', 'apoptosis regulator BAX isoform 6', 86, 'Bcl-2'), ('PR_000002319', 'catenin beta-1 isoform 1', 96, 'Caspase-3'), ('CL_0000899', 'T-helper 17 cell', 109, 'Th17 cells')]
PMC4896250	4/2016	S8294-PMC4896250	['at the first visit, patients underwent Pulmonary function testing, skin prick testing with panel of Aeroallergens, and 25-Hydroxyvitamin D levels were measured.']	N/A	N/A	[('UBERON_0002048', 'lung', 39, 'pulmonary'), ('CHEBI_33656', 'antiaromatic compound', 100, 'aeroallergens'), ('CHEBI_27844', "2',3'-cyclic AMP", 119, '25-Hydroxyvitamin D')]
PMC4896250	4/2016	S8482-PMC4896250	['a598 the concordance between Lung function test and indonesian version of childhood asthma Control test (cact)\n\nnastiti kaswandani, cynthia utami, mardjanis said\n\nfaculty of medicine university of indonesia, indonesia\n\ncorrespondence: nastiti kaswandani – faculty of medicine university of indonesia, indonesia\nbackground.']	N/A	N/A	[('UBERON_0002048', 'lung', 29, 'Lung'), ('GO_0065007', 'biological regulation', 91, 'Control')]
PMC4896250	4/2016	S8491-PMC4896250	['the subjects were consecutively recruited to do the Lung function test and peak flow meter twice a day for 2 weeks.']	N/A	N/A	[('UBERON_0002048', 'lung', 52, 'lung')]
PMC4896250	4/2016	S8562-PMC4896250	['a604 examination of late Pulmonary toxicity in children treated for malignancies\n\nagnes nemeth\n\nsemmelweis university, faculty of medicine, hungary\nthe Chemotherapeutical Drugs and the therapeutic irradiation can demage the Lungs during the anticancer therapy of childhood malignancies.']	N/A	N/A	[('UBERON_0002048', 'lung', 25, 'Pulmonary'), ('CHEBI_59777', 'ketal', 152, 'chemotherapeutical'), ('CHEBI_23888', 'drug', 171, 'drugs'), ('UBERON_0002048', 'lung', 224, 'lungs')]
PMC4896250	4/2016	S8565-PMC4896250	['Lung function test was performed with spirometry in 26 survivors participated in this study (10 felames, 16 males, mean age 19,4 years at the time of second follow-up evaluation).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung')]
PMC4896250	4/2016	S8702-PMC4896250	['histological examination of Lung Tissue was performed to estimate the pathological changes.']	N/A	N/A	[('UBERON_0002048', 'lung', 28, 'lung'), ('UBERON_0000479', 'tissue', 33, 'tissue')]
PMC4896250	4/2016	S8706-PMC4896250	['moreover, the Expression of p-Akt was increased in Lung Tissues of asthmatic Rats, and suppressed by Mscs transplantation.']	N/A	N/A	[('GO_0010467', 'gene expression', 14, 'expression'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 30, 'Akt'), ('UBERON_0002048', 'lung', 51, 'lung'), ('UBERON_0000479', 'tissue', 56, 'tissues'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 77, 'rats'), ('CL_0000186', 'myofibroblast cell', 101, 'MSCs')]
PMC4896250	4/2016	S9126-PMC4896250	['twenty-four hours after last challenge, we collected Blood, Balf, Lungs.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 60, 'BALF'), ('UBERON_0002048', 'lung', 66, 'lungs')]
PMC4896250	4/2016	S9133-PMC4896250	['conclusion\nCgamp acts an Adjuvant and induces allergic inflammation in the Lung.']	N/A	N/A	[('PR_000005000', 'calmodulin-binding transcription activator 1', 11, 'cGAMP'), ('CHEBI_60809', 'adjuvant', 25, 'adjuvant'), ('UBERON_0002048', 'lung', 75, 'lung')]
PMC4896250	4/2016	S9189-PMC4896250	['every nursing home resident who met the inclusion criteria (to be at least 65 years old and to reside in the nursing home for more than 6 months) and did not present any contraindication for Lung function tests was invited to answer a Respiratory health questionnaire administered by an interviewer and to perform a spirometry.']	N/A	N/A	[('UBERON_0002048', 'lung', 191, 'lung'), ('UBERON_0001004', 'respiratory system', 235, 'respiratory')]
PMC4896250	4/2016	S9488-PMC4896250	['twenty pneumonia patients with asthma (2.3%), 1 patient (0.1%) had asthma and congenital Heart disease, and 15 patients (1.5%) had asthma and other comorbid such as Cerebral palsy, anemia, malnutrition, diarrhea, and Pulmonary tuberculosis.']	N/A	N/A	[('UBERON_0000948', 'heart', 89, 'heart'), ('UBERON_0001893', 'telencephalon', 165, 'cerebral'), ('UBERON_0002048', 'lung', 217, 'pulmonary')]
PMC4910255	6/2016	S6-PMC4910255	['secondary outcomes included other anthropometry, body composition, Blood pressure, and Cognitive and Lung function.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0050890', 'cognition', 87, 'cognitive'), ('UBERON_0002048', 'lung', 101, 'lung')]
PMC4910255	6/2016	S47-PMC4910255	['secondary outcomes included categorical proportions of stunting (< –2 z scores height-for-age), underweight (< –2 z scores weight-for-age), wasting (< –2 z scores weight-for-height) and low body mass index (bmi) (< –2 z scores bmi-for-age), descriptions of body composition (lean and fat mass, skinfold thickness), Blood pressure, Cognitive tests, and Lung function.']	N/A	N/A	[('UBERON_0000178', 'blood', 315, 'blood'), ('GO_0050890', 'cognition', 331, 'cognitive'), ('UBERON_0002048', 'lung', 352, 'lung')]
PMC4910255	6/2016	S203-PMC4910255	['Respiratory\nthe nepal janakpur trial investigated Lung function at 8.5\xa0years of age.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 0, 'Respiratory'), ('UBERON_0002048', 'lung', 50, 'lung')]
PMC4910255	6/2016	S205-PMC4910255	['no difference in Lung function was found between allocation groups: forced Expiratory volume in the first second, –0.01\xa0l (95\xa0% ci, –0.04 to 0.02\xa0l); forced vital capacity, –0.01\xa0l (95\xa0% ci, –0.04 to 0.02\xa0l) [52].']	N/A	N/A	[('UBERON_0002048', 'lung', 17, 'lung'), ('GO_0010467', 'gene expression', 75, 'expiratory')]
PMC4912994	6/2016	S15-PMC4912994	['fetal echocardiogram revealed tetralogy of fallot with Pulmonary atresia.']	N/A	N/A	[('UBERON_0002048', 'lung', 55, 'pulmonary')]
PMC4912994	6/2016	S54-PMC4912994	['Chest radiograph noted severe Pulmonary edema.']	N/A	N/A	[('UBERON_0012131', 'centrale', 0, 'Chest'), ('UBERON_0002048', 'lung', 30, 'pulmonary')]
PMC4919374	6/2016	S121-PMC4919374	['for anticipated hyperglycemia when betamethasone is given for fetal Lung maturation, mathiesen et al.']	N/A	N/A	[('UBERON_0002048', 'lung', 68, 'lung')]
PMC4969253	8/2016	S0-PMC4969253	['vitamin a-Retinoid Signaling in Pulmonary Development and disease\n\nabstract\nRetinoic Acid (ra), the active form of Vitamin A, Regulates key developmental processes in multiple Organs.']	N/A	N/A	[('CHEBI_26537', 'retinoid', 10, 'retinoid'), ('GO_0023051', 'regulation of signaling', 19, 'signaling'), ('GO_0060021', 'roof of mouth development', 32, 'pulmonary development'), ('UBERON_0002048', 'lung', 32, 'pulmonary'), ('CHEBI_28592', 'ricinoleic acid', 76, 'Retinoic acid'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A'), ('GO_0065007', 'biological regulation', 126, 'regulates'), ('UBERON_0000062', 'organ', 176, 'organs')]
PMC4969253	8/2016	S8-PMC4969253	['these components are all Expressed in the Foregut as early as at the onset of Lung Development [2].']	N/A	N/A	[('GO_0010467', 'gene expression', 25, 'expressed'), ('UBERON_0001041', 'foregut', 42, 'foregut'), ('GO_0030324', 'lung development', 78, 'lung development'), ('UBERON_0002048', 'lung', 78, 'lung')]
PMC4969253	8/2016	S12-PMC4969253	['while no Lung Buds form in the Ra-deficient Foregut Endoderm Lung, progenitor cells are still specified at the prospective Lung Field.']	N/A	N/A	[('UBERON_0000118', 'lung bud', 9, 'lung buds'), ('PR_000013644', 'Ras-related protein Rab-9A', 31, 'RA'), ('UBERON_0003258', 'endoderm of foregut', 44, 'foregut endoderm'), ('UBERON_0002048', 'lung', 61, 'lung'), ('UBERON_0022361', 'lung field', 123, 'lung field')]
PMC4969253	8/2016	S27-PMC4969253	['a at the onset of Lung Development, Mesodermal ra signaling suppresses Dkk1 to allow induction of Wnt Pathway and inhibits Tgf-Beta signaling to de-repress Fgf10 Expression.']	N/A	N/A	[('GO_0030324', 'lung development', 18, 'lung development'), ('UBERON_0002048', 'lung', 18, 'lung'), ('UBERON_0000926', 'mesoderm', 36, 'mesodermal'), ('PR_000006499', 'dickkopf-related protein 1', 71, 'Dkk1'), ('GO_0016055', 'Wnt signaling pathway', 98, 'Wnt pathway'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 123, 'Tgf-beta'), ('PR_000007499', 'fibroblast growth factor 8', 156, 'Fgf10'), ('GO_0010467', 'gene expression', 162, 'expression')]
PMC4969253	8/2016	S30-PMC4969253	['b during Airway Formation, Mesodermal (Mesenchymal) ra signaling restricts sm Gene Expression (acta2, Myh11, Tagln) in distal Lung, preventing ectopic and excessive sm differentiation while Airways are branching.']	N/A	N/A	[('GO_0019270', 'aerobactin biosynthetic process', 9, 'airway formation'), ('UBERON_0001005', 'respiratory airway', 9, 'airway'), ('UBERON_0000926', 'mesoderm', 27, 'mesodermal'), ('UBERON_0003104', 'mesenchyme', 39, 'mesenchymal'), ('GO_0010467', 'gene expression', 78, 'gene expression'), ('SO_0000704', 'gene', 78, 'gene'), ('PR_000010827', 'myosin-3', 102, 'Myh11'), ('PR_000016333', 'tigger transposable element-derived protein 3', 109, 'Tagln'), ('UBERON_0002048', 'lung', 126, 'lung'), ('UBERON_0001005', 'respiratory airway', 190, 'airways')]
PMC4969253	8/2016	S35-PMC4969253	['Airway sm originates early in the developing Lung Mesenchyme, during formation of the Bronchial Tree, through a mechanism that is distinct from that of the Lung Vascular Musculature.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 0, 'Airway'), ('UBERON_0004883', 'lung mesenchyme', 45, 'lung mesenchyme'), ('UBERON_0002186', 'bronchiole', 86, 'bronchial tree'), ('UBERON_0002048', 'lung', 156, 'lung'), ('UBERON_0002201', 'vasculature of trunk', 161, 'vascular musculature')]
PMC4969253	8/2016	S56-PMC4969253	['in the Adult Lung, Vitamin A deficiency results in marked changes in the Respiratory Epithelium, including necrotizing Tracheobronchiolitis and squamous metaplasias (transformation of a Respiratory pseudostratifed into a skin-like Stratified Epithelium).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 7, 'adult'), ('UBERON_0002048', 'lung', 13, 'lung'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('UBERON_0004802', 'respiratory tract epithelium', 73, 'respiratory epithelium'), ('UBERON_0008426', 'transverse foramen of atlas', 119, 'tracheobronchiolitis'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory'), ('UBERON_0000486', 'multilaminar epithelium', 231, 'stratified epithelium')]
PMC4969253	8/2016	S68-PMC4969253	['for example, Vitamin A-deficient Adult Rats exposed to aerosolized Methacholine have an increase in total Pulmonary resistance compared to control Rats.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin A'), ('UBERON_0007023', 'adult organism', 33, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rats'), ('CHEBI_6805', 'methacycline', 67, 'methacholine'), ('UBERON_0002048', 'lung', 106, 'pulmonary'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 147, 'rats')]
PMC4969253	8/2016	S75-PMC4969253	['mild maternal Vitamin A deficiency in Pregnant Rats resulted in changes in the composition of the Extracellular Matrix of the Lung in Adult offspring; these Mice showed increased collagen and decreased elastin deposition in the Lungs.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('GO_0031012', 'extracellular matrix', 98, 'extracellular matrix'), ('UBERON_0002048', 'lung', 126, 'lung'), ('UBERON_0007023', 'adult organism', 134, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mice'), ('UBERON_0002048', 'lung', 228, 'lungs')]
PMC4975765	1/2016	S13-PMC4975765	['apart from main synthesis in the Liver, Hepcidin messenger rna (mrna) is also Expressed in the Lung, Heart, Brain, and Placenta Tissue.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 40, 'hepcidin'), ('GO_0010467', 'gene expression', 78, 'expressed'), ('UBERON_0002048', 'lung', 95, 'lung'), ('UBERON_0000948', 'heart', 101, 'heart'), ('UBERON_0000955', 'brain', 108, 'brain'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000479', 'tissue', 128, 'tissue')]
PMC4975765	1/2016	S114-PMC4975765	['the decreased concentration of this hormone in chronic obstructive Pulmonary disease (codp) patients and in healthy volunteers exposed to Hypobaric hypoxia at high altitude was observed [35,36].']	N/A	N/A	[('UBERON_0002048', 'lung', 67, 'pulmonary'), ('CHEBI_35859', 'zomepirac', 138, 'hypobaric')]
PMC4996908	5/2016	S19-PMC4996908	['Genetic testing did not reveal an abnormality, but given her constellation of Spinal segmentation and Rib anomalies, a diagnosis of scdo was made, along with Pulmonary hypoplasia, congenital Heart disease with a Ventricular Septal defect, Bicuspid Aortic Valve, Transverse Aortic Arch hypoplasia and severe Aortic coarctation, Pelvic horseshoe Kidney, Uterine didelphys, and Inguinal hernia (with subsequent obstruction).']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genetic'), ('UBERON_0001130', 'vertebral column', 78, 'spinal'), ('UBERON_0002228', 'rib', 102, 'rib'), ('UBERON_0002048', 'lung', 158, 'pulmonary'), ('UBERON_0000948', 'heart', 191, 'heart'), ('UBERON_0002094', 'interventricular septum', 212, 'ventricular septal'), ('UBERON_0003674', 'cuspid', 239, 'bicuspid'), ('UBERON_0002137', 'aortic valve', 248, 'aortic valve'), ('UBERON_0002201', 'vasculature of trunk', 262, 'transverse'), ('UBERON_0001508', 'arch of aorta', 273, 'aortic arch'), ('UBERON_0000947', 'aorta', 307, 'aortic'), ('UBERON_0002108', 'small intestine', 327, 'pelvic'), ('UBERON_0002113', 'kidney', 344, 'kidney'), ('UBERON_0000995', 'uterus', 352, 'uterine'), ('UBERON_0008337', 'inguinal part of abdomen', 375, 'inguinal')]
PMC4996908	5/2016	S31-PMC4996908	['her Pulmonary function remained relatively normal,\xa0and no orthopedic correction of her Spine or Rib deformities was performed.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'pulmonary'), ('UBERON_0001013', 'adipose tissue', 87, 'spine'), ('UBERON_0002228', 'rib', 96, 'rib')]
PMC5005165	1/2016	S4-PMC5005165	['chronic obstructive Pulmonary disease (copd) and chronic bronchitis represent nearly 98% of the deaths from clrds.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'pulmonary')]
PMC5005165	1/2016	S10-PMC5005165	['abstract:short\ncopd asrs have dropped in the last 30 years in italy but number of deaths is stable in men and increasing in women http://ow.ly/yl9od\n\nintroduction\nchronic Lower Respiratory diseases (clrds) are a group of pathologies that obstruct the Lungs, which mainly includes chronic obstructive Pulmonary disease (copd) and asthma.']	N/A	N/A	[('UBERON_0002199', 'integument', 171, 'lower respiratory'), ('UBERON_0002048', 'lung', 251, 'lungs'), ('UBERON_0002048', 'lung', 300, 'pulmonary')]
PMC5005165	1/2016	S23-PMC5005165	['caption (table-wrap): table\xa01\n\ncauses of death for chronic Lower Respiratory diseases, with corresponding international classification of diseases (icd) codesicd-9 basic tabulation list (from 1979 to 1995) \u2003b323bronchitis, chronic and unspecified, emphysema, and asthma\u2003b324bronchiectasis\u2003b325other chronic obstructive Pulmonary diseases icd-9 detailed full list (from 1996 to 2002) \u2003490bronchitis, not specified as acute or chronic\u2003491chronic bronchitis\u2003492emphysema\u2003493asthma\u2003494bronchiectasis\u2003495extrinsic allergic alveolitis\u2003496chronic Airway obstruction, not elsewhere classified icd-10 detailed full list (from 2003 to 2010) \u2003j40bronchitis, not specified as acute or chronic\u2003j41simple and mucopurulent chronic bronchitis\u2003j42unspecified chronic bronchitis\u2003j43emphysema\u2003j44other chronic obstructive Pulmonary disease\u2003j45asthma\u2003j46status asthmaticus\u2003j47bronchiectasis\n\ndata analysis\napproximate Birth cohorts were estimated by subtracting the midpoint of the 5-year age group from the corresponding calendar year.']	N/A	N/A	[('UBERON_0009567', 'nail of pedal digit', 59, 'lower'), ('UBERON_0001004', 'respiratory system', 65, 'respiratory'), ('UBERON_0002048', 'lung', 319, 'pulmonary'), ('UBERON_0001005', 'respiratory airway', 540, 'airway'), ('UBERON_0002048', 'lung', 803, 'pulmonary'), ('GO_0007567', 'parturition', 898, 'birth')]
PMC5005165	1/2016	S44-PMC5005165	['copd: chronic obstructive Pulmonary disease.']	N/A	N/A	[('UBERON_0002048', 'lung', 26, 'pulmonary')]
PMC5005165	1/2016	S100-PMC5005165	['the prevalence of Lung function abnormalities and of Respiratory symptoms is higher in smokers, who suffer from a faster decline of forced Expiratory volume in 1\u2005s than nonsmokers.']	N/A	N/A	[('UBERON_0002048', 'lung', 18, 'lung'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('GO_0010467', 'gene expression', 139, 'expiratory')]
PMC5005165	1/2016	S110-PMC5005165	['Viral and bacterial infections are the most common cause of copd exacerbations, and accelerate the decline in Lung function that characterises copd [20].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Viral'), ('UBERON_0002048', 'lung', 110, 'lung')]
PMC5005165	1/2016	S115-PMC5005165	['copd mortality rates increase exponentially with age, reflecting the accumulation of exposures with passing years, the physiological deterioration of the Lung function and the increased vulnerability to pathogens given by the weakening of the Immune System.']	N/A	N/A	[('UBERON_0002048', 'lung', 154, 'lung'), ('UBERON_0002405', 'immune system', 243, 'immune system')]
PMC5030620	9/2016	S185-PMC5030620	['(2012) * lifestyle factors\u2003smoking:\u2003\u2002cigarette smokeadulthood lifetimeadulthoodcopd Breast and Lung cancer ↓Lung cancer overall \u2002survivaldna Methylation epigenetic machinery mirnaslin et\xa0al.']	N/A	N/A	[('UBERON_0000310', 'breast', 84, 'Breast'), ('UBERON_0002048', 'lung', 95, 'lung'), ('UBERON_0002048', 'lung', 108, 'lung'), ('GO_0032258', 'cytoplasm to vacuole transport by the Cvt pathway', 141, 'methylation')]
PMC5030620	9/2016	S191-PMC5030620	['ad: alzheimer’s disease; copd: chronic obstructive Pulmonary disease; ecat: elemental Carbon attributable to traffic; nsclc: non-small cell Lung cancer; pbl: Peripheral Blood Lymphocyte.']	N/A	N/A	[('UBERON_0002048', 'lung', 51, 'pulmonary'), ('CHEBI_33306', 'carbon group element atom', 86, 'carbon'), ('UBERON_0002048', 'lung', 140, 'lung'), ('CL_0000624', 'CD4-positive, alpha-beta T cell', 158, 'peripheral blood lymphocyte'), ('UBERON_0012101', 'perinatal stage', 158, 'peripheral blood')]
PMC5118969	11/2016	S42-PMC5118969	['probability of Pulmonary embolic disease as well as Aortic and Coronary dissection were considered and effectively ruled out by computed tomography with contrast.']	N/A	N/A	[('UBERON_0002048', 'lung', 15, 'pulmonary'), ('UBERON_0000947', 'aorta', 52, 'aortic'), ('UBERON_0005985', 'coronary vessel', 63, 'coronary')]
PMC5133238	12/2016	S5-PMC5133238	['Glenn Circulation involves a connection between the Superior Vena Cava and the Pulmonary Artery that results in passive Blood flow to the Lungs; thus, the Single Ventricle must supply Cardiac output to both the Systemic and Pulmonary Circulations.']	N/A	N/A	[('UBERON_0009670', 'rectal lumen', 0, 'Glenn circulation'), ('UBERON_0001585', 'anterior vena cava', 52, 'superior vena cava'), ('UBERON_0002012', 'pulmonary artery', 79, 'pulmonary artery'), ('UBERON_0000178', 'blood', 120, 'blood'), ('UBERON_0002048', 'lung', 138, 'lungs'), ('UBERON_0002289', 'midbrain cerebral aqueduct', 155, 'single ventricle'), ('UBERON_0000948', 'heart', 184, 'cardiac'), ('UBERON_0004292', 'cardiac skeleton', 211, 'systemic ...'), ('UBERON_0008874', 'pulmonary acinus', 224, 'pulmonary circulations')]
PMC5133238	12/2016	S6-PMC5133238	['the Glenn connection decreases the workload on the Single Ventricle by diverting Blood flow from the upper half of the body directly to the Lungs.']	N/A	N/A	[('UBERON_0002106', 'spleen', 4, 'Glenn'), ('UBERON_0002289', 'midbrain cerebral aqueduct', 51, 'single ventricle'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0002048', 'lung', 140, 'lungs')]
PMC5133238	12/2016	S13-PMC5133238	['at 27 years of age, she had undergone glenn surgery to allow Blood to be routed directly from the Superior Vena Cava to the Lungs through phasic flow in the Pulmonary Artery (bidirectional Glenn shunt).']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001585', 'anterior vena cava', 98, 'superior vena cava'), ('UBERON_0002048', 'lung', 124, 'lungs'), ('UBERON_0002012', 'pulmonary artery', 157, 'pulmonary artery'), ('UBERON_0002106', 'spleen', 189, 'Glenn')]
PMC5133238	12/2016	S19-PMC5133238	['a preoperative electrocardiogram (ecg) and Transthoracic echocardiogram showed sinus rhythm without signs of ischemia, an ejection fraction of 60%, dysplasia and severe stenosis of the Pulmonary Valve, mild Left Atrio-Ventricular Valve regurgitation, and mild Aortic regurgitation.']	N/A	N/A	[('UBERON_0000980', 'trochanter', 43, 'transthoracic'), ('UBERON_0002048', 'lung', 185, 'pulmonary'), ('UBERON_0003978', 'valve', 195, 'valve'), ('UBERON_0002135', 'mitral valve', 207, 'left atrio-ventricular valve'), ('UBERON_0000947', 'aorta', 260, 'aortic')]
PMC5295525	6/2015	S46-PMC5295525	['further evaluation, with computed tomography and magnetic resonance imaging (mri) of the Chest and Abdomen, showed not only the presence of the Right Atrial mass but also multiple nodules scattered in both Lungs and Liver (fig.']	N/A	N/A	[('UBERON_0001443', 'chest', 89, 'chest'), ('UBERON_0000916', 'abdomen', 99, 'abdomen'), ('UBERON_0002078', 'right cardiac atrium', 144, 'right atrial'), ('UBERON_0002048', 'lung', 206, 'lungs'), ('UBERON_0002107', 'liver', 216, 'liver')]
PMC5295525	6/2015	S53-PMC5295525	['caption (fig): figure 3\n\nCardiac mri revealing large irregular tumor (t) occupying most of the Ra, with numerous bilateral Lung metastases (lm).']	N/A	N/A	[('UBERON_0000948', 'heart', 25, 'Cardiac'), ('UBERON_0004369', "Reichert's membrane", 95, 'RA'), ('UBERON_0002048', 'lung', 123, 'lung')]
PMC5295525	6/2015	S56-PMC5295525	['the final diagnosis was metastatic Cardiac as to the Lungs and Liver.']	N/A	N/A	[('UBERON_0000948', 'heart', 35, 'cardiac'), ('UBERON_0002048', 'lung', 53, 'lungs'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC5298530	12/2016	S19-PMC5298530	['physical exam revealed an alert, oriented, and cooperative patient with normal Respiratory effort and Lungs that were clear to auscultation.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 79, 'respiratory'), ('UBERON_0002048', 'lung', 102, 'lungs')]
PMC5319084	2/2017	S46-PMC5319084	['2\n\nmaternal mri showing small ring-enhancing lesions in both Cerebral and Cerebellar Hemispheres\nimmediately after the diagnosis of maternal tb and due to the complicated Respiratory course of the infant (hfov in case room, repeated doses of Surfactant, presentation with persistent Pulmonary Hypertension of newborn (pphn) within 24\xa0h of Life that required Nitric Oxide (ino)), the infant was fully screened for tb.']	N/A	N/A	[('UBERON_0001893', 'telencephalon', 61, 'cerebral ...'), ('UBERON_0002412', 'vertebra', 74, 'cerebellar hemispheres'), ('UBERON_0001004', 'respiratory system', 171, 'respiratory'), ('CHEBI_35195', 'surfactant', 242, 'surfactant'), ('GO_0061532', 'primary amine secretion, neurotransmission', 283, 'Pulmonary Hypertension'), ('UBERON_0002048', 'lung', 283, 'Pulmonary'), ('UBERON_0000104', 'life cycle', 339, 'life'), ('CHEBI_16480', 'nitric oxide', 358, 'nitric oxide')]
PMC5332602	3/2017	S46-PMC5332602	['the clinical signs in the affected Piglets were consistent with hypoglycemia and septicemia in addition to extraintestinal (Liver, Kidney, Lung, and Peritoneal Cavity swabs) recovery of clostridium perfringens type a and Nonhemolytic, Avirulent escherichia coli (bacterial identification to the species level was conducted at the ohio department of agriculture).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 35, 'piglets'), ('UBERON_0002107', 'liver', 124, 'liver'), ('UBERON_0002113', 'kidney', 131, 'kidney'), ('UBERON_0002048', 'lung', 139, 'lung'), ('UBERON_0001179', 'peritoneal cavity', 149, 'peritoneal cavity'), ('GO_0001822', 'kidney development', 221, 'nonhemolytic'), ('NCBITaxon_33208', 'Metazoa', 235, 'avirulent')]
PMC5340372	3/2017	S6-PMC5340372	['infant Lung function, including tidal breathing analysis, Respiratory mechanics, and forced tidal expiration, was tested at 6 months of age.']	N/A	N/A	[('UBERON_0002048', 'lung', 7, 'lung'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]
PMC5340372	3/2017	S7-PMC5340372	['results\na total of 122 mother—infant pairs were enrolled in this study, and 71 infants underwent Lung function testing at 6 months of age.']	N/A	N/A	[('UBERON_0002048', 'lung', 97, 'lung')]
PMC5340372	3/2017	S34-PMC5340372	['Serum from mother—cord pairs was collected and frozen for later measurement of 25(Oh)D. examinations of infant Lung function were performed at 6 months of age.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 79, '25(OH)D'), ('UBERON_0002048', 'lung', 111, 'lung')]
PMC5340372	3/2017	S42-PMC5340372	['infant Lung function testing\nmeasurements were taken of healthy infants who had had no Respiratory Tract infection for at least 3 weeks.']	N/A	N/A	[('UBERON_0002048', 'lung', 7, 'lung'), ('UBERON_0000065', 'respiratory tract', 87, 'respiratory tract')]
PMC5340372	3/2017	S58-PMC5340372	['all analyses were performed using ibm spss software v. 20 (armonk, ny, usa).10.1371/journal.pone.0173268.t001\n\ncaption (table-wrap): table 1\ndemographic data, family and environmental data, outcomes, and infant Lung function in groups with different 25(Oh)D status of Cord Serum.low Cord 25(Oh)D (n = 36)high Cord 25(Oh)D (n = 35) demographic data Gestational age (weeks)38.6 ± 1.138.4 ± 1.7male (%)36*59nature Delivery (%)6763birth bw (kg)3.1 ± 0.43.0 ± 0.3birth Bl (cm)50.4 ± 2.449.8 ± 1.9bw (kg)8.3 ± 1.08.3 ± 1.0bl (cm)68.8 ± 3.668.2 ± 2.2% of fall/winter Birth47.146.8 family and environmental data asthma, mother2.85.7asthma, father2.82.8ar mother22.237.1ar, father30.622.9ad, mother16.78.6ad, father05.7daycare attendance (%)13.911.4maternal smoke in pregnancy (%)2.85.7postnatal smoke exposure (%)44.442.9 outcomes np colonization rate (%)69.762.0ever rti till 6 months (%)40.0**11.1eczema at 6 months (%)1914ever wheeze at 6 months (%)1118 infant Lung function % of tpef/te<0.21423z score of rrs-0.18 ± -0.37**0.10 ± 0.29z score of Crs-0.19 ± 0.86-0.20± 1.20z score of vmaxfrc0.02 ± 1.0-0.17 ± 1.0\nbw, body weight; bl, body length; ar, allergic rhinitis; ad, atopic dermatitis; Np, Nasopharyngeal Cavity; rti, Respiratory Tract infection, tpef/te, ratio of time to peak expiratory flow to total expiratory time; rrs, resistance of Respiratory System; crs, compliance of Respiratory System; vmaxfrc, maximal expiratory flow at functional residual capacity.']	N/A	N/A	[('UBERON_0002048', 'lung', 211, 'lung'), ('CHEBI_71657', 'versiconol acetate', 250, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 253, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 256, 'D'), ('UBERON_0002240', 'spinal cord', 268, 'cord'), ('UBERON_0001977', 'blood serum', 273, 'serum'), ('UBERON_0002240', 'spinal cord', 283, 'cord'), ('CHEBI_71657', 'versiconol acetate', 288, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 291, 'OH ... D'), ('UBERON_0002240', 'spinal cord', 309, 'cord'), ('CHEBI_71657', 'versiconol acetate', 314, '25(OH)D'), ('GO_0007565', 'female pregnancy', 348, 'Gestational'), ('GO_0007567', 'parturition', 411, 'delivery'), ('UBERON_0006107', 'basolateral amygdaloid nuclear complex', 464, 'BL'), ('GO_0007567', 'parturition', 560, 'birth47'), ('UBERON_0002048', 'lung', 956, 'lung'), ('PR_000005920', 'lambda-crystallin', 1041, 'Crs'), ('UBERON_0003033', 'suprageniculate nucleus of thalamus', 1187, 'NP'), ('UBERON_0010061', 'lumen of nasopharynx', 1191, 'nasopharyngeal cavity'), ('UBERON_0000065', 'respiratory tract', 1219, 'respiratory tract'), ('UBERON_0001004', 'respiratory system', 1340, 'respiratory system'), ('UBERON_0001004', 'respiratory system', 1379, 'respiratory system')]
PMC5340372	3/2017	S59-PMC5340372	['* p <0.05, and ** p < 0.01 comparing “high Cord 25(Oh)D” group.10.1371/journal.pone.0173268.t002\n\ncaption (table-wrap): table 2\ndemographic data, family and environmental data, outcomes, and infant Lung function in groups with different 25(Oh)D status of maternal Serum.low maternal 25(Oh)D (n = 36)high maternal 25(Oh)d (n = 35) demographic data Gestational age (weeks)38.4 ± 1.238.8 ± 1.3male (%)5049nature Delivery (%)6662birth bw (kg)3.1 ± 0.33.2 ± 0.4birth bl (cm)50.6 ± 2.150.4 ± 2.5bw (kg)8.3 ± 1.18.1± 1.0bl (cm)69.0 ± 2.868.6 ± 3.3% of fall/winter Birth38.951.4 family and environmental data asthma, mother2.88.6asthma, father2.80ar mother22.231.4ar, father30.631.4ad, mother13.98.6ad, father02.8daycare attendance (%)11.114.3maternal smoke in Pregnancy (%)8.32.8postnatal smoke exposure (%)41.637.1 outcomes np colonization rate (%)69.766.7ever rti till 6 months (%)25.022.8eczema at 6 months (%)1720ever wheeze at 6 months (%)2523 infant Lung function % of tpef/te< 0.2259z score of rrs-0.04 ± 0.33-0.04 ± 0.39z score of Crs-0.03 ± 1.13-0.39 ± 1.08z score of vmaxfrc0.07 ± 1.01-0.24 ± 1.09\nbw, body weight; bl, body length; ar, allergic rhinitis; ad, atopic dermatitis; Np, Nasopharyngeal Cavity; rti, Respiratory Tract infection, tpef/te, ratio of time to peak expiratory flow to total expiratory time; rrs, resistance of Respiratory System; crs, compliance of Respiratory System; vmaxfrc, maximal Expiratory flow at functional residual capacity.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 43, 'cord'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D'), ('UBERON_0002048', 'lung', 198, 'lung'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 283, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 313, '25(OH'), ('GO_0007565', 'female pregnancy', 347, 'Gestational'), ('GO_0007567', 'parturition', 409, 'delivery'), ('GO_0007567', 'parturition', 557, 'birth38'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy'), ('UBERON_0002048', 'lung', 949, 'lung'), ('PR_000005920', 'lambda-crystallin', 1032, 'Crs'), ('UBERON_0003033', 'suprageniculate nucleus of thalamus', 1181, 'NP'), ('UBERON_0010061', 'lumen of nasopharynx', 1185, 'nasopharyngeal cavity'), ('UBERON_0000065', 'respiratory tract', 1213, 'respiratory tract'), ('UBERON_0001004', 'respiratory system', 1334, 'respiratory system'), ('UBERON_0001004', 'respiratory system', 1373, 'respiratory system'), ('GO_0010467', 'gene expression', 1410, 'expiratory')]
PMC5340372	3/2017	S61-PMC5340372	['examinations of infant Lung function were successfully performed for 71 infants at 6 months of age.']	N/A	N/A	[('UBERON_0002048', 'lung', 23, 'lung')]
PMC5340372	3/2017	S66-PMC5340372	['at the time of the Lung function testing, the mean body weight was 8.3 ± 1.0 kg, and the mean body length was 68.6 ± 3.0 cm.']	N/A	N/A	[('UBERON_0002048', 'lung', 19, 'lung')]
PMC5340372	3/2017	S76-PMC5340372	['among the 71 infants who underwent infant Lung function testing, bacterial cultures from Nasopharyngeal specimens were taken from 66 infants, with a positive culture rate of 68.2% (45/66).']	N/A	N/A	[('UBERON_0002048', 'lung', 42, 'lung'), ('UBERON_0011692', 'enameloid', 89, 'nasopharyngeal')]
PMC5340372	3/2017	S80-PMC5340372	['based on the Lung function and outcome of the analysis intable 1, we had then used those relatively significant variables (p ≤ 0.1) to determine independent predictors with multivariate linear or logistical regression.']	N/A	N/A	[('UBERON_0002048', 'lung', 13, 'lung')]
PMC5340372	3/2017	S111-PMC5340372	['several tests, including the analysis of tidal breathing, mechanics of Respiratory System, flow-volume curves of forced expiration, and measurement of Lung volume, were used to evaluate Respiratory function.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 71, 'respiratory system'), ('UBERON_0002048', 'lung', 151, 'lung'), ('GO_0045333', 'cellular respiration', 186, 'respiratory'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]
PMC5340372	3/2017	S115-PMC5340372	['during resistance measurements, which include intra, extrathoracic, and Pulmonary resistance, the extrathoracic Airway resistance dominates in obligatory Nasal breathing infants [42].']	N/A	N/A	[('UBERON_0002048', 'lung', 72, 'pulmonary'), ('UBERON_0001005', 'respiratory airway', 112, 'airway'), ('UBERON_0000004', 'nose', 154, 'nasal')]
PMC5350159	3/2017	S29-PMC5350159	['additional secondary endpoints included: Il‐6 in Bronchial Alveolar Lavage Fluid (Balf), differential cell counts, total protein, and Lung histology.']	N/A	N/A	[('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 41, 'IL'), ('PR_000017511', "5'-3' exoribonuclease 1", 44, '6'), ('UBERON_0006338', 'lateral ventricle choroid plexus stroma', 49, 'bronchial alveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 82, 'BALF'), ('UBERON_0002048', 'lung', 134, 'lung')]
PMC5350159	3/2017	S46-PMC5350159	['Lung mechanics and Cholinergic challenge\nMice received an Intraperitoneal injection of Ketamine (100\xa0mg/kg) and xylazine (10\xa0mg/kg).']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_15355', 'acetylcholine', 19, 'cholinergic'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'Mice'), ('UBERON_2001932', 'sensory canal tubular ossicle', 58, 'intraperitoneal'), ('CHEBI_6121', 'ketamine', 87, 'ketamine')]
PMC5350159	3/2017	S56-PMC5350159	['reproducible Breaths were selected for Lung mechanics analysis.']	N/A	N/A	[('UBERON_0000310', 'breast', 13, 'breaths'), ('UBERON_0002048', 'lung', 39, 'lung')]
PMC5350159	3/2017	S68-PMC5350159	['Lung histology\nLung Anatomy was studied by uniformly inflating the whole Lung with a Mixture of 4% paraformaldehyde (pfa) and 1% low melt Agarose.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0002048', 'lung', 15, 'Lung'), ('UBERON_0001062', 'anatomical entity', 20, 'anatomy'), ('UBERON_0002048', 'lung', 73, 'lung'), ('CHEBI_60004', 'mixture', 85, 'mixture'), ('CHEBI_2511', 'agarose', 138, 'agarose')]
PMC5350159	3/2017	S69-PMC5350159	['inflated Lungs were fixed in 4% pfa overnight and then stored in 70% Ethanol until paraffin block embedding.']	N/A	N/A	[('UBERON_0002048', 'lung', 9, 'lungs'), ('CHEBI_16236', 'ethanol', 69, 'ethanol')]
PMC5350159	3/2017	S70-PMC5350159	['prior to embedding, the Lung was bisected in the coronal plane.']	N/A	N/A	[('UBERON_0002048', 'lung', 24, 'lung')]
PMC5350159	3/2017	S72-PMC5350159	["sections were stained with masson's Trichrome for microscopic assessment of Lung morphology by two blinded investigators."]	N/A	N/A	[('CHEBI_49106', 'oxepane', 36, 'trichrome'), ('UBERON_0002048', 'lung', 76, 'lung')]
PMC5350159	3/2017	S140-PMC5350159	['caption (fig): figure 4\n\n(a) Lung sections from diet cohorts do not show overt inflammation or gross structural changes.']	N/A	N/A	[('UBERON_0002048', 'lung', 29, 'Lung')]
PMC5350159	3/2017	S141-PMC5350159	["representative images of masson's Trichrome stained Lungs (40x)."]	N/A	N/A	[('CHEBI_49106', 'oxepane', 34, 'trichrome'), ('UBERON_0002048', 'lung', 52, 'lungs')]
PMC5350159	3/2017	S201-PMC5350159	['in our model, offspring did not have significantly different body masses between cohorts at the time of testing we elected to leave the Thorax closed during Lung mechanics testing.']	N/A	N/A	[('UBERON_0000915', 'thoracic segment of trunk', 136, 'thorax'), ('UBERON_0002048', 'lung', 157, 'lung')]
PMC5350159	3/2017	S208-PMC5350159	['Allergen sensitization induces ahr and Lung inflammation resulting in Airway hyperplasia and Eosinophilia (boyce and austen2005).']	N/A	N/A	[('CHEBI_59132', 'antigen', 0, 'Allergen'), ('UBERON_0002048', 'lung', 39, 'lung'), ('UBERON_0001005', 'respiratory airway', 70, 'airway'), ('CL_0000771', 'eosinophil', 93, 'eosinophilia')]
PMC5357333	3/2017	S47-PMC5357333	['her medical history was negative for hypertension and diabetes, and negative for Thyroid, Heart, Lung, or Kidney disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 81, 'thyroid'), ('UBERON_0000948', 'heart', 90, 'heart'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC5405075	4/2017	S61-PMC5405075	['(75)denmark 2009–2010623 mother–child pairs recruited from copsac2010cohort study double-blinded Placebo\u2009+\u2009400\u2009iu ( n \u2009=\u2009308)Cholecalciferol 2,400\u2009+\u2009400\u2009iu ( n \u2009=\u2009315)581/3\u2009yearsmothers: 24\u2009weeks of Gestation to 1\u2009week after deliveryincrease in maternal Serum vitd level in treatment group (mean sd at randomization vs Postpartum: 31 vs 43; control group 31 vs 29)mean group difference 13 [95% ci 11–16, p \u2009<\u20090.001]persistent wheeze, asthma, urti, lrti, episodes of Lung symptoms, spt, specific igeno significant reduction in the risk of persistent wheezing per 4\u2009ng/ml increase in maternal Serum Vitamin D level (hr: 0.86, 95% ci 0.89–0.99 p \u2009=\u20090.03)reduced number of troublesome Lung episodes (irr: 0.83, 95% ci 0.71–0.97 p \u2009=\u20090.02)upregulation or Airway Immune profile (principal component analysis p \u2009=\u20090.04)no effect on additional end pointslitonjua et al.']	N/A	N/A	[('CHEBI_8246', 'Pirbuterol acetate', 97, 'Placebo'), ('CHEBI_16113', 'cholesterol', 125, 'Cholecalciferol'), ('GO_0007565', 'female pregnancy', 199, 'gestation'), ('UBERON_0001977', 'blood serum', 254, 'serum'), ('GO_0007565', 'female pregnancy', 319, 'postpartum'), ('UBERON_0002048', 'lung', 466, 'lung'), ('UBERON_0001977', 'blood serum', 591, 'serum'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin D'), ('UBERON_0002048', 'lung', 681, 'lung'), ('UBERON_0001005', 'respiratory airway', 750, 'airway'), ('UBERON_0002405', 'immune system', 757, 'immune')]
PMC5405075	4/2017	S70-PMC5405075	['pertaining to secondary outcomes, the number of troublesome Lung symptoms was significant lower in children of the intervention arm.']	N/A	N/A	[('UBERON_0002048', 'lung', 60, 'lung')]
PMC5441441	4/2017	S57-PMC5441441	['diagnostic criteria\ndyslipidemia was diagnosed according to the criteria of the national Cholesterol education program (1992) for tc and Ldl-C and us national institutes of health Heart, Lung, and Blood institute (expert panel on integrated guidelines for Cardiovascular health and risk reduction in children and adolescents, 2011) for Hdl-C and tag.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 89, 'Cholesterol'), ('PR_000009780', 'legumain', 137, 'LDL-C'), ('UBERON_0000948', 'heart', 180, 'Heart'), ('UBERON_0002048', 'lung', 187, 'Lung'), ('UBERON_0000178', 'blood', 197, 'Blood'), ('UBERON_0004535', 'cardiovascular system', 256, 'Cardiovascular'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 336, 'HDL-C')]
PMC5472316	6/2017	S68-PMC5472316	['basal vital Organs such as Liver, Heart, Lungs, Spleen, Stomach, Kidneys, and Brain were isolated and weighted.']	N/A	N/A	[('UBERON_0000062', 'organ', 12, 'organs'), ('UBERON_0002107', 'liver', 27, 'liver'), ('UBERON_0000948', 'heart', 34, 'heart'), ('UBERON_0002048', 'lung', 41, 'lungs'), ('UBERON_0002106', 'spleen', 48, 'spleen'), ('UBERON_0000945', 'stomach', 56, 'stomach'), ('UBERON_0002113', 'kidney', 65, 'kidneys'), ('UBERON_0000955', 'brain', 78, 'brain')]
PMC5472316	6/2017	S164-PMC5472316	['moreover, Hmb given to sows during Pregnancy increased the weight of the Liver, Lung, and Stomach.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 10, 'HMB'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('UBERON_0002107', 'liver', 73, 'liver'), ('UBERON_0002048', 'lung', 80, 'lung'), ('UBERON_0000945', 'stomach', 90, 'stomach')]
PMC5485024	3/2017	S168-PMC5485024	['funding\nthis study was supported by the swedish research council, the swedish Heart‐Lung foundation, the stockholm county council (alf), the swedish research council for health working life and welfare, the swedish environmental protection agency, the swedish asthma and allergy foundation, the sfo (strategic research area) epidemiology program at karolinska institutet and mechanisms of the development of allergy (medall), a seventh framework programme project (eu grant agreement number 261357).']	N/A	N/A	[('UBERON_0000948', 'heart', 78, 'Heart'), ('UBERON_0002048', 'lung', 84, 'Lung')]
PMC5504744	7/2017	S39-PMC5504744	['subsequently, Spleen, Kidneys, Heart, Lungs, Liver and Brain were removed and weighed.']	N/A	N/A	[('UBERON_0002106', 'spleen', 14, 'spleen'), ('UBERON_0002113', 'kidney', 22, 'kidneys'), ('UBERON_0000948', 'heart', 31, 'heart'), ('UBERON_0002048', 'lung', 38, 'lungs'), ('UBERON_0002107', 'liver', 45, 'liver'), ('UBERON_0000955', 'brain', 55, 'brain')]
PMC5504744	7/2017	S108-PMC5504744	['compared with l-Piglets, m-Piglets Born from sows Fed the arg, but not the ctrl diet, had heavier stm (l-arg = 2.679 vs. m-arg = 3.401 g), pm (l-arg = 2.840 vs. m-arg = 3.547 g), Hearts (l-arg = 8.387 vs. m-arg = 9.538 g), Livers (l-Arg = 33.87 vs. m-arg = 41.07 g), Spleens (l-arg = 1.07 vs. m-arg = 1.42 g), Lungs (l-arg = 17.00 vs. m-arg = 19.90 g) and Kidneys (l-arg = 9.66 vs. m-arg = 12.00 g).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 16, 'piglets'), ('NCBITaxon_33208', 'Metazoa', 27, 'piglets'), ('GO_0007567', 'parturition', 35, 'born'), ('GO_0007631', 'feeding behavior', 50, 'fed'), ('UBERON_0000948', 'heart', 179, 'hearts'), ('UBERON_0002107', 'liver', 223, 'livers'), ('UBERON_0001885', 'dentate gyrus of hippocampal formation', 233, 'ARG'), ('UBERON_0002367', 'prostate gland', 267, 'spleens'), ('UBERON_0002048', 'lung', 310, 'lungs'), ('UBERON_0002113', 'kidney', 356, 'kidneys')]
PMC5504744	7/2017	S113-PMC5504744	['finally, males and females differed ( p< 0.05) in absolute weights of Liver (34.18 vs. 36.73 g), Lung weight (18.80 vs. 17.82 g) and relative Heart weight (0.69 vs. 0.66 g/100 g btw).']	N/A	N/A	[('UBERON_0002107', 'liver', 70, 'liver'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0000948', 'heart', 142, 'heart')]
PMC5521778	7/2017	S0-PMC5521778	['inhibition of Pulmonary Β-Carotene 15, 15’-oxygenase Expression by Glucocorticoid involves Pparα\n\nabstract\nΒ-Carotene 15,15’-oxygenase (bco1) catalyzes the first step in the conversion of dietary Provitamin A Carotenoids to Vitamin A.']	N/A	N/A	[('UBERON_0002048', 'lung', 14, 'pulmonary'), ('CHEBI_68219', 'aspergillusene B', 24, 'β-carotene 15, 15’-'), ('GO_0010467', 'gene expression', 53, 'expression'), ('CHEBI_24261', 'glucocorticoid', 67, 'glucocorticoid'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 91, 'PPARα'), ('CHEBI_68219', 'aspergillusene B', 107, 'β-carotene 15,15’-'), ('CHEBI_70584', 'Pulicatin A', 196, 'provitamin A'), ('CHEBI_50815', 'norgestimate', 209, 'carotenoids'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin A')]
PMC5521778	7/2017	S3-PMC5521778	['a balance between the actions of Retinoids and Glucocorticoids (gcs) promotes normal Lung Development and, in particular, Alveolarization.']	N/A	N/A	[('CHEBI_26537', 'retinoid', 33, 'retinoids'), ('CHEBI_36597', 'phthalazine', 47, 'glucocorticoids'), ('GO_0030324', 'lung development', 85, 'lung development'), ('UBERON_0002048', 'lung', 85, 'lung'), ('GO_0048286', 'lung alveolus development', 122, 'alveolarization'), ('UBERON_0022234', 'medial longitudinal stria', 122, 'alveolarization')]
PMC5521778	7/2017	S16-PMC5521778	['g ., Liver, Lung, Adipose) [3].']	N/A	N/A	[('UBERON_0002107', 'liver', 5, 'liver'), ('UBERON_0002048', 'lung', 12, 'lung'), ('UBERON_2000251', 'adipose fin', 18, 'adipose')]
PMC5521778	7/2017	S20-PMC5521778	['in Mammals, Pulmonary Vitamin A is accumulated in Lipid Interstitial Cells (Lipofibroblasts) located in the Periacinar fetal Lung during late Gestation and is mobilized during the Perinatal burst in Air Sac (Alveolar) remodeling and differentiation [12].']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('UBERON_0002048', 'lung', 12, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_18059', 'lipid', 50, 'lipid'), ('CL_0002295', 'type-6 epithelial cell of thymus', 50, 'lipid interstitial cells'), ('UBERON_0005169', 'interstitial tissue', 56, 'interstitial'), ('CL_0000057', 'fibroblast', 76, 'lipofibroblasts'), ('UBERON_0001179', 'peritoneal cavity', 108, 'periacinar'), ('UBERON_0002048', 'lung', 125, 'lung'), ('GO_0007565', 'female pregnancy', 142, 'gestation'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('UBERON_0001005', 'respiratory airway', 199, 'air sac'), ('UBERON_0003215', 'alveolus', 208, 'alveolar')]
PMC5521778	7/2017	S23-PMC5521778	['neonatal or Antenatal Vitamin A supplementation either for preterm infants or Vitamin A deficient Pregnant women improves Vitamin A status and Pulmonary function and mitigates chronic Lung disease [16,17].']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'antenatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin A'), ('GO_0007565', 'female pregnancy', 98, 'pregnant'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0002048', 'lung', 143, 'pulmonary'), ('UBERON_0002048', 'lung', 184, 'lung')]
PMC5521778	7/2017	S38-PMC5521778	['gcs also are an adjunct treatment in preterm infants with chronic Lung disease [28] and in children and Adults who have Respiratory compromise from asthmatic, fibrotic, and inflammatory conditions [29–31].']	N/A	N/A	[('UBERON_0002048', 'lung', 66, 'lung'), ('UBERON_0007023', 'adult organism', 104, 'adults'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory')]
PMC5521778	7/2017	S44-PMC5521778	['we report that Human Lung Tissue and a549 cells Express bco1 and Metabolize Β-Carotene to biologically active ra Isomers.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 15, 'human'), ('UBERON_0002048', 'lung', 21, 'lung'), ('UBERON_0000479', 'tissue', 26, 'tissue'), ('GO_0010467', 'gene expression', 48, 'express'), ('GO_0008152', 'metabolic process', 65, 'metabolize'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 76, 'β-carotene'), ('SO_0001060', 'sequence_variant', 113, 'isomers')]
PMC5521778	7/2017	S118-PMC5521778	['as shown infig 1a, the ~2.5 kb Bco1 mrna is readily detected in Human Heart, Skeletal muscle, Kidney, Liver, Placenta, and Lung.10.1371/journal.pone.0181466.g001\n\ncaption (fig): fig 1\nExpression of Bco1 in Human Lung Tissues and a variety of Human cell lines.']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 31, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0000948', 'heart', 70, 'heart'), ('UBERON_0004288', 'skeleton', 77, 'skeletal'), ('UBERON_0002113', 'kidney', 94, 'kidney'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 109, 'placenta'), ('UBERON_0002048', 'lung', 123, 'lung'), ('GO_0010467', 'gene expression', 184, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 198, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 206, 'human'), ('UBERON_0002048', 'lung', 212, 'lung'), ('UBERON_0000479', 'tissue', 217, 'tissues'), ('NCBITaxon_9606', 'Homo sapiens', 242, 'human')]
PMC5521778	7/2017	S273-PMC5521778	['g ., during Alveolar Formation, differentiation, and Lung Repair.']	N/A	N/A	[('GO_0097290', 'alpha-ribazole biosynthetic process', 12, 'alveolar formation'), ('UBERON_0003215', 'alveolus', 12, 'alveolar'), ('GO_0060431', 'primary lung bud formation', 53, 'lung repair'), ('UBERON_0002048', 'lung', 53, 'lung')]
PMC5521778	7/2017	S274-PMC5521778	['both Retinoids and Glucocorticoids are chief regulators of Pulmonary growth and function.']	N/A	N/A	[('CHEBI_26537', 'retinoid', 5, 'retinoids'), ('CHEBI_36597', 'phthalazine', 19, 'glucocorticoids'), ('UBERON_0002048', 'lung', 59, 'pulmonary')]
PMC5521778	7/2017	S279-PMC5521778	['dex is known to increase Pparα mrna and protein levels in Liver Cells [45,46], Kidney [47], and Lung Tissue [48,49].']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 25, 'PPARα'), ('CL_0000592', 'large luteal cell', 58, 'liver cells'), ('UBERON_0002107', 'liver', 58, 'liver'), ('UBERON_0002113', 'kidney', 79, 'kidney'), ('UBERON_0002048', 'lung', 96, 'lung'), ('UBERON_0000479', 'tissue', 101, 'tissue')]
PMC5537520	8/2017	S23-PMC5537520	['Cardiogenic causes of Lung changes (eg, Left Ventricular failure, non-shock) would also fit.']	N/A	N/A	[('GO_0051216', 'cartilage development', 0, 'Cardiogenic'), ('UBERON_0002048', 'lung', 22, 'lung'), ('UBERON_0002084', 'heart left ventricle', 40, 'left ventricular')]
PMC5537520	8/2017	S71-PMC5537520	['indeed many infants have no evidence of Cd68 or Cd54 cells in their Lungs or other Tissues.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 40, 'CD68'), ('PR_000001309', 'CD70 molecule', 48, 'CD54'), ('UBERON_0002048', 'lung', 68, 'lungs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
PMC5540678	7/2017	S33-PMC5540678	['Lung function was measured by spirometry (vitalograph 2120; vitalograph, maids moreton, uk) at age 8.5\u2005years after withholding short-acting bronchodilators for at least 6\u2005h and long-acting Bronchodilators and theophyllines for at least 24\u2005h. the best of three reproducible flow–volume curves was used to measure forced expiratory volume in 1\u2005s (fev1), forced vital capacity (fvc) and maximal mid-expiratory flow (forced expiratory flow at 25–75% of fvc (fef25–75)), which were further transformed to age-, height- and sex-adjusted standard deviation units [17].']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_22928', 'bromine molecular entity', 189, 'bronchodilators')]
PMC5540678	7/2017	S66-PMC5540678	["caption (table-wrap): table\xa01\n\ncharacteristics of mothers and offspring who had information on at least one of the outcomes of interest (wheeze, asthma, atopy, eczema, hay fever, total Ige and Lung function) by maternal Free Sugar intake during Pregnancy#free Sugar intake g·day−1p-valuequintile 1(1.6–34.0)quintile 2(34.0–46.6)quintile 3(46.6–60.8)quintile 4(60.8–82.4)quintile 5(82.4–345.1)mother's age years 29.4±4.729.1±4.529.2±4.628.9±4.527.9±4.7<0.001 parity \u2003043.246.148.644.944.00.001\u2003135.437.235.136.335.9\u2003≥221.416.716.318.820.0 sex of child \u2003male51.252.350.552.349.50.39\u2003female48.847.749.547.750.5 multiple Pregnancy \u2003singleton97.396.798.098.397.30.01\u2003twin2.73.32.01.72.7 season of Birth \u2003winter15.017.616.615.716.0<0.001\u2003spring23.625.326.829.130.7\u2003summer33.129.331.828.927.1\u2003autumn28.327.824.926.426.2 breastfeeding duration months \u2003never21.318.917.522.127.1<0.001\u2003<334.030.030.129.234.2\u20033–613.114.914.613.312.8\u2003≥631.536.337.435.425.9 mother's educational level \u2003certificate of secondary education16.712.913.414.520.4<0.001\u2003vocational8.69.28.18.510.8\u2003ordinary level36.235.032.835.138.8\u2003advanced level24.626.626.326.021.2\u2003degree14.016.219.415.98.9 maternal ethnicity \u2003white97.897.298.598.498.80.003\u2003non-white2.22.81.51.61.2 housing tenure \u2003owned/mortgaged82.686.586.585.176.8<0.001\u2003council rented9.97.26.68.815.8\u2003non-council rented7.56.37.06.17.5 financial difficulties \u2003no82.682.884.385.378.8<0.001\u2003yes17.417.215.714.721.2 maternal history of atopic diseases \u2003no32.232.033.731.428.90.05\u2003yes67.868.066.368.671.1 maternal anxiety score during Pregnancy \u20030–924.023.423.120.814.3<0.001\u200310–1425.127.525.726.124.3\u200315–2024.425.127.327.125.4\u2003≥2026.524.124.026.136.1 maximum maternal tobacco exposure cigarettes·day−1 \u2003none27.827.628.928.219.2<0.001\u2003passive only45.448.547.346.042.3\u20031–97.67.78.18.08.1\u200310–1912.510.19.410.115.2\u2003≥206.76.26.27.715.2 maternal Paracetamol use during Pregnancy \u2003no38.038.037.738.036.40.86\u2003yes62.062.062.362.063.6 maternal Antibiotic use during Pregnancy \u2003no83.785.484.083.782.90.34\u2003yes16.314.616.016.317.1 maternal Supplement use during Pregnancy \u2003no44.543.144.441.941.60.26\u2003yes55.556.955.658.158.4 maternal infections during Pregnancy \u2003no57.255.155.853.349.3<0.001\u2003yes42.844.944.246.750.7 total energy intake kj·day−15567±13766499±13267166±13607931±14889317±1994<0.001 maternal pre-Pregnancy bmi kg·m−2 \u2003<18.502.72.84.44.08.1<0.001\u200318.50–24.9970.874.377.776.777.4\u200325.00–29.9917.717.113.514.811.6\u2003≥30.008.85.84.44.52.9 Birthweight g \u2003<25004.24.03.64.35.60.02\u20032500–299914.213.213.912.815.2\u20033000–349934.834.935.136.735.6\u20033500–399932.233.633.533.633.0\u2003≥400014.714.413.812.611.0 Gestational age weeks 39.4±1.839.5±1.739.5±1.739.5±1.839.4±1.90.28 child's bmi at age 7 \u2005 years kg·m−2 \u2003<15.0025.826.330.327.730.7<0.001\u200315.00–17.4951.952.351.254.452.6\u200317.50–20.4917.216.614.214.313.6\u2003≥20.505.24.84.33.53.1 maternal weight gain during Pregnancy \u2003quartile 130.323.724.523.524.5<0.001\u2003quartile 224.325.025.124.725.0\u2003quartile 324.227.026.326.423.4\u2003quartile 421.324.324.125.427.1\ndata are presented as mean±sdor %, unless otherwise stated."]	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 185, 'IgE'), ('UBERON_0002048', 'lung', 193, 'lung'), ('CHEBI_37958', 'dye', 220, 'free'), ('CHEBI_24870', 'ion', 225, 'sugar'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy'), ('CHEBI_24870', 'ion', 260, 'sugar'), ('GO_0007565', 'female pregnancy', 617, 'pregnancy'), ('GO_0007567', 'parturition', 692, 'birth'), ('GO_0007565', 'female pregnancy', 1552, 'pregnancy'), ('CHEBI_46195', 'paracetamol', 1858, 'paracetamol'), ('GO_0007565', 'female pregnancy', 1881, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 1952, 'antibiotic'), ('GO_0007565', 'female pregnancy', 1974, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 2045, 'supplement'), ('GO_0007565', 'female pregnancy', 2067, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2156, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2313, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 2449, 'Birthweight'), ('GO_0007565', 'female pregnancy', 2605, 'Gestational'), ('GO_0007565', 'female pregnancy', 2856, 'pregnancy')]
PMC555773	9/2004	S230-PMC555773	['Pulmonary Arterial hypertension (pah) is a disease of the Pulmonary Vasculature leading to vasoconstriction and remodeling of the Pulmonary Arteries.']	N/A	N/A	[('UBERON_0002012', 'pulmonary artery', 0, 'Pulmonary arterial'), ('UBERON_0002048', 'lung', 58, 'pulmonary'), ('UBERON_0002049', 'vasculature', 68, 'vasculature'), ('UBERON_0002012', 'pulmonary artery', 130, 'pulmonary arteries')]
PMC555773	9/2004	S232-PMC555773	['No administration restored the stroke volume with a decrease in pah and an improvement of the Pulmonary vascular resistance to systemic vascular resistance ratio.']	N/A	N/A	[('CHEBI_16382', 'iodide', 0, 'NO'), ('UBERON_0002048', 'lung', 94, 'pulmonary')]
PMC5634602	10/2017	S74-PMC5634602	['there were no significant differences in adverse outcomes between the two groups for hyperbilirubenimia requiring phototherapy (15 in each dose group p = 1), need for chronic Diuretics (2 in each dose group, p = 1), or chronic Lung disease (400 iu group 6, 800 iu 3, p = 0.43).']	N/A	N/A	[('CHEBI_35498', 'diuretic', 175, 'diuretics'), ('UBERON_0002048', 'lung', 227, 'lung')]
PMC5659607	10/2017	S36-PMC5659607	['in addition, symptoms between visits were captured with daily diary cards monitoring: (1) troublesome Lung symptoms, including components of cough, wheeze, and dyspnea; (2) skin symptoms; and (3) Respiratory infections.']	N/A	N/A	[('UBERON_0002048', 'lung', 102, 'lung'), ('UBERON_0001004', 'respiratory system', 196, 'respiratory')]
PMC5659607	10/2017	S46-PMC5659607	['in copsac2010, the children were diagnosed during the clinical visits based on the daily symptom recordings, according to a previously validated quantitative symptom algorithm requiring all of the following criteria[19,20]: (1) five episodes of troublesome Lung symptoms within 6 months, each lasting at least 3 consecutive days; (2) symptoms typical of asthma including exercise induced symptoms, prolonged nocturnal cough, and persistent cough outside common cold; (3) need for intermittent rescue use of inhaled β2-Agonist; and (4) response to a 3-month course of Inhaled Corticosteroids and relapse upon ended treatment[19].']	N/A	N/A	[('UBERON_0002048', 'lung', 257, 'lung'), ('CHEBI_86099', '1-[(9Z,12Z)-octadecadienoyl]-2-hexadecanoyl-sn-glycero-3-phosphocholine', 517, '-agonist'), ('CHEBI_38959', 'diphenyl sulfide', 567, 'inhaled'), ('CHEBI_50850', 'etabonate ester', 575, 'corticosteroids')]
